data_2ll8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ll8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG21 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.578 ' HB ' HG21 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.637 HD13 HD13 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 1.3 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.637 HD13 HD13 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.531 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.405 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HA ' HG21 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD11 HD13 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD22 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.345 -0.359 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.544 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HG2' HG13 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG12 HD22 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.42 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.676 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD22 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG13 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.676 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.492 HG12 HD22 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 51' ' ' PHE . 37.0 m . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' HD13 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.698 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.698 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.425 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.439 ' HA ' HG21 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 70' ' ' THR . 77.7 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD11 HD12 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' SG ' HD13 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HA ' HD13 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.615 HD21 HD11 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 HD13 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 HD21 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 59' ' ' LYS . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 HD13 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 85' ' ' ASP . 14.4 m . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.416 HG21 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HB ' HG21 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HA ' HD11 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.806 HD13 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.52 HG12 HD23 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.426 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.412 HD11 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.426 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.412 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD23 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.487 ' HA ' HD12 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB2' HG22 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.3 m . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HD13 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.531 HD13 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.523 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.556 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.441 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG2' HG11 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.426 HG12 HD12 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' HD11 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 9.1 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD13 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HG2' HG11 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.472 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' ILE . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.449 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' HZ1' ' A' ' 78' ' ' LYS . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.523 HD12 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.659 -0.21 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG11 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.156 -0.449 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HG2' ' HZ2' ' A' ' 78' ' ' LYS . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD12 HD13 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HA ' HD11 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' HG21 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 HD13 HD12 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.8 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' HG3' HG21 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.475 HG21 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.558 HD12 HD12 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 72' ' ' GLU . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.558 HD12 HD12 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.525 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HG ' ' HB3' ' A' ' 39' ' ' ASP . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' HD13 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 HD13 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 16' ' ' CYS . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 57' ' ' LEU . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HZ1' ' HB3' ' A' ' 54' ' ' LYS . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 44' ' ' ALA . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.732 HD13 HD12 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.512 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.563 HD12 HD21 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.55 HG12 HD11 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.596 HD11 HD13 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.46 HD12 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.55 HD11 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.596 HD13 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.485 HG12 HD23 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -152.89 119.11 5.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.362 1.065 . . . . 0.0 108.562 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -82.75 176.34 9.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.084 0.554 . . . . 0.0 110.973 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -55.96 -42.54 76.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG21 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.578 ' HB ' HG21 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' HG3' HG22 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.637 HD13 HD13 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG23 ' HB2' ' A' ' 91' ' ' LYS . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 1.3 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.637 HD13 HD13 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.67 69.24 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HB2' HG23 ' A' ' 53' ' ' ILE . 59.8 tttp -65.08 -36.48 84.46 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.842 0.857 . . . . 0.0 110.564 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.76 5.95 80.05 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.456 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.2 5.01 1.79 Allowed 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.386 1.474 . . . . 0.0 114.129 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' A' ' 89' ' ' ALA . 86.0 mt 48.1 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.158 0.983 . . . . 0.0 113.22 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.1 -14.48 1.16 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.83 0.852 . . . . 0.0 110.035 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -104.76 14.55 29.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.363 0.665 . . . . 0.0 110.296 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.1 m80 68.28 165.73 0.24 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.019 1.327 . . . . 0.0 112.033 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.44 ' HA ' HD11 ' A' ' 94' ' ' LEU . 26.6 t-80 -72.39 -80.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.926 0.49 . . . . 0.0 109.824 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -89.03 -67.89 0.81 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.28 -29.37 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.463 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.423 H302 ' O25' ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 m -145.49 88.47 1.86 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.954 0.407 . . . . 0.0 110.682 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.6 p -105.93 179.26 4.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.568 0.747 . . . . 0.0 109.569 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -57.81 -42.81 85.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.993 0.517 . . . . 0.0 110.488 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.405 HG12 HD12 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.675 HD13 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.531 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.405 HD12 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.405 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.43 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HA ' HG21 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD11 HD13 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD22 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.95 -51.85 42.82 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -48.15 -29.98 4.17 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.211 1.004 . . . . 0.0 112.686 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.43 -38.24 7.78 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 112.282 -0.327 . . . . 0.0 112.282 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.28 -31.75 55.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.286 1.034 . . . . 0.0 113.362 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.43 HD22 ' HD2' ' A' ' 99' ' ' HIS . 38.6 mt -84.93 84.92 7.55 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.884 0.849 . . . . 0.0 109.75 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.3 mt-10 -90.02 -175.3 4.53 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.903 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -64.84 98.47 0.28 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.067 0.547 . . . . 0.0 110.095 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t60 73.5 1.37 3.94 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.095 1.758 . . . . 0.0 111.677 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 70.8 m80 -99.32 131.67 45.17 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.879 0.872 . . . . 0.0 109.666 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.43 ' HD2' HD22 ' A' ' 94' ' ' LEU . 45.6 m80 -118.66 82.9 1.93 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 77.89 -45.77 0.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.873 1.669 . . . . 0.0 112.94 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.909 0.884 . . . . 0.0 109.832 -175.078 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 74.4 p 47.76 82.11 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.498 1.519 . . . . 0.0 113.632 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -77.63 125.8 29.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 m -58.45 -48.52 80.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.601 0.563 . . . . 0.0 111.65 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.544 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.626 HD13 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.494 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.418 HG22 H303 ' A' ' 102' ' ' PNS . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HG2' HG13 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.446 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG12 HD22 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.67 -30.6 70.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -85.57 -39.4 17.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.909 . . . . 0.0 110.52 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.58 -47.61 2.94 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.502 -166.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -9.3 59.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.573 0.749 . . . . 0.0 111.609 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt 59.44 -166.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.374 1.07 . . . . 0.0 112.084 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . 47.1 mt-10 -88.63 -50.49 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.1 m170 54.42 78.78 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.591 1.157 . . . . 0.0 112.284 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.436 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 18.3 m-70 -107.27 -78.95 0.58 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -154.87 115.64 3.94 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 m80 62.44 -157.52 0.33 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.93 0.892 . . . . 0.0 109.503 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 64.25 -162.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.535 0.734 . . . . 0.0 111.247 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.119 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.456 H312 HD11 ' A' ' 41' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.0 m -100.64 117.15 34.19 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -62.92 136.45 57.85 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 HG23 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m -57.83 -34.21 69.44 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.298 0.639 . . . . 0.0 111.501 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.676 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.491 HD13 HG22 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD22 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG13 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.676 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.492 HG12 HD22 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -33.22 74.06 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.1 -39.35 60.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.497 0.719 . . . . 0.0 109.979 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.08 -63.17 2.74 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.267 -0.741 . . . . 0.0 111.721 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 160.14 1.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.844 2.057 . . . . 0.0 110.052 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -75.13 162.48 28.47 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.737 0.815 . . . . 0.0 109.69 -173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 75.56 2.71 3.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.801 1.64 . . . . 0.0 111.159 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m80 64.64 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.49 1.516 . . . . 0.0 111.813 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -78.87 59.06 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.246 1.022 . . . . 0.0 110.44 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -143.02 -177.36 5.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 108.648 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -96.21 148.1 23.07 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -66.22 93.36 0.21 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.541 0.737 . . . . 0.0 109.952 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.856 0.862 . . . . 0.0 109.286 -178.143 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.804 -0.072 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 p -94.79 -20.06 19.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.689 0.795 . . . . 0.0 113.011 -167.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.602 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 34.0 t -156.42 163.93 38.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 0.0 110.46 -172.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 ' CE2' ' A' ' 51' ' ' PHE . 37.0 m -72.46 -37.77 68.43 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' HD13 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB3' HD13 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.698 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.409 ' CE2' HG22 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.698 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.425 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' HA ' HG21 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 70' ' ' THR . 77.7 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD11 HD12 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -21.49 61.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -85.8 -27.7 24.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.845 0.458 . . . . 0.0 110.436 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.42 -7.64 65.01 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.609 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.64 169.22 24.21 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.726 1.21 . . . . 0.0 109.153 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.6 mt -125.28 164.25 20.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.182 0.593 . . . . 0.0 110.318 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.08 137.73 50.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.933 166.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.33 97.73 2.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -155.71 170.89 20.99 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.584 0.707 . . . . 0.0 110.741 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -126.05 -55.55 1.47 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 54.23 74.55 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.632 1.173 . . . . 0.0 109.195 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -54.08 108.23 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.15 0.98 . . . . 0.0 111.705 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.484 ' O25' H301 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.2 t -150.09 -170.72 3.72 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -131.52 149.81 52.38 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.3 m -62.04 -42.26 98.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' SG ' HD13 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HA ' HD13 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.615 HD21 HD11 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 HD13 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 HD21 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 59' ' ' LYS . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.694 HD11 HD13 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.0 -40.78 78.53 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -47.13 60.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.794 0.838 . . . . 0.0 109.622 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.54 -61.97 4.14 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 45.1 63.46 1.74 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.513 1.125 . . . . 0.0 110.889 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.8 18.94 14.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.018 0.927 . . . . 0.0 110.716 -172.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.82 -26.66 36.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.156 0.982 . . . . 0.0 110.597 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 66.48 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.196 1.398 . . . . 0.0 109.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 77.0 -34.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.498 1.519 . . . . 0.0 113.716 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 69.77 101.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.823 1.249 . . . . 0.0 109.844 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -71.79 103.3 3.08 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.068 0.461 . . . . 0.0 110.243 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -67.4 -35.6 79.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.239 0.542 . . . . 0.0 109.832 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.481 1.113 . . . . 0.0 108.66 174.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -160.47 117.34 2.42 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.03 0.532 . . . . 0.0 111.108 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 32.7 t 178.54 172.39 0.73 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 126.172 1.789 . . . . 0.0 108.035 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 85' ' ' ASP . 14.4 m -68.14 -54.19 19.8 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.32 0.509 . . . . 0.0 110.116 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 3' ' ' SER . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.416 HG21 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HB ' HG21 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HA ' HD11 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.806 HD13 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.52 HG12 HD23 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.423 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.49 67.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 52' ' ' GLY . 25.8 ttpp -89.92 -21.09 22.65 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.684 0.794 . . . . 0.0 110.544 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.31 -59.61 1.09 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.773 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 174.62 123.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.459 1.104 . . . . 0.0 110.028 -166.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.1 mt -127.67 38.76 3.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.367 0.667 . . . . 0.0 111.975 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 121.67 30.98 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -177.2 12.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.078 0.951 . . . . 0.0 110.72 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.46 162.88 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.438 1.495 . . . . 0.0 109.45 -166.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.0 t60 90.32 -32.14 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.796 2.038 . . . . 0.0 110.071 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.7 t60 72.79 108.1 0.07 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.442 1.497 . . . . 0.0 112.843 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -147.25 161.45 40.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.228 1.011 . . . . 0.0 109.298 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.0 t60 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.312 1.445 . . . . 0.0 110.828 -174.494 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.753 0.311 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.2 m -73.62 78.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 p -82.78 74.6 9.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.457 0.703 . . . . 0.0 109.782 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m -63.04 -39.86 95.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.968 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.426 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.69 62.53 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.36 -28.38 21.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.025 0.53 . . . . 0.0 109.678 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.18 -15.29 69.75 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.225 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.63 -40.71 28.71 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.843 1.257 . . . . 0.0 112.07 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.5 mt -126.23 -173.45 2.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.908 1.283 . . . . 0.0 108.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.45 -29.17 62.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.577 0.351 . . . . 0.0 110.072 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t60 59.92 19.37 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.632 1.573 . . . . 0.0 112.444 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 66.74 3.41 2.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.909 1.283 . . . . 0.0 112.383 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.38 -26.01 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.685 -0.635 . . . . 0.0 110.081 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.19 128.59 9.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.929 0.892 . . . . 0.0 109.335 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -166.39 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.916 1.286 . . . . 0.0 107.712 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.25 1.13 0 O-C-N 124.283 0.989 . . . . 0.0 109.623 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m -151.71 113.18 4.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.101 0.56 . . . . 0.0 109.936 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.6 p -88.66 -179.36 6.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m -62.32 -38.02 87.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.169 0.588 . . . . 0.0 110.519 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG22 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.426 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.412 HD11 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.425 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD23 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.426 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.412 ' HA ' HG22 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD23 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -28.8 68.43 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -74.0 -41.86 61.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.763 0.825 . . . . 0.0 110.09 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.35 -15.1 59.22 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.183 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.43 -53.18 14.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.699 1.2 . . . . 0.0 112.636 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.05 -167.82 0.12 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 111.706 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -95.62 26.73 3.79 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 111.382 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -131.2 122.97 27.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.304 1.042 . . . . 0.0 108.917 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -60.49 132.82 55.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.5 0.72 . . . . 0.0 110.298 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -81.95 -70.4 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 73.49 -54.67 0.68 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.233 1.413 . . . . 0.0 110.646 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -86.45 -167.49 1.89 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.818 0.847 . . . . 0.0 110.184 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.318 1.447 . . . . 0.0 110.469 179.531 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 t -66.59 98.57 0.52 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.516 1.15 . . . . 0.0 111.239 -173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m -144.38 -179.8 6.76 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.624 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m -51.41 -47.65 62.89 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.149 0.58 . . . . 0.0 112.05 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' HA ' HD12 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB2' HG22 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.24 64.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -90.03 -21.86 22.14 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.747 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.33 -25.44 36.53 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.62 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.89 3.6 25.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.094 0.957 . . . . 0.0 111.52 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.02 -163.84 0.9 Allowed 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.438 0.695 . . . . 0.0 109.429 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.2 129.61 42.79 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.191 0.596 . . . . 0.0 110.256 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -84.4 83.98 7.8 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -136.32 125.03 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.386 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -105.59 158.21 16.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 108.97 171.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -64.0 -41.78 97.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -168.12 -39.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.431 1.092 . . . . 0.0 108.195 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 107.831 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -72.59 135.02 45.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.773 0.429 . . . . 0.0 110.125 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -69.49 117.77 11.52 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.485 0.714 . . . . 0.0 109.194 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.3 m -60.84 -50.03 75.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.026 0.829 . . . . 0.0 111.09 -175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' SG ' HD13 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.531 HD13 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.68 -45.69 71.03 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -29.59 62.73 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -174.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.72 -40.69 85.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.781 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.87 -60.52 1.82 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.416 0.686 . . . . 0.0 111.419 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.2 mt 80.3 130.62 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.159 1.784 . . . . 0.0 110.043 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 99' ' ' HIS . 44.0 mt-10 -81.83 87.69 6.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -71.54 94.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.313 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.3 t60 65.48 -74.59 0.05 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.129 1.372 . . . . 0.0 111.358 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -70.06 87.26 0.56 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.545 0.738 . . . . 0.0 109.912 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 14.7 p-80 -76.28 153.28 36.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 66.23 96.92 0.05 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.295 1.038 . . . . 0.0 110.042 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.2 t60 . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.413 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m -99.8 128.77 45.88 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -95.02 144.64 25.53 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.109 0.563 . . . . 0.0 109.84 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -65.78 -55.89 14.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.899 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.436 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.523 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD21 H303 ' A' ' 102' ' ' PNS . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.556 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD23 HD11 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.441 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG2' HG11 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.44 -30.63 71.38 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -82.74 -46.52 13.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.525 0.73 . . . . 0.0 110.359 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -41.15 13.29 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.03 -165.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.22 4.42 48.73 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.442 0.697 . . . . 0.0 110.685 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.5 mt 62.85 -169.29 0.19 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 124.695 1.198 . . . . 0.0 111.14 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.43 -3.03 21.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.172 0.589 . . . . 0.0 111.65 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -95.87 25.16 4.87 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.594 1.158 . . . . 0.0 109.842 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -69.33 80.57 0.37 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.892 0.853 . . . . 0.0 112.016 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -72.7 -29.94 63.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.004 0.922 . . . . 0.0 109.264 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -136.24 138.29 41.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -82.12 38.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.542 H303 HD21 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 m -90.58 76.13 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 171.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -81.43 76.21 8.37 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.572 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m -69.11 -51.41 38.79 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.164 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.426 HG12 HD12 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' HD11 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG22 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.535 HG22 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.474 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 9.1 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.514 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HA ' HD11 ' A' ' 94' ' ' LEU . . . -59.74 -29.27 68.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -83.42 -43.55 15.74 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.849 0.46 . . . . 0.0 111.564 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.73 -44.07 0.71 Allowed Glycine 0 N--CA 1.479 1.557 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 -44.63 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.466 0.706 . . . . 0.0 112.782 -167.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 90' ' ' ALA . 71.3 mt -70.51 95.38 1.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.241 0.617 . . . . 0.0 110.993 -172.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.6 15.98 1.44 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.727 0.811 . . . . 0.0 110.712 175.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -64.31 105.42 0.91 Allowed 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -70.68 82.84 0.62 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.303 1.049 . . . . 0.0 108.885 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.53 129.82 21.06 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.992 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -77.88 88.05 4.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 109.881 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -103.5 -65.58 1.0 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.156 0.982 . . . . 0.0 108.972 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.186 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtp . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.0 m 63.46 73.07 0.46 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.325 1.05 . . . . 0.0 108.87 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -79.83 176.73 9.47 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.721 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.402 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m -57.93 -40.25 80.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.861 170.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB3' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD13 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.401 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.565 HD13 HD12 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HG2' HG11 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.472 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.39 68.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -83.94 -32.23 25.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.458 0.703 . . . . 0.0 110.558 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.71 -39.88 9.27 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.522 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.57 -53.86 0.07 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.635 0.774 . . . . 0.0 111.232 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.24 -170.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.119 0.968 . . . . 0.0 113.155 -172.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -39.74 3.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.952 1.701 . . . . 0.0 108.446 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.2 136.61 0.84 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.577 1.551 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -80.42 -60.59 2.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.235 0.54 . . . . 0.0 109.634 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -131.52 160.07 36.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.791 1.236 . . . . 0.0 108.233 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 36.9 t60 69.19 137.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -49.78 -63.25 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.974 0.91 . . . . 0.0 112.145 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 t60 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 124.238 1.015 . . . . 0.0 108.597 166.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.495 ' O26' ' H32' ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.7 p -98.69 122.85 42.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.459 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -73.1 176.43 5.83 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.871 0.468 . . . . 0.0 110.443 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 m -60.84 -41.25 95.43 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 11' ' ' ILE . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.424 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.449 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG2' ' HZ1' ' A' ' 78' ' ' LYS . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 HD11 H302 ' A' ' 102' ' ' PNS . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG22 ' HD3' ' A' ' 91' ' ' LYS . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.507 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.592 HD13 HD13 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.523 HD12 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.17 75.02 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HD3' HG22 ' A' ' 53' ' ' ILE . 30.7 ttpt -79.78 -16.95 54.55 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.167 0.987 . . . . 0.0 109.38 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.78 -21.97 79.36 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.561 0.601 . . . . 0.0 112.904 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.58 3.18 45.45 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.447 0.699 . . . . 0.0 110.618 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.7 mt 58.29 107.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.599 1.96 . . . . 0.0 113.347 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.85 110.64 1.06 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.463 172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -71.19 86.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.157 0.911 . . . . 0.0 109.937 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -120.72 24.7 10.13 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.542 1.137 . . . . 0.0 109.588 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 64.66 86.2 0.13 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.924 1.29 . . . . 0.0 111.295 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -90.97 91.95 8.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 0.0 109.618 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -114.27 -62.17 1.64 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 124.919 1.288 . . . . 0.0 107.585 173.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.424 H302 HD11 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.435 ' HB ' ' HD2' ' A' ' 5' ' ' PHE . 9.0 m -82.18 66.58 7.83 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.003 0.521 . . . . 0.0 110.441 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 18.3 m 21.94 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.489 2.315 . . . . 0.0 116.268 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m -69.68 -46.62 65.65 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.453 0.701 . . . . 0.0 110.569 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.435 ' HD2' ' HB ' ' A' ' 2' ' ' THR . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 3' ' ' SER . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.532 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG11 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.06 64.59 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.95 68.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.97 1.02 76.45 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.128 -0.487 . . . . 0.0 114.26 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.72 -43.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.252 0.621 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.0 mt 68.13 26.54 7.11 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.471 1.109 . . . . 0.0 111.6 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.83 -47.13 66.77 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.146 0.978 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -110.6 134.31 52.53 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.461 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -147.15 165.26 30.54 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.464 1.106 . . . . 0.0 108.972 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -145.5 100.15 3.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 62.85 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 110.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -87.19 42.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.501 0.72 . . . . 0.0 109.898 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t60 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.306 1.042 . . . . 0.0 109.62 -172.265 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.567 HG21 HH21 ' A' ' 7' ' ' ARG . 4.7 m 65.73 18.91 11.31 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.613 1.165 . . . . 0.0 111.865 170.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -67.0 157.22 33.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.697 0.799 . . . . 0.0 112.377 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -63.73 -46.66 84.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.104 -172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.567 HH21 HG21 ' A' ' 2' ' ' THR . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HG2' ' HZ2' ' A' ' 78' ' ' LYS . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD12 HD13 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.506 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HA ' HD11 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' HG21 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 HD13 HD12 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.44 97.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -64.88 -29.26 70.2 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.262 1.025 . . . . 0.0 111.474 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.82 -10.3 57.8 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.808 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -175.85 108.1 0.09 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.492 0.717 . . . . 0.0 110.407 -171.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.81 161.6 13.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.425 0.69 . . . . 0.0 109.886 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.46 115.37 2.7 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.09 0.869 . . . . 0.0 109.989 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.6 m170 71.7 -67.69 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.659 1.584 . . . . 0.0 111.25 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -172.7 -171.76 0.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.777 1.231 . . . . 0.0 109.298 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -65.6 83.38 0.06 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -91.51 86.11 5.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.008 0.908 . . . . 0.0 110.419 -171.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.21 95.14 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 125.384 1.474 . . . . 0.0 109.736 -165.247 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.1 m 54.75 52.05 12.76 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.271 1.034 . . . . 0.0 110.719 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -121.3 -171.84 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.399 1.08 . . . . 0.0 109.697 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.8 m -55.54 -42.42 74.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.052 0.941 . . . . 0.0 110.293 173.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' HG3' HG21 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.475 HG21 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.558 HD12 HD12 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 72' ' ' GLU . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.558 HD12 HD12 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.525 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.56 67.4 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -78.95 -20.45 49.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.729 0.812 . . . . 0.0 110.074 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.5 -32.74 85.2 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.21 -170.03 1.73 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.756 0.823 . . . . 0.0 108.957 165.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.4 mt 65.36 21.99 11.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.876 0.87 . . . . 0.0 111.261 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -74.84 87.04 2.25 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.742 0.782 . . . . 0.0 111.793 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -96.71 33.34 1.87 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.435 1.494 . . . . 0.0 109.761 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 68.52 10.64 7.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.869 1.268 . . . . 0.0 112.75 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -74.4 99.15 3.44 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.02 85.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.457 1.103 . . . . 0.0 109.57 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -93.14 104.29 16.49 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.58 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 CA--C 1.559 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.821 -175.836 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 m 59.87 29.89 19.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.334 1.064 . . . . 0.0 109.53 -173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -69.77 154.93 41.29 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.163 -170.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -55.63 -50.63 69.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.159 0.912 . . . . 0.0 112.255 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HG ' ' HB3' ' A' ' 39' ' ' ASP . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' HD13 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 HD13 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 16' ' ' CYS . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 57' ' ' LEU . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HZ1' ' HB3' ' A' ' 54' ' ' LYS . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.563 HD21 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 44' ' ' ALA . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.732 HD13 HD12 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.512 ' HA ' HD13 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.563 HD12 HD21 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.39 67.45 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -81.67 -22.61 37.38 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.834 0.854 . . . . 0.0 108.732 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.99 -18.96 75.98 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.634 0.635 . . . . 0.0 111.796 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.61 14.51 3.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.782 0.833 . . . . 0.0 111.699 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.5 mt -110.69 140.43 45.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.44 1.096 . . . . 0.0 108.068 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.0 92.14 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.288 0.635 . . . . 0.0 111.053 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -118.07 -46.83 2.61 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.912 0.885 . . . . 0.0 110.501 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.0 m80 68.09 119.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 111.215 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.92 91.17 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.554 0.741 . . . . 0.0 109.43 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -58.35 151.86 18.82 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.322 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -54.57 132.32 44.78 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.215 0.947 . . . . 0.0 111.566 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.476 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . 0.485 ' O25' H303 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.429 HG22 HH21 ' A' ' 7' ' ' ARG . 44.9 p -101.07 100.07 10.6 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.063 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 m -81.68 170.62 15.57 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -61.96 -37.27 84.13 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.429 HH21 HG22 ' A' ' 2' ' ' THR . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.55 HG12 HD11 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' HD13 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.596 HD11 HD13 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.46 HD12 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.55 HD11 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.55 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.596 HD13 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.485 HG12 HD23 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.56 74.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.08 -39.75 90.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.22 18.06 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 95' ' ' GLU . . . -135.72 2.43 2.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.476 0.71 . . . . 0.0 111.403 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt 57.18 41.45 27.02 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.524 1.13 . . . . 0.0 110.817 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 93' ' ' ALA . 45.8 mm-40 -73.67 110.05 7.65 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.748 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -74.57 88.87 2.18 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -64.51 -21.31 66.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -86.52 64.72 8.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -168.27 82.76 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.931 0.892 . . . . 0.0 108.925 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -94.43 136.99 34.1 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.887 0.875 . . . . 0.0 109.326 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 117.767 -1.111 . . . . 0.0 109.202 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.584 HG22 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.584 ' HB ' HG22 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.419 ' HB2' HG13 ' A' ' 53' ' ' ILE . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.42 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 7.4 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 71' ' ' THR . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HG2' ' A' ' 72' ' ' GLU . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 HG13 ' A' ' 64' ' ' VAL . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD13 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.412 HD13 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.404 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG23 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 88' ' ' VAL . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 81' ' ' ALA . 28.3 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.345 -0.359 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.553 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.657 HG13 HD11 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' HG13 ' A' ' 53' ' ' ILE . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG13 HD11 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.471 HD11 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HB2' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.556 HG12 HD21 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.0 m . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 16' ' ' CYS . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.715 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.51 HD11 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' ASP . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HG3' ' NH2' ' A' ' 83' ' ' ARG . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.3 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HE2' ' CB ' ' A' ' 71' ' ' THR . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 84' ' ' ILE . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD21 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.415 ' CB ' ' HE2' ' A' ' 28' ' ' HIS . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.548 HG12 HD21 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.4 m . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 53' ' ' ILE . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 77' ' ' LEU . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.404 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 60' ' ' TRP . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 33' ' ' LEU . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.661 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.596 HG21 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.578 HG12 HD21 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.571 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' HB2' HG21 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD12 HD23 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 84' ' ' ILE . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.3 m . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 43' ' ' ILE . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.547 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 84' ' ' ILE . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD22 ' H ' ' A' ' 38' ' ' LEU . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.608 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.427 HG12 HD13 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG11 ' HE2' ' A' ' 75' ' ' PHE . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HG2' ' A' ' 72' ' ' GLU . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HE2' HG11 ' A' ' 64' ' ' VAL . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.551 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 84' ' ' ILE . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 HG21 ' HB1' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 39' ' ' ASP . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.9 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.431 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.576 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HD1' HD12 ' A' ' 43' ' ' ILE . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG12 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.659 -0.21 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.408 HD21 HG12 ' A' ' 84' ' ' ILE . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' ILE . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . . . . . . 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.156 -0.449 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 77' ' ' LEU . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 34.8 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 18' ' ' ILE . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 53' ' ' ILE . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 78' ' ' LYS . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.626 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HA ' HD22 ' A' ' 79' ' ' ASN . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 84' ' ' ILE . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HD13 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 HD11 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.425 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.522 HG12 HD21 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -152.89 119.11 5.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.362 1.065 . . . . 0.0 108.562 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -82.75 176.34 9.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.084 0.554 . . . . 0.0 110.973 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -55.96 -42.54 76.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.584 HG22 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.584 ' HB ' HG22 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.419 ' HB2' HG13 ' A' ' 53' ' ' ILE . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.42 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 7.4 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 71' ' ' THR . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HG2' ' A' ' 72' ' ' GLU . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 HG13 ' A' ' 64' ' ' VAL . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB1' HD21 ' A' ' 94' ' ' LEU . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.67 69.24 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HB2' HG22 ' A' ' 53' ' ' ILE . 59.8 tttp -65.08 -36.48 84.46 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.842 0.857 . . . . 0.0 110.564 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.76 5.95 80.05 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.456 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.2 5.01 1.79 Allowed 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.386 1.474 . . . . 0.0 114.129 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.662 HD21 ' HB1' ' A' ' 89' ' ' ALA . 86.0 mt 48.1 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.158 0.983 . . . . 0.0 113.22 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.1 -14.48 1.16 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.83 0.852 . . . . 0.0 110.035 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -104.76 14.55 29.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.363 0.665 . . . . 0.0 110.296 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.1 m80 68.28 165.73 0.24 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.019 1.327 . . . . 0.0 112.033 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.427 ' HA ' HD12 ' A' ' 94' ' ' LEU . 26.6 t-80 -72.39 -80.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.926 0.49 . . . . 0.0 109.824 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -89.03 -67.89 0.81 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.28 -29.37 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.463 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.437 ' O25' H301 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 m -145.49 88.47 1.86 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.954 0.407 . . . . 0.0 110.682 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.6 p -105.93 179.26 4.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.568 0.747 . . . . 0.0 109.569 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -57.81 -42.81 85.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.993 0.517 . . . . 0.0 110.488 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD13 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.412 HD13 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG23 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 88' ' ' VAL . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.95 -51.85 42.82 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -48.15 -29.98 4.17 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.211 1.004 . . . . 0.0 112.686 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.43 -38.24 7.78 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 112.282 -0.327 . . . . 0.0 112.282 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.28 -31.75 55.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.286 1.034 . . . . 0.0 113.362 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.6 mt -84.93 84.92 7.55 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.884 0.849 . . . . 0.0 109.75 -174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.3 mt-10 -90.02 -175.3 4.53 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.903 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -64.84 98.47 0.28 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.067 0.547 . . . . 0.0 110.095 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t60 73.5 1.37 3.94 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.095 1.758 . . . . 0.0 111.677 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.672 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 70.8 m80 -99.32 131.67 45.17 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.879 0.872 . . . . 0.0 109.666 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -118.66 82.9 1.93 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 77.89 -45.77 0.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.873 1.669 . . . . 0.0 112.94 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.909 0.884 . . . . 0.0 109.832 -175.078 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 74.4 p 47.76 82.11 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.498 1.519 . . . . 0.0 113.632 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -77.63 125.8 29.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 81' ' ' ALA . 28.3 m -58.45 -48.52 80.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.601 0.563 . . . . 0.0 111.65 -173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.553 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.657 HG13 HD11 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' HG13 ' A' ' 53' ' ' ILE . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.431 HG21 H302 ' A' ' 102' ' ' PNS . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.67 -30.6 70.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -85.57 -39.4 17.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.909 . . . . 0.0 110.52 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.58 -47.61 2.94 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.502 -166.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -9.3 59.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.573 0.749 . . . . 0.0 111.609 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt 59.44 -166.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.374 1.07 . . . . 0.0 112.084 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . 47.1 mt-10 -88.63 -50.49 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.1 m170 54.42 78.78 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.591 1.157 . . . . 0.0 112.284 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.439 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 18.3 m-70 -107.27 -78.95 0.58 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.408 ' H ' ' HB2' ' A' ' 97' ' ' HIS . 55.3 m80 -154.87 115.64 3.94 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 m80 62.44 -157.52 0.33 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.93 0.892 . . . . 0.0 109.503 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 64.25 -162.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.535 0.734 . . . . 0.0 111.247 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.119 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.465 H312 HD11 ' A' ' 41' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.0 m -100.64 117.15 34.19 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -62.92 136.45 57.85 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m -57.83 -34.21 69.44 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.298 0.639 . . . . 0.0 111.501 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG13 HD11 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.471 HD11 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HB2' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.556 HG12 HD21 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -33.22 74.06 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.1 -39.35 60.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.497 0.719 . . . . 0.0 109.979 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.08 -63.17 2.74 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.267 -0.741 . . . . 0.0 111.721 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 94' ' ' LEU . . . 160.14 1.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.844 2.057 . . . . 0.0 110.052 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 93' ' ' ALA . 2.0 mm? -75.13 162.48 28.47 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.737 0.815 . . . . 0.0 109.69 -173.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 75.56 2.71 3.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.801 1.64 . . . . 0.0 111.159 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m80 64.64 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.49 1.516 . . . . 0.0 111.813 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -78.87 59.06 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.246 1.022 . . . . 0.0 110.44 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -143.02 -177.36 5.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 108.648 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -96.21 148.1 23.07 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -66.22 93.36 0.21 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.541 0.737 . . . . 0.0 109.952 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.856 0.862 . . . . 0.0 109.286 -178.143 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.804 -0.072 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 p -94.79 -20.06 19.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.689 0.795 . . . . 0.0 113.011 -167.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 34.0 t -156.42 163.93 38.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 0.0 110.46 -172.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.0 m -72.46 -37.77 68.43 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 16' ' ' CYS . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.715 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.51 HD11 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' ASP . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HG3' ' NH2' ' A' ' 83' ' ' ARG . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -21.49 61.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -85.8 -27.7 24.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.845 0.458 . . . . 0.0 110.436 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.42 -7.64 65.01 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.609 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.64 169.22 24.21 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.726 1.21 . . . . 0.0 109.153 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.6 mt -125.28 164.25 20.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.182 0.593 . . . . 0.0 110.318 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.08 137.73 50.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.933 166.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.33 97.73 2.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -155.71 170.89 20.99 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.584 0.707 . . . . 0.0 110.741 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -126.05 -55.55 1.47 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 54.23 74.55 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.632 1.173 . . . . 0.0 109.195 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -54.08 108.23 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.15 0.98 . . . . 0.0 111.705 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.663 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.505 ' O25' H301 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.2 t -150.09 -170.72 3.72 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -131.52 149.81 52.38 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.3 m -62.04 -42.26 98.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HE2' ' CB ' ' A' ' 71' ' ' THR . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 84' ' ' ILE . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD21 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.415 ' CB ' ' HE2' ' A' ' 28' ' ' HIS . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.548 HG12 HD21 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.0 -40.78 78.53 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -47.13 60.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.794 0.838 . . . . 0.0 109.622 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.54 -61.97 4.14 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 45.1 63.46 1.74 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.513 1.125 . . . . 0.0 110.889 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.8 18.94 14.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.018 0.927 . . . . 0.0 110.716 -172.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.82 -26.66 36.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.156 0.982 . . . . 0.0 110.597 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 66.48 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.196 1.398 . . . . 0.0 109.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 77.0 -34.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.498 1.519 . . . . 0.0 113.716 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 69.77 101.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.823 1.249 . . . . 0.0 109.844 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -71.79 103.3 3.08 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.068 0.461 . . . . 0.0 110.243 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -67.4 -35.6 79.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.239 0.542 . . . . 0.0 109.832 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.481 1.113 . . . . 0.0 108.66 174.854 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -160.47 117.34 2.42 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.03 0.532 . . . . 0.0 111.108 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 32.7 t 178.54 172.39 0.73 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 126.172 1.789 . . . . 0.0 108.035 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.4 m -68.14 -54.19 19.8 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.32 0.509 . . . . 0.0 110.116 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 3' ' ' SER . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 53' ' ' ILE . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.49 67.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 52' ' ' GLY . 25.8 ttpp -89.92 -21.09 22.65 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.684 0.794 . . . . 0.0 110.544 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.31 -59.61 1.09 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.773 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 174.62 123.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.459 1.104 . . . . 0.0 110.028 -166.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.1 mt -127.67 38.76 3.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.367 0.667 . . . . 0.0 111.975 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 121.67 30.98 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -177.2 12.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.078 0.951 . . . . 0.0 110.72 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.46 162.88 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.438 1.495 . . . . 0.0 109.45 -166.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.0 t60 90.32 -32.14 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.796 2.038 . . . . 0.0 110.071 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.7 t60 72.79 108.1 0.07 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.442 1.497 . . . . 0.0 112.843 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -147.25 161.45 40.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.228 1.011 . . . . 0.0 109.298 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.0 t60 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.312 1.445 . . . . 0.0 110.828 -174.494 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.432 H311 ' HB3' ' A' ' 37' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.753 0.311 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.2 m -73.62 78.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 p -82.78 74.6 9.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.457 0.703 . . . . 0.0 109.782 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m -63.04 -39.86 95.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.968 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 77' ' ' LEU . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 60' ' ' TRP . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 33' ' ' LEU . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.661 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.69 62.53 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.36 -28.38 21.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.025 0.53 . . . . 0.0 109.678 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.18 -15.29 69.75 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.225 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.63 -40.71 28.71 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.843 1.257 . . . . 0.0 112.07 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.5 mt -126.23 -173.45 2.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.908 1.283 . . . . 0.0 108.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.45 -29.17 62.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.577 0.351 . . . . 0.0 110.072 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t60 59.92 19.37 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.632 1.573 . . . . 0.0 112.444 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 66.74 3.41 2.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.909 1.283 . . . . 0.0 112.383 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.38 -26.01 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.685 -0.635 . . . . 0.0 110.081 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.19 128.59 9.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.929 0.892 . . . . 0.0 109.335 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -166.39 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.916 1.286 . . . . 0.0 107.712 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.25 1.13 0 O-C-N 124.283 0.989 . . . . 0.0 109.623 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m -151.71 113.18 4.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.101 0.56 . . . . 0.0 109.936 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.6 p -88.66 -179.36 6.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m -62.32 -38.02 87.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.169 0.588 . . . . 0.0 110.519 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.596 HG21 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.578 HG12 HD21 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -28.8 68.43 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -74.0 -41.86 61.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.763 0.825 . . . . 0.0 110.09 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.35 -15.1 59.22 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.183 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.43 -53.18 14.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.699 1.2 . . . . 0.0 112.636 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.05 -167.82 0.12 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 111.706 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -95.62 26.73 3.79 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 111.382 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -131.2 122.97 27.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.304 1.042 . . . . 0.0 108.917 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -60.49 132.82 55.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.5 0.72 . . . . 0.0 110.298 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -81.95 -70.4 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 73.49 -54.67 0.68 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.233 1.413 . . . . 0.0 110.646 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -86.45 -167.49 1.89 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.818 0.847 . . . . 0.0 110.184 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.318 1.447 . . . . 0.0 110.469 179.531 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 t -66.59 98.57 0.52 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.516 1.15 . . . . 0.0 111.239 -173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 52.7 m -144.38 -179.8 6.76 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.624 175.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m -51.41 -47.65 62.89 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.149 0.58 . . . . 0.0 112.05 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 3' ' ' SER . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.571 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' HB2' HG21 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD12 HD23 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 84' ' ' ILE . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.24 64.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -90.03 -21.86 22.14 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.747 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.33 -25.44 36.53 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.62 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.89 3.6 25.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.094 0.957 . . . . 0.0 111.52 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.02 -163.84 0.9 Allowed 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.438 0.695 . . . . 0.0 109.429 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.2 129.61 42.79 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.191 0.596 . . . . 0.0 110.256 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -84.4 83.98 7.8 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -136.32 125.03 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.386 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -105.59 158.21 16.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 108.97 171.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -64.0 -41.78 97.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -168.12 -39.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.431 1.092 . . . . 0.0 108.195 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 107.831 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -72.59 135.02 45.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.773 0.429 . . . . 0.0 110.125 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -69.49 117.77 11.52 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.485 0.714 . . . . 0.0 109.194 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.3 m -60.84 -50.03 75.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.026 0.829 . . . . 0.0 111.09 -175.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 43' ' ' ILE . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.547 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 84' ' ' ILE . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.68 -45.69 71.03 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -29.59 62.73 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -174.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.72 -40.69 85.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.781 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.87 -60.52 1.82 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.416 0.686 . . . . 0.0 111.419 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.2 mt 80.3 130.62 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.159 1.784 . . . . 0.0 110.043 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' HIS . 44.0 mt-10 -81.83 87.69 6.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -71.54 94.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.313 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.3 t60 65.48 -74.59 0.05 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.129 1.372 . . . . 0.0 111.358 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -70.06 87.26 0.56 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.545 0.738 . . . . 0.0 109.912 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 14.7 p-80 -76.28 153.28 36.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 66.23 96.92 0.05 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.295 1.038 . . . . 0.0 110.042 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.2 t60 . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.413 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.406 ' H32' H382 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m -99.8 128.77 45.88 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -95.02 144.64 25.53 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.109 0.563 . . . . 0.0 109.84 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -65.78 -55.89 14.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.899 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 H301 ' A' ' 102' ' ' PNS . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.608 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.44 -30.63 71.38 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -82.74 -46.52 13.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.525 0.73 . . . . 0.0 110.359 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -41.15 13.29 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.03 -165.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.22 4.42 48.73 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.442 0.697 . . . . 0.0 110.685 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.5 mt 62.85 -169.29 0.19 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 124.695 1.198 . . . . 0.0 111.14 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.43 -3.03 21.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.172 0.589 . . . . 0.0 111.65 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -95.87 25.16 4.87 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.594 1.158 . . . . 0.0 109.842 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -69.33 80.57 0.37 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.892 0.853 . . . . 0.0 112.016 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -72.7 -29.94 63.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.004 0.922 . . . . 0.0 109.264 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -136.24 138.29 41.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -82.12 38.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.582 H301 HD21 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 m -90.58 76.13 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 171.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -81.43 76.21 8.37 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.572 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m -69.11 -51.41 38.79 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.164 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.427 HG12 HD13 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG11 ' HE2' ' A' ' 75' ' ' PHE . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HG2' ' A' ' 72' ' ' GLU . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HE2' HG11 ' A' ' 64' ' ' VAL . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.551 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 84' ' ' ILE . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 94' ' ' LEU . . . -59.74 -29.27 68.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -83.42 -43.55 15.74 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.849 0.46 . . . . 0.0 111.564 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.73 -44.07 0.71 Allowed Glycine 0 N--CA 1.479 1.557 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 -44.63 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.466 0.706 . . . . 0.0 112.782 -167.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 90' ' ' ALA . 71.3 mt -70.51 95.38 1.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.241 0.617 . . . . 0.0 110.993 -172.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.6 15.98 1.44 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.727 0.811 . . . . 0.0 110.712 175.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -64.31 105.42 0.91 Allowed 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -70.68 82.84 0.62 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.303 1.049 . . . . 0.0 108.885 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.53 129.82 21.06 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.992 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -77.88 88.05 4.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 109.881 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -103.5 -65.58 1.0 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.156 0.982 . . . . 0.0 108.972 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.186 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtp . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.0 m 63.46 73.07 0.46 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.325 1.05 . . . . 0.0 108.87 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -79.83 176.73 9.47 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.721 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m -57.93 -40.25 80.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.861 170.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.448 HG21 ' HB1' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 39' ' ' ASP . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.39 68.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -83.94 -32.23 25.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.458 0.703 . . . . 0.0 110.558 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.71 -39.88 9.27 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.522 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.57 -53.86 0.07 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.635 0.774 . . . . 0.0 111.232 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.24 -170.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.119 0.968 . . . . 0.0 113.155 -172.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -39.74 3.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.952 1.701 . . . . 0.0 108.446 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.2 136.61 0.84 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.577 1.551 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -80.42 -60.59 2.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.235 0.54 . . . . 0.0 109.634 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -131.52 160.07 36.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.791 1.236 . . . . 0.0 108.233 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 36.9 t60 69.19 137.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -49.78 -63.25 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.974 0.91 . . . . 0.0 112.145 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 t60 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 124.238 1.015 . . . . 0.0 108.597 166.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.529 ' O26' ' H32' ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.7 p -98.69 122.85 42.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.459 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -73.1 176.43 5.83 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.871 0.468 . . . . 0.0 110.443 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.9 m -60.84 -41.25 95.43 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.576 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.419 HD11 H302 ' A' ' 102' ' ' PNS . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HD1' HD12 ' A' ' 43' ' ' ILE . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD3' ' A' ' 91' ' ' LYS . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG12 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.17 75.02 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HD3' HG23 ' A' ' 53' ' ' ILE . 30.7 ttpt -79.78 -16.95 54.55 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.167 0.987 . . . . 0.0 109.38 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.78 -21.97 79.36 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.561 0.601 . . . . 0.0 112.904 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.58 3.18 45.45 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.447 0.699 . . . . 0.0 110.618 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.7 mt 58.29 107.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.599 1.96 . . . . 0.0 113.347 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.85 110.64 1.06 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.463 172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -71.19 86.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.157 0.911 . . . . 0.0 109.937 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -120.72 24.7 10.13 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.542 1.137 . . . . 0.0 109.588 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 64.66 86.2 0.13 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.924 1.29 . . . . 0.0 111.295 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -90.97 91.95 8.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 0.0 109.618 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -114.27 -62.17 1.64 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 124.919 1.288 . . . . 0.0 107.585 173.332 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.419 H302 HD11 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 5' ' ' PHE . 9.0 m -82.18 66.58 7.83 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.003 0.521 . . . . 0.0 110.441 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 18.3 m 21.94 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.489 2.315 . . . . 0.0 116.268 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m -69.68 -46.62 65.65 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.453 0.701 . . . . 0.0 110.569 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 2' ' ' THR . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 3' ' ' SER . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.408 HD21 HG12 ' A' ' 84' ' ' ILE . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' ILE . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -68.7 -25.06 64.59 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.95 68.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.97 1.02 76.45 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.128 -0.487 . . . . 0.0 114.26 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.72 -43.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.252 0.621 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.0 mt 68.13 26.54 7.11 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.471 1.109 . . . . 0.0 111.6 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.83 -47.13 66.77 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.146 0.978 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -110.6 134.31 52.53 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.461 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -147.15 165.26 30.54 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.464 1.106 . . . . 0.0 108.972 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -145.5 100.15 3.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 62.85 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 110.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -87.19 42.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.501 0.72 . . . . 0.0 109.898 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t60 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.306 1.042 . . . . 0.0 109.62 -172.265 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.58 HG23 HH21 ' A' ' 7' ' ' ARG . 4.7 m 65.73 18.91 11.31 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.613 1.165 . . . . 0.0 111.865 170.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -67.0 157.22 33.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.697 0.799 . . . . 0.0 112.377 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -63.73 -46.66 84.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.104 -172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.58 HH21 HG23 ' A' ' 2' ' ' THR . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 77' ' ' LEU . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.44 97.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -64.88 -29.26 70.2 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.262 1.025 . . . . 0.0 111.474 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.82 -10.3 57.8 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.808 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -175.85 108.1 0.09 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.492 0.717 . . . . 0.0 110.407 -171.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.81 161.6 13.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.425 0.69 . . . . 0.0 109.886 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.46 115.37 2.7 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.09 0.869 . . . . 0.0 109.989 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.6 m170 71.7 -67.69 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.659 1.584 . . . . 0.0 111.25 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -172.7 -171.76 0.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.777 1.231 . . . . 0.0 109.298 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -65.6 83.38 0.06 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -91.51 86.11 5.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.008 0.908 . . . . 0.0 110.419 -171.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.21 95.14 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 125.384 1.474 . . . . 0.0 109.736 -165.247 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.1 m 54.75 52.05 12.76 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.271 1.034 . . . . 0.0 110.719 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -121.3 -171.84 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.399 1.08 . . . . 0.0 109.697 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 34.8 m -55.54 -42.42 74.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.052 0.941 . . . . 0.0 110.293 173.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 18' ' ' ILE . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 53' ' ' ILE . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 78' ' ' LYS . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.626 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.56 67.4 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -78.95 -20.45 49.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.729 0.812 . . . . 0.0 110.074 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.5 -32.74 85.2 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.21 -170.03 1.73 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.756 0.823 . . . . 0.0 108.957 165.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.4 mt 65.36 21.99 11.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.876 0.87 . . . . 0.0 111.261 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -74.84 87.04 2.25 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.742 0.782 . . . . 0.0 111.793 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -96.71 33.34 1.87 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.435 1.494 . . . . 0.0 109.761 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 68.52 10.64 7.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.869 1.268 . . . . 0.0 112.75 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -74.4 99.15 3.44 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.02 85.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.457 1.103 . . . . 0.0 109.57 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -93.14 104.29 16.49 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.58 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 CA--C 1.559 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.821 -175.836 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 m 59.87 29.89 19.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.334 1.064 . . . . 0.0 109.53 -173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -69.77 154.93 41.29 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.163 -170.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -55.63 -50.63 69.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.159 0.912 . . . . 0.0 112.255 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HA ' HD22 ' A' ' 79' ' ' ASN . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 84' ' ' ILE . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.39 67.45 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -81.67 -22.61 37.38 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.834 0.854 . . . . 0.0 108.732 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.99 -18.96 75.98 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.634 0.635 . . . . 0.0 111.796 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.61 14.51 3.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.782 0.833 . . . . 0.0 111.699 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.5 mt -110.69 140.43 45.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.44 1.096 . . . . 0.0 108.068 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.0 92.14 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.288 0.635 . . . . 0.0 111.053 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.07 -46.83 2.61 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.912 0.885 . . . . 0.0 110.501 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.0 m80 68.09 119.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 111.215 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.92 91.17 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.554 0.741 . . . . 0.0 109.43 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -58.35 151.86 18.82 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.322 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -54.57 132.32 44.78 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.215 0.947 . . . . 0.0 111.566 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.476 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PNS . . . . . 0.506 H302 ' O25' ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.451 HG21 HH21 ' A' ' 7' ' ' ARG . 44.9 p -101.07 100.07 10.6 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.063 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 m -81.68 170.62 15.57 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -61.96 -37.27 84.13 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 2' ' ' THR . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HD13 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 HD11 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.425 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.522 HG12 HD21 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.56 74.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.08 -39.75 90.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.22 18.06 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' HG2' ' A' ' 95' ' ' GLU . . . -135.72 2.43 2.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.476 0.71 . . . . 0.0 111.403 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt 57.18 41.45 27.02 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.524 1.13 . . . . 0.0 110.817 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 93' ' ' ALA . 45.8 mm-40 -73.67 110.05 7.65 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.748 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.57 88.87 2.18 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -64.51 -21.31 66.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -86.52 64.72 8.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -168.27 82.76 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.931 0.892 . . . . 0.0 108.925 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -94.43 136.99 34.1 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.887 0.875 . . . . 0.0 109.326 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 117.767 -1.111 . . . . 0.0 109.202 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.584 HG22 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.584 ' HB ' HG22 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.419 ' HB2' HG13 ' A' ' 53' ' ' ILE . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.42 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 1.3 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 71' ' ' THR . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HG2' ' A' ' 72' ' ' GLU . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 HG13 ' A' ' 64' ' ' VAL . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD13 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.412 HD13 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.404 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG23 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 88' ' ' VAL . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 81' ' ' ALA . 28.3 m . . . . . 0 CA--C 1.545 0.757 0 CA-C-O 119.345 -0.359 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.553 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.657 HG13 HD11 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' HG13 ' A' ' 53' ' ' ILE . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.354 -0.355 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG13 HD11 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.471 HD11 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HB2' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.556 HG12 HD21 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.0 m . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 16' ' ' CYS . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.715 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.51 HD11 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' ASP . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.457 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.457 ' NE2' ' H ' ' A' ' 70' ' ' THR . 77.7 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HG3' ' NH2' ' A' ' 83' ' ' ARG . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.3 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HE2' ' CB ' ' A' ' 71' ' ' THR . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 84' ' ' ILE . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD21 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.439 ' N ' HE21 ' A' ' 73' ' ' GLN . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.415 ' CB ' ' HE2' ' A' ' 28' ' ' HIS . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.439 HE21 ' N ' ' A' ' 70' ' ' THR . 46.1 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.548 HG12 HD21 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.4 m . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 53' ' ' ILE . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 77' ' ' LEU . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.404 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 60' ' ' TRP . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 33' ' ' LEU . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.661 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.596 HG21 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.578 HG12 HD21 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.571 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.507 ' HB2' HG21 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD12 HD23 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 84' ' ' ILE . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.3 m . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 119.423 -0.322 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 43' ' ' ILE . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.547 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 84' ' ' ILE . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 119.372 -0.347 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD22 ' H ' ' A' ' 38' ' ' LEU . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.608 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.427 HG12 HD13 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG11 ' HE2' ' A' ' 75' ' ' PHE . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HG2' ' A' ' 72' ' ' GLU . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.429 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 9.1 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HE2' HG11 ' A' ' 64' ' ' VAL . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.551 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 84' ' ' ILE . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 HG21 ' HB1' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 39' ' ' ASP . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.9 m . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.431 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.576 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HD1' HD12 ' A' ' 43' ' ' ILE . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG12 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.659 -0.21 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.408 HD21 HG12 ' A' ' 84' ' ' ILE . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' ILE . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . . . . . . 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.156 -0.449 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 77' ' ' LEU . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 34.8 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 18' ' ' ILE . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 53' ' ' ILE . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 78' ' ' LYS . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.626 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HA ' HD22 ' A' ' 79' ' ' ASN . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 84' ' ' ILE . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HD13 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 HD11 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.425 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.452 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.522 HG12 HD21 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -152.89 119.11 5.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.362 1.065 . . . . 0.0 108.562 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -82.75 176.34 9.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.084 0.554 . . . . 0.0 110.973 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -55.96 -42.54 76.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.745 0.818 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -56.52 -47.7 78.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.889 0.876 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.42 -36.17 82.14 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.559 0.743 . . . . 0.0 110.627 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -61.51 -51.13 69.91 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.926 0.766 . . . . 0.0 110.19 173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 12' ' ' ILE . 57.0 t -56.08 -45.71 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.375 1.07 . . . . 0.0 110.808 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.2 -38.61 91.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.616 1.167 . . . . 0.0 111.418 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.5 m -61.78 -47.21 86.19 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.639 0.587 . . . . 0.0 109.949 172.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.6 mt -62.17 -33.84 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 124.3 1.04 . . . . 0.0 111.333 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.584 HG22 ' HB ' ' A' ' 18' ' ' ILE . 80.2 mt -68.54 -43.09 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.171 0.588 . . . . 0.0 109.472 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.68 95.66 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.855 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.2 mm-40 -64.57 -47.95 76.83 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.304 0.641 . . . . 0.0 110.884 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -82.63 -57.34 3.37 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.362 -167.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -109.19 2.04 20.7 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.149 0.579 . . . . 0.0 111.363 -169.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.7 t70 52.05 69.1 0.71 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.584 ' HB ' HG22 ' A' ' 12' ' ' ILE . 42.9 mm -115.06 124.2 30.65 Favored Pre-proline 0 C--O 1.242 0.673 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.19 127.46 21.18 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.112 2.541 . . . . 0.0 111.937 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -53.35 -34.81 58.99 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 111.975 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 22' ' ' THR . 8.2 pt-20 -63.37 -38.39 90.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.637 0.775 . . . . 0.0 111.169 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.7 p -93.59 18.44 10.01 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.3 mt -112.89 103.05 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.3 p -96.57 155.18 38.14 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.574 0.75 . . . . 0.0 109.603 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.7 -28.71 82.62 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.301 2.001 . . . . 0.0 111.976 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -96.94 16.68 18.73 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.234 0.614 . . . . 0.0 110.851 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -83.68 143.9 29.75 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.454 0.701 . . . . 0.0 109.897 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.63 115.99 28.61 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.77 -35.12 42.51 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.062 0.945 . . . . 0.0 113.176 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 mt -95.06 -45.37 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -82.33 -49.21 10.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.989 0.515 . . . . 0.0 111.104 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.49 -51.82 6.26 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.155 0.582 . . . . 0.0 111.141 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 77' ' ' LEU . 77.6 mt -75.64 -15.5 60.32 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.534 0.333 . . . . 0.0 111.741 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 48.96 66.85 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.627 0.58 . . . . 0.0 112.988 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 78.5 mt -109.85 124.86 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.17 157.85 37.45 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.6 p -61.18 -28.62 69.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.339 0.655 . . . . 0.0 112.315 -178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.23 -45.92 65.54 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.675 0.79 . . . . 0.0 110.57 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.49 -30.86 71.88 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.709 0.804 . . . . 0.0 110.07 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -75.39 -26.47 58.48 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.565 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 37' ' ' SER . 68.8 mt -62.01 -47.59 84.1 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.26 -41.07 87.95 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.636 0.585 . . . . 0.0 110.878 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 12' ' ' ILE . 75.6 mt -65.63 -43.39 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.591 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.74 -29.33 51.08 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.436 0.694 . . . . 0.0 111.365 -169.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.97 -33.07 59.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.045 0.938 . . . . 0.0 109.819 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.12 -37.51 78.39 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.216 0.322 . . . . 0.0 110.251 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 8' ' ' VAL . 96.1 mt -65.36 -47.73 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.19 0.996 . . . . 0.0 110.216 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.37 -53.81 32.7 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.37 1.468 . . . . 0.0 111.239 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -73.35 -35.21 65.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.486 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.01 -56.46 21.91 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.139 0.575 . . . . 0.0 111.795 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.419 ' HB2' HG13 ' A' ' 53' ' ' ILE . 82.3 m-85 -79.16 -7.13 57.95 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.653 0.781 . . . . 0.0 111.894 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.66 29.42 74.72 Favored Glycine 0 C--N 1.357 1.721 0 O-C-N 123.235 0.334 . . . . 0.0 113.567 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -112.86 -169.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.646 0.778 . . . . 0.0 110.807 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 111.34 8.27 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.42 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -82.44 122.74 79.13 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.357 0.663 . . . . 0.0 109.277 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.44 69.15 7.78 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.739 2.293 . . . . 0.0 109.735 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.41 -39.69 94.33 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.749 0.82 . . . . 0.0 110.943 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.02 -40.71 96.95 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.128 0.893 . . . . 0.0 109.642 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 39.6 ttmt -63.08 -49.66 73.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.295 175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -60.48 -42.78 96.99 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.658 0.783 . . . . 0.0 111.07 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -74.03 -30.93 62.68 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.716 0.806 . . . . 0.0 110.785 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 1.3 pt20 -75.97 -36.13 59.39 Favored 'General case' 0 C--O 1.209 -1.05 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.73 -45.18 83.61 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.715 0.806 . . . . 0.0 110.248 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 71' ' ' THR . 4.3 t -56.0 -56.09 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.2 1.0 . . . . 0.0 111.029 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -80.45 -5.43 56.57 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.65 -6.69 42.81 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.604 0.638 . . . . 0.0 110.525 172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.59 15.51 79.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.664 -0.52 . . . . 0.0 114.211 -173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.6 mmpt? -71.31 -39.55 71.36 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.647 0.723 . . . . 0.0 110.147 172.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 150.06 52.28 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.324 1.05 . . . . 0.0 109.231 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HG2' ' A' ' 72' ' ' GLU . 6.8 m -72.37 150.84 43.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 170.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 HG13 ' A' ' 64' ' ' VAL . 79.3 p -55.71 -55.33 33.49 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.541 0.736 . . . . 0.0 110.941 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.3 pt-20 -50.92 -28.92 10.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.643 1.577 . . . . 0.0 114.882 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -58.29 -33.28 69.27 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.81 0.444 . . . . 0.0 111.43 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -112.03 -30.48 7.24 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.187 0.595 . . . . 0.0 111.464 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -103.48 7.71 37.87 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -167.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.17 125.29 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 33' ' ' LEU . 79.1 mt -54.84 -28.71 51.89 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -164.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -77.11 -37.06 55.01 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.324 0.511 . . . . 0.0 110.293 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -70.85 -40.89 72.07 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.769 0.827 . . . . 0.0 109.594 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.6 tp -61.59 -49.44 76.64 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 125.024 1.33 . . . . 0.0 109.276 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.21 73.82 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.852 0.72 . . . . 0.0 111.129 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -72.44 -36.04 68.44 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.506 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -66.54 -44.09 83.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.272 0.629 . . . . 0.0 110.719 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 58.3 mt -62.98 -48.54 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.993 0.917 . . . . 0.0 109.451 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.79 -36.39 80.97 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.077 0.951 . . . . 0.0 111.404 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 3.7 tm-20 -64.19 -35.07 79.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.63 1.172 . . . . 0.0 110.184 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -84.71 -21.26 30.18 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.745 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.1 t -73.28 -33.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.629 0.728 . . . . 0.0 109.069 169.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB1' HD21 ' A' ' 94' ' ' LEU . . . -70.37 -40.75 73.83 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.974 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.67 69.24 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.61 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HB2' HG22 ' A' ' 53' ' ' ILE . 59.8 tttp -65.08 -36.48 84.46 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.842 0.857 . . . . 0.0 110.564 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.76 5.95 80.05 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.456 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.2 5.01 1.79 Allowed 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.386 1.474 . . . . 0.0 114.129 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.662 HD21 ' HB1' ' A' ' 89' ' ' ALA . 86.0 mt 48.1 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.158 0.983 . . . . 0.0 113.22 -171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.1 -14.48 1.16 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.83 0.852 . . . . 0.0 110.035 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -104.76 14.55 29.47 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.363 0.665 . . . . 0.0 110.296 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.1 m80 68.28 165.73 0.24 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.019 1.327 . . . . 0.0 112.033 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.427 ' HA ' HD12 ' A' ' 94' ' ' LEU . 26.6 t-80 -72.39 -80.29 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.926 0.49 . . . . 0.0 109.824 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -89.03 -67.89 0.81 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 171.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -133.28 -29.37 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.463 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.437 ' O25' H301 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 m -145.49 88.47 1.86 Allowed 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.954 0.407 . . . . 0.0 110.682 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.6 p -105.93 179.26 4.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.568 0.747 . . . . 0.0 109.569 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -57.81 -42.81 85.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.993 0.517 . . . . 0.0 110.488 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -59.68 -47.1 86.96 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 124.009 0.818 . . . . 0.0 110.808 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.5 -41.54 85.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.44 0.462 . . . . 0.0 111.348 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.91 -55.16 24.66 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.199 0.937 . . . . 0.0 111.16 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.2 -38.92 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 124.51 1.131 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.04 -45.44 88.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.126 0.97 . . . . 0.0 111.267 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -64.01 -40.82 97.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.77 -50.63 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.976 0.798 . . . . 0.0 110.73 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.412 HG12 HD13 ' A' ' 43' ' ' ILE . 79.1 mt -64.19 -44.03 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.133 0.573 . . . . 0.0 110.467 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.16 -48.36 76.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.302 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -77.23 -30.16 54.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.331 0.653 . . . . 0.0 112.355 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.1 m -77.97 -53.03 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.932 0.493 . . . . 0.0 111.567 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -112.47 8.08 19.26 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.818 0.447 . . . . 0.0 112.116 -170.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.4 51.8 10.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.411 1.101 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 35' ' ' ILE . 37.7 mm -97.23 129.26 32.51 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.678 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.42 120.09 7.63 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.417 2.078 . . . . 0.0 111.653 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -50.62 -34.75 27.31 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.338 1.055 . . . . 0.0 112.124 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.08 -30.46 70.98 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.906 0.882 . . . . 0.0 112.591 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -84.11 -20.2 32.94 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.775 0.43 . . . . 0.0 110.218 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -78.06 93.34 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.1 p -121.96 161.19 43.76 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 0.0 109.376 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.12 -28.76 26.26 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.839 2.36 . . . . 0.0 114.332 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -90.08 -2.2 58.07 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.577 0.751 . . . . 0.0 112.029 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.7 m -80.14 130.21 35.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -88.73 118.4 28.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.48 -38.27 29.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.97 0.908 . . . . 0.0 113.021 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -92.9 -45.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.316 -0.24 . . . . 0.0 110.623 -172.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -81.72 -51.3 8.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.56 0.744 . . . . 0.0 111.108 -174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.5 -61.23 1.94 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.535 0.734 . . . . 0.0 110.668 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 77' ' ' LEU . 83.5 mt -71.88 -19.29 61.97 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.297 0.639 . . . . 0.0 111.984 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 55.83 11.64 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.319 0.387 . . . . 0.0 113.388 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 18' ' ' ILE . 73.4 mt -124.9 119.5 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.348 1.059 . . . . 0.0 108.807 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -98.73 175.69 5.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.432 0.293 . . . . 0.0 110.214 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.9 p -48.43 -38.61 20.19 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.334 1.454 . . . . 0.0 113.006 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.99 -48.64 43.21 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 0.0 111.125 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 4.8 m-20 -88.13 -32.37 18.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.469 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.3 -26.1 55.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.898 0.479 . . . . 0.0 111.085 -168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -67.74 -39.82 84.19 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.21 -44.41 95.4 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.502 0.721 . . . . 0.0 109.357 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.412 HD13 HG12 ' A' ' 12' ' ' ILE . 64.6 mt -58.74 -44.53 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.318 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -71.78 -28.69 63.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.288 0.635 . . . . 0.0 111.57 -174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -72.54 -38.11 68.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.059 0.944 . . . . 0.0 110.454 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.93 81.74 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.36 -44.05 83.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.053 0.941 . . . . 0.0 110.659 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.9 t70 -51.42 -53.15 39.71 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.319 1.448 . . . . 0.0 110.557 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -75.3 -40.27 58.76 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.597 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.31 -52.51 65.03 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -85.26 -0.26 54.13 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.274 0.63 . . . . 0.0 112.061 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.86 20.05 63.9 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 114.241 0.456 . . . . 0.0 114.241 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.62 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.344 1.058 . . . . 0.0 110.08 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -133.42 117.12 16.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 87' ' ' LEU . 83.9 mt -78.96 124.93 84.67 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.528 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 73.3 Cg_endo -75.4 58.13 5.04 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.47 2.114 . . . . 0.0 110.641 163.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -40.52 97.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.601 1.16 . . . . 0.0 109.294 -173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -61.11 -43.24 99.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.24 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -59.54 -48.68 80.71 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.741 0.651 . . . . 0.0 109.337 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 52.4 m0 -57.73 -43.93 85.65 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.524 1.14 . . . . 0.0 112.039 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.7 m -64.15 -39.03 93.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.577 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -77.81 -34.76 51.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 0.0 110.578 -175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.45 -42.99 98.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.568 0.747 . . . . 0.0 110.337 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.0 t -55.52 -51.9 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.438 172.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -28.63 69.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.644 0.778 . . . . 0.0 112.589 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -91.43 0.73 57.47 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.451 0.7 . . . . 0.0 111.665 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 7.89 84.34 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 113.584 0.194 . . . . 0.0 113.584 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.64 -25.03 61.97 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.403 0.681 . . . . 0.0 109.996 174.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.32 164.44 32.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.749 1.22 . . . . 0.0 109.286 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 m -92.58 160.28 15.1 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.8 p -50.12 -54.26 21.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.148 0.579 . . . . 0.0 111.211 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG23 ' A' ' 76' ' ' VAL . 10.6 pt-20 -44.56 -37.18 3.4 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -32.99 65.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.433 1.093 . . . . 0.0 111.265 -172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.42 -17.68 8.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.172 0.589 . . . . 0.0 111.957 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -115.4 13.34 16.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -167.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.5 t -99.97 134.67 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 165.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 33' ' ' LEU . 63.9 mt -56.79 -33.85 67.07 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -166.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -73.53 -36.36 65.67 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.27 0.486 . . . . 0.0 110.669 175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.4 m-20 -68.14 -51.29 47.74 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.535 0.734 . . . . 0.0 109.686 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.19 -47.93 80.04 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 125.241 1.416 . . . . 0.0 110.264 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.7 77.84 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.796 0.685 . . . . 0.0 110.513 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.7 -42.6 77.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.013 0.525 . . . . 0.0 110.616 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.1 mmp_? -59.43 -47.33 85.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.536 0.735 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 88' ' ' VAL . 59.0 mt -63.67 -48.15 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.69 -32.94 72.15 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.591 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.83 -36.56 78.34 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.422 0.689 . . . . 0.0 110.961 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD12 HD23 ' A' ' 55' ' ' LEU . 62.1 mt -74.53 -27.18 60.42 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.601 0.36 . . . . 0.0 110.739 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.3 t -79.89 -31.86 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.53 -27.78 66.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.076 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.95 -51.85 42.82 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.966 0.791 . . . . 0.0 110.08 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -48.15 -29.98 4.17 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.211 1.004 . . . . 0.0 112.686 168.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.43 -38.24 7.78 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 112.282 -0.327 . . . . 0.0 112.282 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.28 -31.75 55.04 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.286 1.034 . . . . 0.0 113.362 -170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.431 HD22 ' HD2' ' A' ' 99' ' ' HIS . 38.6 mt -84.93 84.92 7.55 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.884 0.849 . . . . 0.0 109.75 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.3 mt-10 -90.02 -175.3 4.53 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.903 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -64.84 98.47 0.28 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.067 0.547 . . . . 0.0 110.095 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t60 73.5 1.37 3.94 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.095 1.758 . . . . 0.0 111.677 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.672 ' HB2' ' HB2' ' A' ' 95' ' ' GLU . 70.8 m80 -99.32 131.67 45.17 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.879 0.872 . . . . 0.0 109.666 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.431 ' HD2' HD22 ' A' ' 94' ' ' LEU . 45.6 m80 -118.66 82.9 1.93 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 77.89 -45.77 0.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.873 1.669 . . . . 0.0 112.94 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.909 0.884 . . . . 0.0 109.832 -175.078 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 74.4 p 47.76 82.11 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.498 1.519 . . . . 0.0 113.632 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -77.63 125.8 29.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 81' ' ' ALA . 28.3 m -58.45 -48.52 80.45 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.601 0.563 . . . . 0.0 111.65 -173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -60.48 -43.49 96.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.312 0.382 . . . . 0.0 111.152 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.75 -44.04 94.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.767 0.427 . . . . 0.0 110.578 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.553 HH21 ' HB1' ' A' ' 50' ' ' ALA . 27.1 mmm180 -59.38 -52.06 67.23 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.38 1.05 . . . . 0.0 110.657 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 4' ' ' THR . 74.3 t -62.3 -41.43 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.258 1.023 . . . . 0.0 111.431 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.71 94.82 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.357 1.063 . . . . 0.0 110.987 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.8 m -62.44 -41.99 99.13 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.521 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.98 -48.57 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.207 1.003 . . . . 0.0 111.195 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.1 mt -66.15 -39.45 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.099 0.559 . . . . 0.0 110.35 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' ASP . . . -58.48 -35.91 72.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.086 173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.34 -30.79 27.2 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -78.98 -64.01 1.28 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.272 0.629 . . . . 0.0 111.308 -173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -109.33 6.69 24.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.445 0.698 . . . . 0.0 110.8 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 36.6 t70 49.7 73.03 0.27 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 0.0 112.102 -173.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.657 HG13 HD11 ' A' ' 35' ' ' ILE . 40.3 mm -114.85 125.2 29.31 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.93 135.47 66.96 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.908 2.405 . . . . 0.0 112.751 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -56.69 -27.54 59.11 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.079 0.952 . . . . 0.0 111.779 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -70.18 -31.7 69.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.038 0.535 . . . . 0.0 110.715 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -94.85 12.03 29.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.158 0.583 . . . . 0.0 110.78 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.69 93.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.8 p -103.69 159.54 28.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.53 -19.08 67.05 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.961 1.774 . . . . 0.0 112.079 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -95.78 10.02 38.48 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.47 0.708 . . . . 0.0 110.659 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.2 m -81.02 136.07 35.93 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.506 0.722 . . . . 0.0 110.26 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -94.65 129.71 41.42 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.555 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.21 -43.21 15.14 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.69 1.196 . . . . 0.0 113.933 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -103.67 -44.86 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.765 0.426 . . . . 0.0 109.934 -169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -77.73 -35.24 52.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.814 0.846 . . . . 0.0 111.882 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.35 -61.59 1.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.585 0.354 . . . . 0.0 111.068 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 77' ' ' LEU . 91.7 mt -65.88 -20.46 66.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.724 0.81 . . . . 0.0 111.845 -174.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.83 39.76 95.25 Favored Glycine 0 C--N 1.354 1.542 0 O-C-N 123.479 0.487 . . . . 0.0 113.281 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 18' ' ' ILE . 85.6 mt -108.52 127.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -75.86 157.99 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.1 0.409 . . . . 0.0 109.948 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.2 p -57.38 -26.24 60.75 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.481 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.23 -44.89 93.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.028 0.931 . . . . 0.0 111.09 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -74.6 -32.7 62.43 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.468 0.707 . . . . 0.0 109.817 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.7 -20.58 62.66 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.418 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.6 mt -58.73 -52.2 66.7 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.162 0.585 . . . . 0.0 109.479 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -70.19 -33.51 71.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.821 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.7 mt -59.57 -45.36 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.946 0.498 . . . . 0.0 109.802 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.58 78.8 Favored 'General case' 0 C--O 1.212 -0.905 0 C-N-CA 123.237 0.615 . . . . 0.0 110.676 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -65.76 -37.91 87.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.993 0.917 . . . . 0.0 110.946 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.53 81.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.083 0.553 . . . . 0.0 110.454 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.26 -44.7 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.106 0.963 . . . . 0.0 110.613 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -56.67 -51.7 67.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.695 0.798 . . . . 0.0 110.664 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -61.96 -49.22 76.97 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.553 ' HB1' HH21 ' A' ' 7' ' ' ARG . . . -58.94 -51.29 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.688 0.795 . . . . 0.0 112.331 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' HB2' HG13 ' A' ' 53' ' ' ILE . 86.7 m-85 -86.98 -9.28 55.99 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.571 0.748 . . . . 0.0 112.443 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.58 10.59 85.75 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 113.652 0.221 . . . . 0.0 113.652 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.9 pp -104.4 -173.97 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.1 0.96 . . . . 0.0 109.454 -176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -142.48 119.69 11.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.6 mt -74.36 123.48 89.18 Favored Pre-proline 0 N--CA 1.467 0.382 0 C-N-CA 123.812 0.845 . . . . 0.0 109.208 175.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 22.0 Cg_exo -66.97 61.91 0.61 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.179 2.586 . . . . 0.0 111.315 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.58 -48.53 69.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.508 1.123 . . . . 0.0 109.647 -167.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 47.6 mt-10 -61.18 -44.89 96.58 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.082 0.864 . . . . 0.0 110.487 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -61.19 -49.77 75.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.796 0.685 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 53.3 m0 -56.44 -41.14 75.94 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.993 0.808 . . . . 0.0 110.392 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.431 HG21 H302 ' A' ' 102' ' ' PNS . 87.0 m -64.66 -34.99 79.58 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.924 0.765 . . . . 0.0 110.373 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 26.1 mm-40 -73.63 -41.05 63.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.67 -40.53 88.62 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.19 0.996 . . . . 0.0 110.606 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.72 -47.93 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.994 0.518 . . . . 0.0 109.77 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.57 -22.12 63.56 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.103 0.561 . . . . 0.0 111.605 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.97 25.76 68.4 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 116.945 -0.116 . . . . 0.0 113.374 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.586 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.7 mmpt? -89.71 -29.38 18.78 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.642 0.777 . . . . 0.0 110.284 169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.43 162.65 33.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.47 1.108 . . . . 0.0 108.663 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.1 p -105.49 165.09 11.39 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 109.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -61.97 -62.94 1.43 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.838 0.455 . . . . 0.0 111.783 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -35.94 54.76 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.66 -29.57 27.1 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 124.625 1.203 . . . . 0.0 111.983 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -114.9 -31.36 6.12 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.336 0.655 . . . . 0.0 112.301 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -94.03 3.05 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -166.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.7 t -94.53 132.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD11 HD11 ' A' ' 33' ' ' LEU . 79.4 mt -57.33 -26.65 61.29 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -73.16 -40.96 64.43 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.319 0.509 . . . . 0.0 110.2 174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -70.53 -51.61 27.56 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.97 0.908 . . . . 0.0 109.128 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 84' ' ' ILE . 57.2 tp -50.44 -50.4 52.32 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 125.05 1.34 . . . . 0.0 110.521 174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.528 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -59.86 -38.57 82.52 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.72 0.638 . . . . 0.0 111.106 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.41 -28.33 63.93 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.395 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.2 mmp_? -69.54 -42.85 74.06 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.194 0.521 . . . . 0.0 109.725 175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 42.0 mt -64.06 -48.96 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.492 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.37 -35.25 78.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.489 1.116 . . . . 0.0 111.269 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -59.69 -41.35 90.53 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 55' ' ' LEU . 90.0 mt -74.8 -29.38 61.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.3 t -73.78 -28.18 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.24 -36.28 61.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.74 0.816 . . . . 0.0 110.16 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.67 -30.6 70.01 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.129 0.49 . . . . 0.0 110.613 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -85.57 -39.4 17.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.974 0.909 . . . . 0.0 110.52 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.58 -47.61 2.94 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.0 -0.546 . . . . 0.0 113.502 -166.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -9.3 59.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.573 0.749 . . . . 0.0 111.609 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt 59.44 -166.07 0.18 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.374 1.07 . . . . 0.0 112.084 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . 47.1 mt-10 -88.63 -50.49 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.1 m170 54.42 78.78 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.591 1.157 . . . . 0.0 112.284 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.439 ' NE2' ' HB3' ' A' ' 95' ' ' GLU . 18.3 m-70 -107.27 -78.95 0.58 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.408 ' H ' ' HB2' ' A' ' 97' ' ' HIS . 55.3 m80 -154.87 115.64 3.94 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 39.9 m80 62.44 -157.52 0.33 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.93 0.892 . . . . 0.0 109.503 -170.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 64.25 -162.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.535 0.734 . . . . 0.0 111.247 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.555 1.148 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.119 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.465 H312 HD11 ' A' ' 41' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.0 m -100.64 117.15 34.19 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -62.92 136.45 57.85 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.43 HG21 ' HB ' ' A' ' 84' ' ' ILE . 43.2 m -57.83 -34.21 69.44 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.298 0.639 . . . . 0.0 111.501 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -57.75 -49.15 77.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.713 0.405 . . . . 0.0 111.353 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -57.79 -44.97 86.62 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.894 0.478 . . . . 0.0 110.628 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -50.64 72.94 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 124.347 1.03 . . . . 0.0 111.253 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 t -58.02 -46.77 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 124.67 1.188 . . . . 0.0 111.369 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.1 -37.72 88.37 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.626 1.17 . . . . 0.0 111.357 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 48.1 m -62.58 -45.15 94.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.396 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.75 -36.06 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.489 0.716 . . . . 0.0 111.189 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 8' ' ' VAL . 77.7 mt -67.62 -45.61 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.7 69.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.535 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.0 mm-40 -79.23 -44.19 22.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.052 0.541 . . . . 0.0 112.091 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.1 m -76.48 -43.29 40.33 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.317 0.647 . . . . 0.0 111.431 -170.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.4 t -111.6 -3.68 15.01 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.464 0.706 . . . . 0.0 111.599 -168.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 53.25 66.98 1.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.031 0.932 . . . . 0.0 110.385 -172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG13 HD11 ' A' ' 35' ' ' ILE . 49.5 mm -121.1 124.05 27.54 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.698 0.799 . . . . 0.0 108.901 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.32 123.1 12.74 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.018 2.478 . . . . 0.0 112.489 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -55.91 -31.09 62.57 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.09 0.956 . . . . 0.0 111.464 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.1 pt-20 -66.3 -32.7 74.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 0.0 111.577 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 HG23 ' HG3' ' A' ' 21' ' ' GLU . 75.5 p -89.89 3.4 53.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.31 0.644 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.2 mt -103.01 103.5 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.676 0.79 . . . . 0.0 109.164 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.6 p -99.14 157.54 33.87 Favored Pre-proline 0 N--CA 1.483 1.198 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.67 -21.78 73.28 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.495 2.13 . . . . 0.0 112.166 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.24 17.43 22.57 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.073 0.949 . . . . 0.0 110.209 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.5 m -84.67 141.05 30.88 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.222 0.609 . . . . 0.0 109.741 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -84.77 116.07 23.06 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 168.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -47.76 -31.77 5.21 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.65 -54.68 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.698 0.399 . . . . 0.0 110.431 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.25 -33.13 33.0 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.899 0.88 . . . . 0.0 112.184 -166.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -93.32 -50.23 5.57 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.764 0.426 . . . . 0.0 110.597 -176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 77' ' ' LEU . 84.8 mt -73.57 -11.58 60.48 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.27 36.53 63.51 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 123.334 0.396 . . . . 0.0 113.013 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.471 HD11 HG13 ' A' ' 18' ' ' ILE . 57.6 mt -107.38 128.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.76 155.6 38.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 p -56.58 -39.44 73.52 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.296 1.038 . . . . 0.0 112.641 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 73.9 mt -64.14 -35.94 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.841 0.713 . . . . 0.0 110.392 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.48 -31.83 60.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.223 0.609 . . . . 0.0 109.97 175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -70.52 -21.27 62.75 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.65 0.38 . . . . 0.0 110.664 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.54 -40.5 97.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.736 0.414 . . . . 0.0 110.055 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.83 -45.95 91.59 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.725 0.81 . . . . 0.0 109.836 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.78 -43.61 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.482 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.72 -42.19 70.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.934 0.494 . . . . 0.0 109.874 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.71 -25.47 61.23 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.888 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.67 -40.01 76.67 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.621 0.368 . . . . 0.0 110.042 173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.15 -46.12 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.81 0.844 . . . . 0.0 110.461 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -54.45 -53.65 51.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.237 1.015 . . . . 0.0 111.77 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -66.44 -34.52 78.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.167 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.02 -44.26 93.11 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.359 0.664 . . . . 0.0 111.845 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -92.52 0.17 57.4 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.732 0.813 . . . . 0.0 112.66 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.63 71.03 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 113.965 0.346 . . . . 0.0 113.965 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 84' ' ' ILE . 25.8 pt -127.39 -165.53 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 0.0 109.352 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -135.69 149.41 49.24 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 166.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 84' ' ' ILE . 98.1 mt -95.2 130.13 33.36 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 162.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.21 68.53 5.03 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.694 2.262 . . . . 0.0 110.848 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.81 1.244 . . . . 0.0 109.563 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -65.2 -48.01 74.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.924 0.89 . . . . 0.0 108.995 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.72 -44.81 95.27 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.026 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.9 m0 -59.08 -46.72 87.55 Favored 'General case' 0 C--O 1.217 -0.658 0 O-C-N 123.982 0.801 . . . . 0.0 110.405 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -58.58 -45.52 88.87 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.762 0.664 . . . . 0.0 110.596 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -74.15 -45.28 49.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.681 0.393 . . . . 0.0 110.585 -172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 35.9 mt-10 -65.11 -38.3 90.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.048 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 42.5 t -58.94 -47.68 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.398 0.436 . . . . 0.0 110.209 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.42 -39.13 82.51 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.927 0.891 . . . . 0.0 112.498 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.99 8.91 30.04 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.398 0.679 . . . . 0.0 112.646 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.74 3.56 59.54 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 114.532 0.573 . . . . 0.0 114.532 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 59.3 mttm -66.81 -34.6 78.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.631 0.773 . . . . 0.0 109.152 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.25 179.74 6.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.112 1.365 . . . . 0.0 109.038 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 p -129.42 164.7 23.08 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.629 0.772 . . . . 0.0 110.28 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -60.71 -68.21 0.32 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.129 0.572 . . . . 0.0 111.86 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HB2' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -56.79 -24.69 52.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.141 0.977 . . . . 0.0 113.044 -174.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -48.85 -38.32 22.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.203 1.001 . . . . 0.0 111.848 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -116.44 -29.47 6.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.886 0.474 . . . . 0.0 111.171 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -95.1 13.51 25.0 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.291 0.636 . . . . 0.0 112.067 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 78' ' ' LYS . 45.3 t -96.14 130.81 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 163.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.702 HD11 HD11 ' A' ' 33' ' ' LEU . 88.8 mt -54.59 -31.16 56.45 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -78.37 -35.59 47.13 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 118.197 0.453 . . . . 0.0 111.004 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -69.32 -45.27 69.9 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.767 0.827 . . . . 0.0 109.567 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 84' ' ' ILE . 35.0 tp -56.52 -51.72 67.47 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.266 1.427 . . . . 0.0 109.372 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.14 72.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.76 0.824 . . . . 0.0 112.244 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.6 -43.11 81.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.934 0.493 . . . . 0.0 110.393 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -65.33 -43.0 92.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.788 0.835 . . . . 0.0 111.365 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.556 HG12 HD21 ' A' ' 55' ' ' LEU . 61.7 mt -61.0 -53.48 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.836 0.855 . . . . 0.0 110.263 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.34 -35.03 77.84 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.728 0.811 . . . . 0.0 111.111 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.5 -41.32 89.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.293 1.037 . . . . 0.0 110.912 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.66 -28.11 61.6 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.994 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.76 -39.28 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.209 0.604 . . . . 0.0 109.922 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.77 64.59 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.586 0.754 . . . . 0.0 110.598 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.12 -33.22 74.06 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.695 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.1 -39.35 60.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.497 0.719 . . . . 0.0 109.979 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.08 -63.17 2.74 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.267 -0.741 . . . . 0.0 111.721 -175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 94' ' ' LEU . . . 160.14 1.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 126.844 2.057 . . . . 0.0 110.052 175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 93' ' ' ALA . 2.0 mm? -75.13 162.48 28.47 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.737 0.815 . . . . 0.0 109.69 -173.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 75.56 2.71 3.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.801 1.64 . . . . 0.0 111.159 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m80 64.64 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.49 1.516 . . . . 0.0 111.813 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -78.87 59.06 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.246 1.022 . . . . 0.0 110.44 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -143.02 -177.36 5.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.252 1.421 . . . . 0.0 108.648 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -96.21 148.1 23.07 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -66.22 93.36 0.21 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.541 0.737 . . . . 0.0 109.952 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 123.856 0.862 . . . . 0.0 109.286 -178.143 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.804 -0.072 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 p -94.79 -20.06 19.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.689 0.795 . . . . 0.0 113.011 -167.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 34.0 t -156.42 163.93 38.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.539 0.736 . . . . 0.0 110.46 -172.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' VAL . 37.0 m -72.46 -37.77 68.43 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -66.57 -41.71 88.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.438 0.295 . . . . 0.0 110.435 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 0.0 OUTLIER -58.21 -43.39 87.62 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.141 0.577 . . . . 0.0 109.726 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -59.96 -60.39 3.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.062 0.945 . . . . 0.0 110.906 175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 4' ' ' THR . 90.5 t -59.41 -42.57 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.296 1.038 . . . . 0.0 111.679 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.11 85.3 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.1 0.96 . . . . 0.0 111.161 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 36.9 m -63.09 -47.48 82.69 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.123 176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.7 -49.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.957 0.903 . . . . 0.0 112.356 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.19 -39.4 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.688 0.395 . . . . 0.0 109.949 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -48.89 75.14 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.246 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 10' ' ' THR . 15.8 mm-40 -71.26 -34.59 70.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.71 0.404 . . . . 0.0 111.668 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.7 m -70.46 -55.39 9.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.997 0.519 . . . . 0.0 111.677 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -109.01 14.95 23.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.027 0.531 . . . . 0.0 112.083 -171.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 49.77 49.68 19.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.497 1.119 . . . . 0.0 111.291 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 16' ' ' CYS . 38.3 mm -88.68 130.55 44.75 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.25 111.36 0.73 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 121.97 1.78 . . . . 0.0 111.078 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -54.85 -35.25 63.81 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.552 1.141 . . . . 0.0 110.13 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.35 -35.54 81.2 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.566 1.146 . . . . 0.0 112.037 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -83.01 -10.52 58.72 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.722 0.409 . . . . 0.0 111.516 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.2 mt -78.58 104.35 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.6 p -103.67 159.71 28.45 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.489 1.116 . . . . 0.0 110.348 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.92 -30.57 77.14 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.584 2.189 . . . . 0.0 112.583 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -93.78 7.03 46.41 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.573 0.749 . . . . 0.0 110.311 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB3' HD12 ' A' ' 77' ' ' LEU . 34.5 t -75.64 128.86 36.16 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 62.6 t-80 -95.0 126.15 40.15 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.7 -38.54 55.53 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 124.093 0.957 . . . . 0.0 113.032 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.84 -49.92 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.6 t70 -73.08 -48.17 38.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.681 0.792 . . . . 0.0 111.579 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.16 -59.42 2.24 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 0.0 111.027 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 77' ' ' LEU . 94.4 mt -73.49 -22.12 60.23 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.034 0.533 . . . . 0.0 112.251 -174.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.94 49.24 29.19 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 121.153 0.307 . . . . 0.0 112.511 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.52 113.99 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.392 1.077 . . . . 0.0 108.524 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.7 169.75 11.04 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.657 0.783 . . . . 0.0 109.148 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.715 ' HB2' HG21 ' A' ' 61' ' ' THR . 1.3 t -43.55 -49.22 7.53 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.426 1.49 . . . . 0.0 112.563 173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.07 -36.46 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.178 0.591 . . . . 0.0 112.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.99 -40.09 63.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.339 0.656 . . . . 0.0 109.885 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -76.63 -16.75 59.48 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.057 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.7 mt -52.85 -53.09 53.85 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.752 0.421 . . . . 0.0 111.14 174.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.65 -34.87 77.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.933 0.493 . . . . 0.0 110.948 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.51 HD11 ' SG ' ' A' ' 16' ' ' CYS . 50.9 mt -65.52 -35.74 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.37 175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.16 -26.25 60.19 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 123.815 0.846 . . . . 0.0 110.041 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.1 -32.53 63.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.736 0.815 . . . . 0.0 110.823 172.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -47.87 57.39 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 120.984 0.421 . . . . 0.0 110.185 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.0 -38.37 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.91 0.884 . . . . 0.0 110.47 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.5 t70 -50.86 -64.7 0.73 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 0.0 111.241 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -68.46 -34.24 75.6 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.572 -172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.72 -59.68 4.83 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.793 0.683 . . . . 0.0 111.583 177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 4' ' ' THR . 83.9 m-85 -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 0.0 112.471 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.68 15.13 79.45 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 123.16 0.288 . . . . 0.0 113.225 -176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' ASP . 2.2 pp -118.33 164.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.433 1.093 . . . . 0.0 108.806 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -108.93 137.81 46.25 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 84' ' ' ILE . 74.9 mt -82.1 128.27 68.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 167.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.94 58.17 3.34 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 122.271 1.98 . . . . 0.0 110.303 163.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.06 -38.73 91.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.238 1.015 . . . . 0.0 109.733 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.4 -44.78 93.7 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.114 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -67.86 -45.5 74.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.815 0.846 . . . . 0.0 111.267 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -59.33 -52.93 63.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.434 1.093 . . . . 0.0 110.256 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 37' ' ' SER . 7.7 m -73.64 -19.52 60.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.927 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -73.94 -41.53 61.91 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 47.5 mt-10 -65.64 -33.51 76.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.204 1.002 . . . . 0.0 110.705 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.09 -47.62 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 122.823 0.449 . . . . 0.0 109.972 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.54 -25.13 65.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.716 0.806 . . . . 0.0 112.159 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -91.83 3.89 54.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.706 0.802 . . . . 0.0 111.651 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.1 3.82 53.61 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.928 0.731 . . . . 0.0 114.928 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.4 mmtp -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.843 0.857 . . . . 0.0 110.692 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.56 164.14 31.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.097 0.959 . . . . 0.0 109.857 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.457 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 7.0 m -97.35 155.06 17.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 109.083 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 p -52.0 -50.65 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.669 0.788 . . . . 0.0 111.163 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 76' ' ' VAL . 39.1 mt-10 -40.41 -47.56 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.599 1.559 . . . . 0.0 114.194 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.457 ' NE2' ' H ' ' A' ' 70' ' ' THR . 77.7 mt-30 -55.13 -30.57 60.04 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.688 -1.142 . . . . 0.0 112.862 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -118.55 -16.64 9.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.29 2.09 13.19 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' HA ' ' A' ' 72' ' ' GLU . 82.4 t -88.38 117.66 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 171.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 33' ' ' LEU . 87.5 mt -55.78 -24.29 34.8 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -160.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -78.3 -39.95 38.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.417 0.553 . . . . 0.0 110.756 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 13.9 m120 -66.65 -48.27 69.93 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.036 0.934 . . . . 0.0 109.579 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 84' ' ' ILE . 58.7 tp -53.19 -49.91 65.73 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 125.206 1.402 . . . . 0.0 110.517 174.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.93 82.74 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.633 0.583 . . . . 0.0 110.9 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.75 -37.53 79.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.904 0.481 . . . . 0.0 111.115 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' NH2' ' HG3' ' A' ' 86' ' ' GLU . 4.9 mmp_? -69.21 -38.51 78.63 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.257 0.623 . . . . 0.0 110.702 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 55' ' ' LEU . 80.5 mt -66.23 -40.63 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.83 0.852 . . . . 0.0 109.659 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.18 -35.16 77.98 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.04 0.936 . . . . 0.0 110.508 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' HG3' ' NH2' ' A' ' 83' ' ' ARG . 54.1 mm-40 -65.78 -38.22 88.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.815 0.846 . . . . 0.0 111.012 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.3 mt -74.42 -27.9 60.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.928 0.491 . . . . 0.0 111.655 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.26 -40.18 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.15 75.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.341 0.657 . . . . 0.0 110.353 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.34 -21.49 61.31 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.81 0.844 . . . . 0.0 112.059 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -85.8 -27.7 24.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.845 0.458 . . . . 0.0 110.436 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.42 -7.64 65.01 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.527 -0.306 . . . . 0.0 112.609 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -159.64 169.22 24.21 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.726 1.21 . . . . 0.0 109.153 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.6 mt -125.28 164.25 20.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.182 0.593 . . . . 0.0 110.318 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.08 137.73 50.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.933 166.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.33 97.73 2.55 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -155.71 170.89 20.99 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.584 0.707 . . . . 0.0 110.741 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -126.05 -55.55 1.47 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 165.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 54.23 74.55 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.632 1.173 . . . . 0.0 109.195 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -54.08 108.23 0.34 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.15 0.98 . . . . 0.0 111.705 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.505 ' O25' H301 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.2 t -150.09 -170.72 3.72 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -131.52 149.81 52.38 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.3 m -62.04 -42.26 98.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -60.76 -36.27 78.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.872 0.869 . . . . 0.0 111.45 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.21 -45.56 90.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -65.8 -55.32 17.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.802 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 4' ' ' THR . 69.6 t -54.98 -45.64 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.462 1.105 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.14 91.95 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.453 1.101 . . . . 0.0 111.277 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 41.6 m -63.65 -44.7 93.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.799 0.687 . . . . 0.0 110.819 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.4 mt -59.45 -44.33 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.236 0.614 . . . . 0.0 110.898 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 43' ' ' ILE . 64.4 mt -68.28 -39.52 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.324 0.649 . . . . 0.0 110.426 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.79 80.17 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.804 0.841 . . . . 0.0 111.839 172.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 10' ' ' THR . 26.8 mm-40 -79.8 -22.63 42.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.66 0.784 . . . . 0.0 112.041 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.2 m -78.75 -62.4 1.7 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.249 0.62 . . . . 0.0 111.303 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 43' ' ' ILE . 83.0 m -106.85 15.05 25.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.111 0.565 . . . . 0.0 111.9 -169.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 52.9 57.5 6.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.35 1.06 . . . . 0.0 111.268 -177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.6 mm -99.53 129.45 28.97 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.42 121.44 9.6 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 121.954 1.769 . . . . 0.0 111.201 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 23' ' ' ILE . 9.1 tpt180 -54.93 -32.41 61.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.334 1.053 . . . . 0.0 111.508 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.8 pt-20 -66.94 -32.13 73.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.724 0.809 . . . . 0.0 111.11 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 21' ' ' GLU . 78.3 p -95.1 19.55 10.33 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.671 0.788 . . . . 0.0 111.238 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 20' ' ' ARG . 71.3 mt -110.0 106.26 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.2 p -99.77 161.64 23.73 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.34 0.656 . . . . 0.0 109.548 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 40.9 Cg_exo -60.12 -25.41 79.8 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.282 1.988 . . . . 0.0 112.224 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.21 11.54 29.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.168 0.987 . . . . 0.0 110.652 -176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.4 m -73.25 125.43 27.75 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' HE2' ' CB ' ' A' ' 71' ' ' THR . 66.1 t-80 -90.03 125.6 35.46 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.21 -42.98 21.17 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.117 0.967 . . . . 0.0 113.574 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.59 -49.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -78.63 -29.17 45.76 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.849 -167.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.24 -66.72 0.96 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.102 0.561 . . . . 0.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 77' ' ' LEU . 92.1 mt -65.39 -23.58 67.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.478 0.711 . . . . 0.0 112.676 -173.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.97 51.85 21.86 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 121.455 0.475 . . . . 0.0 112.387 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -125.7 111.88 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -71.71 162.91 28.72 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.3 m -60.2 -29.86 68.99 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.085 0.554 . . . . 0.0 111.581 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.13 -43.0 88.38 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.721 0.808 . . . . 0.0 110.497 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -69.32 -28.37 66.19 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.074 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -75.09 -18.93 60.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.09 0.956 . . . . 0.0 110.725 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 57' ' ' LEU . 90.3 mt -62.83 -50.94 68.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.83 -39.28 93.32 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.178 0.991 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 16' ' ' CYS . 13.3 mm -51.03 -51.16 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 0.0 109.668 169.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -74.1 -27.15 60.74 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 114.746 -1.115 . . . . 0.0 112.246 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -63.03 -45.34 92.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -46.48 79.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 84' ' ' ILE . 67.2 mt -66.44 -45.51 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.285 0.634 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 16.0 t70 -48.7 -59.55 3.44 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.152 1.381 . . . . 0.0 110.705 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -69.11 -35.98 77.02 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.575 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.25 24.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.405 0.682 . . . . 0.0 112.138 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.65 -7.18 58.4 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.316 0.646 . . . . 0.0 112.181 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.55 28.4 73.72 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.01 0.194 . . . . 0.0 113.367 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.41 171.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.222 1.009 . . . . 0.0 109.705 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -116.25 112.52 21.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD21 HG12 ' A' ' 84' ' ' ILE . 95.8 mt -81.59 125.17 79.06 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.201 0.601 . . . . 0.0 110.282 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.67 60.28 7.57 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.634 2.222 . . . . 0.0 111.119 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 41' ' ' LEU . 1.3 tm? -66.01 -44.31 85.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.828 0.851 . . . . 0.0 110.19 -171.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.81 -35.82 79.33 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.605 0.566 . . . . 0.0 110.762 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -63.62 -48.09 78.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -59.33 -38.96 81.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.153 0.981 . . . . 0.0 111.404 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.9 m -68.94 -36.33 77.84 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.651 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.68 -34.04 60.42 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.455 0.302 . . . . 0.0 110.199 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.68 -37.7 85.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.649 0.38 . . . . 0.0 110.365 174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.03 -56.51 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.545 0.738 . . . . 0.0 111.102 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.77 -28.12 69.22 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.705 0.802 . . . . 0.0 112.935 -176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -100.55 6.66 44.27 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.219 0.608 . . . . 0.0 111.863 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.02 16.81 53.79 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 115.094 0.797 . . . . 0.0 115.094 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -65.83 -40.03 91.39 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.147 0.979 . . . . 0.0 109.762 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.8 141.29 40.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.103 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.439 ' N ' HE21 ' A' ' 73' ' ' GLN . 55.5 m -67.84 145.51 54.57 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.962 0.905 . . . . 0.0 110.412 177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.415 ' CB ' ' HE2' ' A' ' 28' ' ' HIS . 57.9 p -48.38 -57.38 6.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.031 1.332 . . . . 0.0 112.527 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 45.1 mt-10 -43.54 -37.03 2.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.602 1.561 . . . . 0.0 115.166 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.439 HE21 ' N ' ' A' ' 70' ' ' THR . 46.1 mt-30 -58.19 -27.45 63.89 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.445 0.698 . . . . 0.0 112.437 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.23 -26.78 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.356 0.662 . . . . 0.0 111.939 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -100.87 -9.49 21.57 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 72' ' ' GLU . 38.0 t -91.92 122.93 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD11 HD11 ' A' ' 33' ' ' LEU . 43.3 mt -57.08 -25.87 59.46 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -161.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 57.1 pttt -76.68 -38.05 55.14 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.16 0.437 . . . . 0.0 110.638 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 78.9 m-20 -72.55 -42.06 65.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.846 0.858 . . . . 0.0 109.651 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.1 -50.55 73.61 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.782 1.233 . . . . 0.0 109.898 173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.75 74.81 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.195 0.598 . . . . 0.0 110.947 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -68.65 -42.49 77.9 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.503 0.502 . . . . 0.0 110.451 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 4.3 mmp_? -58.29 -44.79 88.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.402 0.681 . . . . 0.0 110.425 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.548 HG12 HD21 ' A' ' 55' ' ' LEU . 54.9 mt -65.74 -44.88 93.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.158 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.55 -37.5 85.11 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.879 0.872 . . . . 0.0 111.24 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 8.4 mm-40 -63.5 -39.39 94.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.742 0.817 . . . . 0.0 109.576 174.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.28 -27.69 62.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.611 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.8 t -64.88 -47.34 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 118.245 0.475 . . . . 0.0 109.833 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.23 -41.77 96.86 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.362 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.0 -40.78 78.53 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.884 0.874 . . . . 0.0 111.971 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -47.13 60.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.794 0.838 . . . . 0.0 109.622 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.54 -61.97 4.14 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.833 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 45.1 63.46 1.74 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.513 1.125 . . . . 0.0 110.889 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.8 18.94 14.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.018 0.927 . . . . 0.0 110.716 -172.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -80.82 -26.66 36.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.156 0.982 . . . . 0.0 110.597 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 66.48 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.196 1.398 . . . . 0.0 109.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 t60 77.0 -34.34 0.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.498 1.519 . . . . 0.0 113.716 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 69.77 101.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.823 1.249 . . . . 0.0 109.844 -171.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -71.79 103.3 3.08 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.068 0.461 . . . . 0.0 110.243 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -67.4 -35.6 79.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.239 0.542 . . . . 0.0 109.832 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.481 1.113 . . . . 0.0 108.66 174.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 ttm . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.833 -0.127 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -160.47 117.34 2.42 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.03 0.532 . . . . 0.0 111.108 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 32.7 t 178.54 172.39 0.73 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 126.172 1.789 . . . . 0.0 108.035 174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.4 m -68.14 -54.19 19.8 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.32 0.509 . . . . 0.0 110.116 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.63 -32.73 71.87 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.483 0.489 . . . . 0.0 110.62 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.49 -45.33 92.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.454 0.302 . . . . 0.0 110.628 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 3' ' ' SER . 32.2 mmt180 -62.41 -45.78 91.56 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.096 0.872 . . . . 0.0 110.681 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 98.2 t -58.93 -44.1 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 124.059 0.944 . . . . 0.0 111.184 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.11 -39.07 75.72 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.747 1.219 . . . . 0.0 110.884 -176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.2 m -58.66 -49.38 77.75 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.576 0.75 . . . . 0.0 110.337 171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.1 mt -56.1 -50.97 67.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.157 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 18' ' ' ILE . 77.1 mt -67.27 -38.97 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 117.905 0.321 . . . . 0.0 111.244 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.29 -53.51 57.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.44 0.696 . . . . 0.0 112.696 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.9 -30.86 45.11 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.223 0.609 . . . . 0.0 112.335 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.4 m -83.0 -58.85 2.69 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.831 0.852 . . . . 0.0 111.594 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.8 t -97.38 -1.17 45.01 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.071 -169.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.02 49.05 9.99 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.484 1.114 . . . . 0.0 110.699 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' A' ' 12' ' ' ILE . 48.4 mm -101.92 129.2 26.98 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 117.2 3.77 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.455 2.103 . . . . 0.0 112.434 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.4 tpt180 -52.01 -34.06 41.22 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.256 1.023 . . . . 0.0 112.49 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.92 -26.88 63.4 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.666 0.786 . . . . 0.0 111.837 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.6 p -94.83 6.78 47.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.597 0.359 . . . . 0.0 110.91 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ARG . 77.2 mt -97.65 94.39 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -98.06 158.3 33.05 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.355 0.662 . . . . 0.0 109.494 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.43 -26.71 72.6 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.588 2.192 . . . . 0.0 112.387 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.28 17.73 22.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.187 0.995 . . . . 0.0 110.842 -174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.8 m -79.33 135.33 36.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.681 170.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 64.2 t-80 -90.49 124.54 35.07 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.63 52.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.091 0.956 . . . . 0.0 112.504 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mt -86.39 -43.49 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.8 t70 -79.87 -56.31 4.36 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.961 0.905 . . . . 0.0 111.716 -172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.56 -56.1 3.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.528 0.731 . . . . 0.0 111.12 -170.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 77' ' ' LEU . 85.7 mt -74.33 -14.44 60.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.116 0.566 . . . . 0.0 112.205 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.9 33.26 86.78 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.408 0.442 . . . . 0.0 113.394 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.2 mt -81.56 147.32 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.13 0.972 . . . . 0.0 108.561 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.46 165.59 11.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.2 t -51.61 -50.72 59.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.503 0.721 . . . . 0.0 111.895 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -56.91 -33.62 67.12 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.993 0.517 . . . . 0.0 112.021 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.02 -47.5 36.54 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -65.76 -24.99 67.07 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.42 -172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.7 mt -62.82 -47.73 82.15 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.981 0.512 . . . . 0.0 109.682 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 45' ' ' PHE . 17.7 t70 -76.63 -26.4 54.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.193 0.597 . . . . 0.0 110.898 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.01 -40.4 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.28 -23.82 43.34 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.419 0.688 . . . . 0.0 110.719 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 5.6 m-85 -65.91 -43.11 89.14 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.628 0.771 . . . . 0.0 109.612 168.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.91 82.64 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.597 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.04 -42.4 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.699 0.8 . . . . 0.0 110.718 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -53.15 -52.33 59.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.544 1.138 . . . . 0.0 111.048 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -70.36 -46.79 63.39 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.079 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.28 -61.96 2.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.888 0.875 . . . . 0.0 112.851 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 53' ' ' ILE . 97.2 m-85 -83.68 -7.15 59.55 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.884 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' O ' ' HE2' ' A' ' 91' ' ' LYS . . . 68.96 31.4 72.51 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.455 0.472 . . . . 0.0 113.607 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.7 pp -126.46 -172.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.093 0.957 . . . . 0.0 110.126 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -142.72 123.69 14.39 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -76.0 131.93 75.02 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.84 76.23 2.04 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.371 2.047 . . . . 0.0 111.398 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.76 -54.1 42.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.293 1.037 . . . . 0.0 111.186 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.21 -49.33 76.32 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 124.355 1.035 . . . . 0.0 111.149 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -58.56 -52.24 66.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.588 0.755 . . . . 0.0 110.268 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -59.88 -40.96 90.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 124.411 1.069 . . . . 0.0 111.379 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.3 m -62.55 -42.01 99.26 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.542 0.737 . . . . 0.0 110.361 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.42 -41.54 69.4 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.617 0.367 . . . . 0.0 110.125 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.21 -41.84 93.89 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.376 0.67 . . . . 0.0 111.096 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.07 -53.2 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.435 0.694 . . . . 0.0 110.272 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -58.59 -35.96 73.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.904 0.882 . . . . 0.0 113.126 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -88.96 1.45 55.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.66 17.5 62.6 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.559 0.584 . . . . 0.0 114.559 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -76.58 -24.18 53.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.29 0.636 . . . . 0.0 109.593 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.83 158.28 43.79 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.96 1.304 . . . . 0.0 109.58 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.3 p -91.12 164.84 13.79 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 123.362 0.665 . . . . 0.0 110.04 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -62.36 -50.96 69.52 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.164 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.6 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.2 tm-20 -40.83 -44.21 2.21 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.811 1.644 . . . . 0.0 113.93 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -55.15 -32.06 61.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.14 -29.13 6.37 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.23 -7.54 29.05 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.6 HG23 ' HA ' ' A' ' 72' ' ' GLU . 74.9 t -88.12 124.28 41.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 174.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 33' ' ' LEU . 42.1 mt -61.46 -22.67 65.26 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -160.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.5 pttt -76.3 -35.94 58.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.41 -50.27 47.49 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 84' ' ' ILE . 50.8 tp -56.54 -43.89 80.31 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 124.177 0.991 . . . . 0.0 110.338 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.48 91.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.178 0.591 . . . . 0.0 111.078 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.05 75.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.027 0.531 . . . . 0.0 111.842 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -64.85 -47.66 77.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.364 1.066 . . . . 0.0 110.249 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 64.8 mt -62.24 -50.74 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.719 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB2' HG21 ' A' ' 4' ' ' THR . 26.8 t70 -56.75 -46.42 81.43 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.564 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.03 -26.36 63.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.84 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.71 -30.72 56.79 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.136 0.574 . . . . 0.0 111.343 174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 54.5 t -67.12 -39.89 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 172.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -30.76 60.3 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.92 -29.49 67.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.933 0.493 . . . . 0.0 111.234 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 52' ' ' GLY . 25.8 ttpp -89.92 -21.09 22.65 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.684 0.794 . . . . 0.0 110.544 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.31 -59.61 1.09 Allowed Glycine 0 C--N 1.35 1.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.773 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 174.62 123.19 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.459 1.104 . . . . 0.0 110.028 -166.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.1 mt -127.67 38.76 3.99 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.367 0.667 . . . . 0.0 111.975 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.33 121.67 30.98 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 173.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -177.2 12.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.078 0.951 . . . . 0.0 110.72 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.46 162.88 0.24 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.438 1.495 . . . . 0.0 109.45 -166.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.0 t60 90.32 -32.14 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.796 2.038 . . . . 0.0 110.071 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 65.7 t60 72.79 108.1 0.07 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.442 1.497 . . . . 0.0 112.843 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -147.25 161.45 40.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.228 1.011 . . . . 0.0 109.298 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.0 t60 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.312 1.445 . . . . 0.0 110.828 -174.494 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.432 H311 ' HB3' ' A' ' 37' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ttt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.753 0.311 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.2 m -73.62 78.55 1.5 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 p -82.78 74.6 9.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.457 0.703 . . . . 0.0 109.782 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.1 m -63.04 -39.86 95.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.968 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.15 -47.33 85.71 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.034 0.379 . . . . 0.0 110.351 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.2 -45.62 83.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.635 0.774 . . . . 0.0 111.155 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -63.22 -52.75 60.96 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.198 0.936 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.92 -38.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.316 1.046 . . . . 0.0 111.031 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.95 -46.85 79.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.607 1.163 . . . . 0.0 110.694 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 11.4 m -64.76 -39.53 93.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.873 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.18 -47.56 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.717 0.807 . . . . 0.0 111.013 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.45 -40.97 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.236 0.614 . . . . 0.0 109.844 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.76 86.19 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.292 1.037 . . . . 0.0 113.187 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 29.9 mm-40 -79.36 -39.21 33.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.178 0.591 . . . . 0.0 111.705 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.1 m -76.15 -54.27 7.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.459 0.704 . . . . 0.0 111.375 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -105.54 10.52 33.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.266 0.626 . . . . 0.0 111.434 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.5 t70 52.3 59.8 4.26 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.44 1.096 . . . . 0.0 110.939 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -99.57 126.62 36.74 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.968 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.19 125.17 17.69 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.474 2.116 . . . . 0.0 110.809 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HA ' HD12 ' A' ' 23' ' ' ILE . 8.3 tpt180 -57.36 -28.87 63.54 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.999 0.519 . . . . 0.0 111.914 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.8 pt-20 -61.58 -36.67 81.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.389 0.676 . . . . 0.0 111.453 176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 61.9 p -92.23 23.82 3.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.608 0.763 . . . . 0.0 110.615 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.545 HG21 ' HB1' ' A' ' 9' ' ' ALA . 68.6 mt -117.19 97.06 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.468 0.651 . . . . 0.0 109.43 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.3 p -111.92 159.49 33.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 52.2 Cg_exo -55.9 -22.3 37.35 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.655 2.237 . . . . 0.0 113.172 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -100.06 8.72 43.75 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.163 0.985 . . . . 0.0 111.747 -172.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -79.9 140.63 36.65 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.048 0.539 . . . . 0.0 110.115 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -97.88 121.52 39.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.558 0.743 . . . . 0.0 109.242 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.96 58.73 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.031 0.933 . . . . 0.0 113.18 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.82 -49.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.93 -32.04 20.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.365 0.666 . . . . 0.0 112.159 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -100.6 -58.47 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 77' ' ' LEU . 47.8 mt -77.22 -15.78 59.33 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.502 0.721 . . . . 0.0 111.857 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 56.01 11.94 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.451 0.47 . . . . 0.0 113.132 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.2 mt -119.48 124.71 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.17 0.988 . . . . 0.0 109.209 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.0 165.88 22.13 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.186 0.594 . . . . 0.0 109.603 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -53.32 -43.57 67.74 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.901 0.48 . . . . 0.0 110.912 177.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -58.74 -43.93 90.37 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.24 0.962 . . . . 0.0 111.026 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -71.56 -31.4 66.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.339 0.656 . . . . 0.0 110.615 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -75.31 -20.51 59.04 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.762 0.825 . . . . 0.0 110.399 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 92.8 mt -67.43 -43.68 80.57 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.07 -39.07 93.25 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.139 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.93 -47.25 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.383 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.35 -29.21 66.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.193 0.597 . . . . 0.0 110.831 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -74.5 -38.3 62.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.328 1.051 . . . . 0.0 111.034 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.66 -34.42 73.96 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.625 0.37 . . . . 0.0 110.257 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 53' ' ' ILE . 95.5 mt -68.87 -43.4 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.897 0.879 . . . . 0.0 110.404 172.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -53.81 -46.63 71.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.993 1.317 . . . . 0.0 110.402 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -75.91 -51.24 12.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.25 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.26 -51.68 68.78 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.404 0.682 . . . . 0.0 112.79 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 53' ' ' ILE . 88.0 m-85 -81.75 -16.45 51.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.969 0.508 . . . . 0.0 111.571 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.12 18.55 79.25 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -103.84 -172.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.599 0.76 . . . . 0.0 109.97 -176.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -140.17 114.85 9.46 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD21 HG12 ' A' ' 84' ' ' ILE . 82.0 mt -83.05 130.66 56.48 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 122.992 0.517 . . . . 0.0 110.457 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.65 61.26 5.33 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.621 2.214 . . . . 0.0 110.644 166.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -64.33 -33.62 76.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.322 1.049 . . . . 0.0 109.337 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.36 -48.83 80.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 109.665 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.19 -50.13 74.61 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.016 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.5 m0 -60.97 -40.92 95.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.495 1.122 . . . . 0.0 111.575 -175.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -63.16 -42.14 99.36 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.804 0.842 . . . . 0.0 110.921 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.4 -39.15 78.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.87 0.468 . . . . 0.0 110.537 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.45 -49.15 77.99 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.983 0.802 . . . . 0.0 110.736 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 60' ' ' TRP . 63.6 t -57.02 -53.82 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.629 0.771 . . . . 0.0 110.567 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -60.28 -35.51 75.71 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.25 1.02 . . . . 0.0 112.684 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.07 4.74 47.35 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.184 0.594 . . . . 0.0 111.417 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.9 61.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.379 0.511 . . . . 0.0 114.379 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -72.36 -22.11 61.2 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.966 0.906 . . . . 0.0 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.17 33.3 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.618 1.167 . . . . 0.0 109.417 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -93.55 162.22 14.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.5 p -58.84 -53.85 53.7 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.99 -41.5 11.91 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.185 1.394 . . . . 0.0 113.53 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.97 -37.75 46.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.915 0.886 . . . . 0.0 112.708 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -118.58 -14.12 9.64 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -108.39 8.25 27.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.012 0.525 . . . . 0.0 111.996 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -93.17 128.05 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 167.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 33' ' ' LEU . 21.7 mt -56.18 -33.31 65.16 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -165.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 23.0 pttp -76.53 -35.79 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 117.983 0.356 . . . . 0.0 111.196 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -66.32 -46.31 77.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.853 0.861 . . . . 0.0 109.573 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -52.42 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.509 1.124 . . . . 0.0 110.022 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -65.1 -27.29 68.65 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.44 0.696 . . . . 0.0 111.448 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.25 69.9 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.2 mmp_? -57.14 -44.15 83.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 123.851 0.719 . . . . 0.0 110.72 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.661 HG12 HD21 ' A' ' 55' ' ' LEU . 70.0 mt -64.04 -49.93 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.465 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.92 -34.56 78.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.835 0.854 . . . . 0.0 111.269 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.54 -33.38 75.78 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.561 0.744 . . . . 0.0 111.319 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.81 -28.77 44.58 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.165 0.586 . . . . 0.0 111.156 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 84' ' ' ILE . 95.4 t -69.36 -41.51 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.59 -29.05 63.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.423 1.089 . . . . 0.0 110.535 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.69 62.53 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.491 0.717 . . . . 0.0 111.138 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -88.36 -28.38 21.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.025 0.53 . . . . 0.0 109.678 172.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.18 -15.29 69.75 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.225 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.63 -40.71 28.71 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.843 1.257 . . . . 0.0 112.07 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 69.5 mt -126.23 -173.45 2.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.908 1.283 . . . . 0.0 108.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.45 -29.17 62.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.577 0.351 . . . . 0.0 110.072 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t60 59.92 19.37 8.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.632 1.573 . . . . 0.0 112.444 167.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 66.74 3.41 2.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.909 1.283 . . . . 0.0 112.383 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -74.38 -26.01 59.84 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.685 -0.635 . . . . 0.0 110.081 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.19 128.59 9.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.929 0.892 . . . . 0.0 109.335 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -166.39 -63.15 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.916 1.286 . . . . 0.0 107.712 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.25 1.13 0 O-C-N 124.283 0.989 . . . . 0.0 109.623 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 mtm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.5 m -151.71 113.18 4.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.101 0.56 . . . . 0.0 109.936 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.6 p -88.66 -179.36 6.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.0 m -62.32 -38.02 87.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.169 0.588 . . . . 0.0 110.519 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -59.72 -45.81 91.02 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.39 0.431 . . . . 0.0 110.823 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.68 -43.52 89.99 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 123.878 0.736 . . . . 0.0 111.571 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -60.68 -51.8 67.84 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.928 0.767 . . . . 0.0 110.7 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -36.78 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.812 0.845 . . . . 0.0 111.682 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.22 89.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.936 0.895 . . . . 0.0 110.536 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.7 m -65.61 -38.83 90.56 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.696 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.37 -46.7 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.79 0.836 . . . . 0.0 111.031 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.441 HG12 HD13 ' A' ' 43' ' ' ILE . 90.9 mt -64.14 -40.01 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.292 0.637 . . . . 0.0 110.492 -177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.95 -46.03 82.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.546 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -75.24 -31.56 60.84 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.607 0.763 . . . . 0.0 112.621 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.2 m -80.22 -62.91 1.54 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.752 0.421 . . . . 0.0 111.888 -174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 74.0 m -111.02 5.89 20.58 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -167.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.58 69.98 0.69 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.447 1.099 . . . . 0.0 112.401 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.596 HG21 HD22 ' A' ' 33' ' ' LEU . 3.9 mp -118.1 126.73 27.06 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 167.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.03 122.82 11.21 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.534 2.156 . . . . 0.0 111.253 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.0 tmt_? -56.13 -30.51 62.23 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.772 0.829 . . . . 0.0 110.741 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -69.36 -29.75 67.62 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.421 0.688 . . . . 0.0 111.164 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.0 p -90.8 2.1 56.36 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.088 0.555 . . . . 0.0 111.378 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.07 96.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 p -97.03 153.18 38.6 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.347 1.059 . . . . 0.0 110.528 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.5 -32.52 80.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.65 2.233 . . . . 0.0 113.037 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.89 13.01 23.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.321 0.648 . . . . 0.0 110.518 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -81.83 140.16 34.32 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.756 0.822 . . . . 0.0 109.523 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 55.7 t-80 -94.05 116.14 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.01 11.97 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 57.4 mt -95.8 -55.19 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 122.863 0.465 . . . . 0.0 109.831 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -84.27 -7.78 59.23 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.32 -62.33 1.48 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.092 0.405 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 77' ' ' LEU . 80.0 mt -71.68 -17.07 62.26 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.696 0.398 . . . . 0.0 111.792 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.7 35.62 92.14 Favored Glycine 0 C--N 1.35 1.356 0 O-C-N 123.457 0.473 . . . . 0.0 113.174 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -86.35 118.92 33.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -73.19 172.42 11.15 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.529 0.518 . . . . 0.0 110.96 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 21.1 t -65.68 -52.33 52.42 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.608 -167.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 mt -64.23 -31.4 72.58 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.798 0.439 . . . . 0.0 110.46 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.557 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 14.6 m-20 -64.67 -44.98 88.61 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.431 0.693 . . . . 0.0 110.356 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -68.63 -29.74 68.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.636 0.774 . . . . 0.0 110.619 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.9 mt -65.31 -43.81 89.88 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.416 0.687 . . . . 0.0 110.021 174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -70.65 -29.83 66.28 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 48.4 mt -65.53 -42.4 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 170.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.26 -24.24 60.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.048 0.539 . . . . 0.0 110.368 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -72.12 -34.75 68.82 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.686 1.194 . . . . 0.0 110.939 172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.07 -38.7 66.33 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.91 0.484 . . . . 0.0 109.925 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 53' ' ' ILE . 96.3 mt -66.0 -42.32 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.405 1.082 . . . . 0.0 110.585 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.29 -57.55 7.62 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.792 1.237 . . . . 0.0 110.25 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -68.67 -45.43 71.72 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.742 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.1 62.02 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.522 0.729 . . . . 0.0 112.006 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB2' HG13 ' A' ' 53' ' ' ILE . 94.7 m-85 -87.63 -6.18 58.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.364 0.666 . . . . 0.0 112.274 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.56 16.92 72.28 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.202 0.314 . . . . 0.0 113.544 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -104.91 -174.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.927 0.891 . . . . 0.0 110.171 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -142.03 114.29 8.25 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 84' ' ' ILE . 82.2 mt -74.16 130.61 82.29 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.95 58.16 3.34 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.04 2.493 . . . . 0.0 111.449 168.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -36.46 82.91 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 110.043 -172.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -59.44 -47.85 83.89 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.591 0.757 . . . . 0.0 110.204 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.64 -46.29 88.93 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.929 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -59.33 -43.75 92.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.46 1.104 . . . . 0.0 111.342 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -63.69 -42.69 97.97 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.256 0.973 . . . . 0.0 110.202 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.09 -42.66 84.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.5 -42.34 78.19 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.674 0.79 . . . . 0.0 110.851 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.0 t -60.37 -53.0 54.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.035 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.426 HD21 H372 ' A' ' 102' ' ' PNS . 63.0 m-80 -68.63 -25.07 64.65 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -85.22 -5.03 59.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.384 0.674 . . . . 0.0 111.848 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.55 16.6 69.85 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.114 0.406 . . . . 0.0 114.114 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.36 -34.43 61.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.288 0.635 . . . . 0.0 110.058 175.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.8 153.09 51.98 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.645 1.178 . . . . 0.0 108.644 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.0 m -86.27 155.32 20.72 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.482 0.713 . . . . 0.0 109.218 174.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -53.88 -49.53 68.32 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.839 0.856 . . . . 0.0 110.565 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.7 tp10 -32.9 -55.52 0.38 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.448 1.899 . . . . 0.0 113.494 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -57.54 -31.24 65.9 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.604 -1.18 . . . . 0.0 113.561 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -119.64 -27.86 5.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -101.95 6.96 41.53 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -170.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 72' ' ' GLU . 52.3 t -98.82 128.31 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 HD11 ' A' ' 33' ' ' LEU . 64.8 mt -55.51 -30.93 61.55 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.123 1.369 . . . . 0.0 114.565 -165.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.1 pttp -75.29 -38.26 60.44 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.778 0.263 . . . . 0.0 110.467 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -74.67 -38.6 62.37 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.875 0.87 . . . . 0.0 109.851 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HG13 ' A' ' 84' ' ' ILE . 67.2 tp -60.25 -53.09 61.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.737 1.215 . . . . 0.0 109.182 175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -64.69 -31.33 72.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.486 0.714 . . . . 0.0 111.266 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 86' ' ' GLU . . . -69.05 -38.55 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 122.916 0.486 . . . . 0.0 110.245 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -67.54 -41.4 84.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.918 0.487 . . . . 0.0 110.868 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.578 HG12 HD21 ' A' ' 55' ' ' LEU . 76.7 mt -61.93 -51.71 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 109.885 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.27 -36.95 85.36 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.298 1.039 . . . . 0.0 111.603 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -59.84 -43.42 94.63 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.412 1.085 . . . . 0.0 109.613 174.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.15 -26.78 59.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.444 0.697 . . . . 0.0 111.844 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 84' ' ' ILE . 84.3 t -70.02 -42.03 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.37 74.43 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.242 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -28.8 68.43 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.669 0.788 . . . . 0.0 111.464 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -74.0 -41.86 61.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.763 0.825 . . . . 0.0 110.09 176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.35 -15.1 59.22 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.183 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.43 -53.18 14.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.699 1.2 . . . . 0.0 112.636 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.05 -167.82 0.12 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 111.706 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -95.62 26.73 3.79 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.052 0.453 . . . . 0.0 111.382 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -131.2 122.97 27.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.304 1.042 . . . . 0.0 108.917 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -60.49 132.82 55.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.5 0.72 . . . . 0.0 110.298 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -81.95 -70.4 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 73.49 -54.67 0.68 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.233 1.413 . . . . 0.0 110.646 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -86.45 -167.49 1.89 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.818 0.847 . . . . 0.0 110.184 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 125.318 1.447 . . . . 0.0 110.469 179.531 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.426 H372 HD21 ' A' ' 65' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.7 t -66.59 98.57 0.52 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.516 1.15 . . . . 0.0 111.239 -173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 52.7 m -144.38 -179.8 6.76 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.624 175.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 85' ' ' ASP . 23.6 m -51.41 -47.65 62.89 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.149 0.58 . . . . 0.0 112.05 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.29 -49.11 78.9 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.784 0.678 . . . . 0.0 111.638 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 3' ' ' SER . 17.9 t70 -58.12 -43.59 87.3 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.772 0.67 . . . . 0.0 110.99 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -63.12 -50.89 68.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' THR . 92.1 t -61.39 -40.96 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.156 0.982 . . . . 0.0 111.142 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.48 94.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.999 0.919 . . . . 0.0 110.979 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.6 m -66.68 -33.35 75.44 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.512 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 47' ' ' ILE . 81.1 mt -61.2 -48.92 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.511 0.724 . . . . 0.0 111.042 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.4 mt -60.89 -44.34 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-O 121.516 0.674 . . . . 0.0 109.615 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.03 -45.34 75.18 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.888 -1.505 . . . . 0.0 113.44 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -78.12 -40.04 39.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.166 0.587 . . . . 0.0 112.368 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.1 m -69.58 -57.14 5.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.003 0.521 . . . . 0.0 111.875 -169.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.5 m -107.86 15.27 24.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.936 0.494 . . . . 0.0 111.406 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 49.41 70.96 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.574 1.15 . . . . 0.0 111.488 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.5 130.7 22.61 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.41 117.9 4.64 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.031 1.821 . . . . 0.0 111.005 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -54.24 -33.82 59.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.488 1.115 . . . . 0.0 111.835 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.57 -34.83 77.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.718 0.807 . . . . 0.0 111.335 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.9 p -86.15 5.93 31.65 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.933 0.493 . . . . 0.0 111.621 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.4 mt -98.65 119.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 p -132.64 159.43 72.48 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 123.341 0.657 . . . . 0.0 110.483 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.34 -39.91 88.44 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.801 2.334 . . . . 0.0 113.257 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.68 3.48 53.88 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.023 0.529 . . . . 0.0 111.458 -171.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -79.28 134.68 36.63 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 54.2 t-80 -90.87 125.7 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -43.81 -42.96 5.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.404 1.082 . . . . 0.0 112.752 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -96.2 -43.89 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.044 0.45 . . . . 0.0 110.339 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -83.73 -35.29 24.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.481 0.712 . . . . 0.0 111.899 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -98.42 -61.98 1.3 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.123 0.569 . . . . 0.0 110.263 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 77' ' ' LEU . 88.1 mt -69.95 -26.57 64.18 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.48 0.712 . . . . 0.0 111.771 -175.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.68 53.22 16.93 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.5 mt -129.63 117.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.606 1.563 . . . . 0.0 107.579 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.28 170.86 14.18 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 21.9 p -63.93 -22.68 67.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 174.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.0 mt -51.41 -52.29 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.058 1.343 . . . . 0.0 111.408 171.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HB2' HG23 ' A' ' 35' ' ' ILE . 3.7 m-20 -74.3 -38.07 63.47 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.983 0.913 . . . . 0.0 109.603 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 25.3 t80 -68.65 -17.98 64.2 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.359 -174.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -50.95 -55.5 16.92 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.876 0.47 . . . . 0.0 109.894 172.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -59.5 -43.2 93.39 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.029 0.83 . . . . 0.0 110.469 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.9 mt -60.05 -39.52 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -40.57 69.48 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.028 0.531 . . . . 0.0 109.679 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -61.44 -38.45 87.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.425 0.69 . . . . 0.0 110.93 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.83 81.51 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.035 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 11' ' ' ILE . 96.6 mt -65.72 -44.13 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.539 0.736 . . . . 0.0 110.621 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.95 -45.67 93.78 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 111.357 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.37 -42.82 71.26 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.726 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.48 65.33 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.883 0.873 . . . . 0.0 112.69 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -90.63 -0.81 57.82 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.694 0.798 . . . . 0.0 111.918 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.76 29.14 73.87 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.4 0.438 . . . . 0.0 113.666 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.5 -170.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.354 1.062 . . . . 0.0 109.618 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -141.27 124.04 16.11 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD21 HG12 ' A' ' 84' ' ' ILE . 73.7 mt -78.13 132.7 66.23 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 109.258 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.08 64.67 7.82 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.63 2.22 . . . . 0.0 110.632 167.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.17 -43.02 96.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 110.303 -173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.36 -39.6 93.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.781 0.832 . . . . 0.0 110.503 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 26.9 ttpp -64.15 -49.88 70.37 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.494 178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -56.38 -42.76 78.4 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.001 0.921 . . . . 0.0 111.3 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 m -60.94 -42.9 99.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.291 0.994 . . . . 0.0 110.855 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.3 -33.29 61.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -40.02 94.68 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.558 0.743 . . . . 0.0 110.407 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.0 -50.98 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.518 0.727 . . . . 0.0 110.572 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -57.57 -39.75 77.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.978 0.911 . . . . 0.0 112.149 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.79 -6.29 59.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.291 0.636 . . . . 0.0 111.443 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.24 5.94 82.34 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.41 -25.48 65.97 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 117.74 0.77 . . . . 0.0 111.138 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.13 155.04 39.09 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.992 0.917 . . . . 0.0 109.2 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.3 m -74.0 153.76 39.57 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.982 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.9 p -49.24 -50.6 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 123.841 0.713 . . . . 0.0 110.455 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.39 -46.88 18.8 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.193 1.397 . . . . 0.0 113.848 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -58.44 -31.27 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.921 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -118.04 9.42 12.73 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -140.24 16.95 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.362 0.983 . . . . 0.0 112.688 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.4 t -99.4 131.14 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.718 HD11 HD11 ' A' ' 33' ' ' LEU . 34.9 mt -62.38 -26.58 68.54 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -76.76 -35.38 57.77 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.471 0.578 . . . . 0.0 110.413 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.54 -33.09 73.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.02 -50.19 62.88 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.576 1.151 . . . . 0.0 109.953 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.21 75.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.153 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.85 -46.08 72.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.404 0.682 . . . . 0.0 111.606 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -63.07 -45.0 94.23 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.744 0.818 . . . . 0.0 112.012 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.571 HG12 HD21 ' A' ' 55' ' ' LEU . 83.4 mt -65.51 -47.52 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.219 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.507 ' HB2' HG21 ' A' ' 4' ' ' THR . 32.9 t70 -60.96 -34.39 74.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.627 0.771 . . . . 0.0 111.039 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.7 -39.35 94.09 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.285 1.034 . . . . 0.0 110.049 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD12 HD23 ' A' ' 55' ' ' LEU . 96.7 mt -73.39 -29.98 62.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.01 0.524 . . . . 0.0 111.629 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 84' ' ' ILE . 92.6 t -74.24 -29.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.74 -31.02 41.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.355 1.062 . . . . 0.0 110.278 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.84 -29.24 64.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.761 0.824 . . . . 0.0 110.71 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -90.03 -21.86 22.14 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.747 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.33 -25.44 36.53 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.62 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.89 3.6 25.57 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.094 0.957 . . . . 0.0 111.52 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.02 -163.84 0.9 Allowed 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.438 0.695 . . . . 0.0 109.429 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -58.2 129.61 42.79 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.191 0.596 . . . . 0.0 110.256 173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -84.4 83.98 7.8 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -136.32 125.03 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.386 -172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -105.59 158.21 16.85 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.73 0.812 . . . . 0.0 108.97 171.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -64.0 -41.78 97.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -168.12 -39.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.431 1.092 . . . . 0.0 108.195 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 107.831 174.447 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -72.59 135.02 45.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.773 0.429 . . . . 0.0 110.125 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -69.49 117.77 11.52 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.485 0.714 . . . . 0.0 109.194 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.3 m -60.84 -50.03 75.06 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.026 0.829 . . . . 0.0 111.09 -175.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.9 -40.82 96.76 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.3 0.375 . . . . 0.0 111.492 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -61.32 -39.77 91.75 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.12 0.263 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -61.74 -52.33 64.71 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.835 0.709 . . . . 0.0 111.251 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 96.2 t -59.43 -45.84 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.126 0.971 . . . . 0.0 111.106 -176.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.88 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.271 1.028 . . . . 0.0 111.395 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.3 m -60.4 -48.11 83.19 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.561 0.538 . . . . 0.0 110.038 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.9 -49.72 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 111.169 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.46 -45.2 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.142 0.577 . . . . 0.0 110.501 -176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.11 67.73 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.165 0.986 . . . . 0.0 112.548 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -73.32 -36.61 66.25 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.656 0.782 . . . . 0.0 111.884 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -75.44 -48.13 24.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.014 0.526 . . . . 0.0 111.685 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 43' ' ' ILE . 66.5 m -116.44 17.16 15.56 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.855 0.462 . . . . 0.0 112.026 -169.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 t70 57.0 38.41 29.33 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.472 1.109 . . . . 0.0 110.841 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -85.87 128.15 59.49 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.55 112.94 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.601 2.2 . . . . 0.0 111.87 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -56.82 -40.75 76.58 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.047 0.939 . . . . 0.0 112.373 -174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -24.62 62.79 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.363 0.265 . . . . 0.0 111.552 -177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -81.06 -17.24 50.81 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.568 0.167 . . . . 0.0 110.565 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.8 mt -73.21 97.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.771 0 C-N-CA 123.41 0.684 . . . . 0.0 109.44 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 p -92.58 154.78 42.47 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.773 0.829 . . . . 0.0 109.604 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.14 -19.0 45.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.033 1.822 . . . . 0.0 112.032 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.53 -1.99 58.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.106 0.562 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.8 t -75.35 142.67 43.12 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 123.261 0.624 . . . . 0.0 109.953 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -97.57 121.76 39.85 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.62 -40.43 27.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.331 1.053 . . . . 0.0 113.307 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.82 -49.82 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -77.6 -41.01 40.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.028 0.531 . . . . 0.0 111.612 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.14 -63.74 1.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.989 0.516 . . . . 0.0 110.27 -177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 77' ' ' LEU . 88.7 mt -70.99 -14.2 62.27 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.158 0.583 . . . . 0.0 112.138 -173.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.9 37.19 74.54 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.329 0.393 . . . . 0.0 113.151 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 43' ' ' ILE . 77.4 mt -103.94 120.53 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.646 0.779 . . . . 0.0 109.312 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -86.75 166.61 15.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.248 0.619 . . . . 0.0 109.74 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 1.3 t -46.31 -47.86 18.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.648 1.179 . . . . 0.0 112.238 174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -50.53 -48.48 57.15 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.98 0.912 . . . . 0.0 111.581 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.83 -36.78 67.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.95 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -76.81 -20.7 56.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.452 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 37' ' ' SER . 79.8 mt -62.68 -40.42 97.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.446 0.298 . . . . 0.0 110.618 176.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.05 -38.65 66.4 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.98 0.512 . . . . 0.0 110.058 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.547 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.4 mt -59.98 -48.25 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 122.95 0.5 . . . . 0.0 110.677 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.92 61.06 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.845 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -29.16 65.88 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.712 0.405 . . . . 0.0 110.55 177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.48 71.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.098 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.64 -47.48 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.312 0.645 . . . . 0.0 110.401 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -53.57 -53.45 51.55 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.203 1.001 . . . . 0.0 110.176 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -62.6 -48.94 77.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 113.614 -1.63 . . . . 0.0 110.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.93 83.98 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 112.078 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -87.34 -5.58 58.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 112.496 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.7 81.8 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.929 0.143 . . . . 0.0 113.331 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 84' ' ' ILE . 41.7 pt -106.02 -174.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.862 0.865 . . . . 0.0 109.653 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -134.78 119.99 18.86 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 162.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD21 HG12 ' A' ' 84' ' ' ILE . 94.0 mt -70.86 126.72 92.18 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 168.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -72.67 60.38 3.51 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.445 2.097 . . . . 0.0 111.047 170.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -64.56 -42.68 95.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.435 1.094 . . . . 0.0 109.991 -169.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.69 -38.59 91.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.329 0.651 . . . . 0.0 111.17 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 4.5 ptmm? -71.22 -38.52 71.99 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -60.94 -38.46 85.9 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.828 0.851 . . . . 0.0 110.394 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.3 m -64.84 -39.52 93.7 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.99 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.39 -33.2 67.01 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.784 0.434 . . . . 0.0 110.408 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.5 mt-10 -65.26 -43.76 90.25 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.777 0.673 . . . . 0.0 110.545 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.8 t -61.58 -51.44 72.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 O-C-N 123.915 0.76 . . . . 0.0 110.09 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -62.57 -31.16 71.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.791 0.837 . . . . 0.0 112.722 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.64 -10.75 44.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.03 0.532 . . . . 0.0 111.754 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.18 10.08 86.48 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.39 -39.23 93.94 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.448 0.642 . . . . 0.0 110.234 172.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.37 175.17 9.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.858 1.263 . . . . 0.0 108.151 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -125.42 164.72 19.81 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.834 0.454 . . . . 0.0 110.038 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.7 p -55.09 -62.77 1.45 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.153 0.981 . . . . 0.0 113.105 -172.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -31.8 17.52 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -30.84 69.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.272 1.029 . . . . 0.0 111.01 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.36 -29.98 8.2 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.275 0.63 . . . . 0.0 111.922 176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -112.29 14.32 20.47 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -162.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 78' ' ' LYS . 41.1 t -95.59 128.58 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 162.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.641 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.29 -24.11 63.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -163.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.0 pttp -80.12 -38.42 31.61 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 118.224 0.465 . . . . 0.0 110.328 173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.84 -43.27 89.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.143 0.977 . . . . 0.0 109.593 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.23 -47.73 83.13 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 124.678 1.191 . . . . 0.0 109.37 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.93 -26.41 68.8 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.08 0.552 . . . . 0.0 110.96 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.76 -41.34 30.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.796 0.439 . . . . 0.0 110.084 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 1.6 mmp_? -57.77 -47.53 82.25 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.831 0.853 . . . . 0.0 110.608 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.5 mt -62.16 -52.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.512 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -59.07 -37.02 76.07 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.216 0.948 . . . . 0.0 111.934 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.21 -47.63 83.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.485 0.714 . . . . 0.0 109.917 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.8 mt -72.38 -26.15 61.78 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.848 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.0 t -74.52 -44.68 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.366 0.666 . . . . 0.0 110.306 176.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.99 -35.16 79.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.242 0.617 . . . . 0.0 110.039 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.68 -45.69 71.03 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.575 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -29.59 62.73 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -174.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.72 -40.69 85.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.781 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.87 -60.52 1.82 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.416 0.686 . . . . 0.0 111.419 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.2 mt 80.3 130.62 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.159 1.784 . . . . 0.0 110.043 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' HIS . 44.0 mt-10 -81.83 87.69 6.36 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -71.54 94.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.313 -172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.3 t60 65.48 -74.59 0.05 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.129 1.372 . . . . 0.0 111.358 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -70.06 87.26 0.56 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.545 0.738 . . . . 0.0 109.912 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 95' ' ' GLU . 14.7 p-80 -76.28 153.28 36.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 66.23 96.92 0.05 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.295 1.038 . . . . 0.0 110.042 -169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.2 t60 . . . . . 0 CA--C 1.551 1.012 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.413 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.406 ' H32' H382 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m -99.8 128.77 45.88 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -95.02 144.64 25.53 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.109 0.563 . . . . 0.0 109.84 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -65.78 -55.89 14.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.899 -174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.21 -34.96 78.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.339 0.256 . . . . 0.0 111.511 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.53 -44.39 93.19 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.528 0.331 . . . . 0.0 110.835 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -64.2 -48.92 74.04 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 0.0 110.83 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.57 -47.79 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.755 0.822 . . . . 0.0 110.843 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.31 94.55 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.327 1.051 . . . . 0.0 111.605 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.1 m -60.78 -44.18 97.13 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -39.7 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.057 0.943 . . . . 0.0 111.58 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' HB ' ' A' ' 18' ' ' ILE . 89.4 mt -69.31 -42.12 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.113 0.565 . . . . 0.0 109.969 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.71 78.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.552 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -69.0 -46.73 67.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.479 0.712 . . . . 0.0 112.173 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -69.18 -56.19 8.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.241 0.616 . . . . 0.0 111.161 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.0 t -107.88 -5.19 17.35 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.111 0.565 . . . . 0.0 112.108 -166.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.12 64.29 1.67 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.917 0.865 . . . . 0.0 110.227 -167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.537 HG21 HD22 ' A' ' 33' ' ' LEU . 47.5 mm -107.23 125.69 31.85 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.634 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.62 124.64 16.78 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.683 2.256 . . . . 0.0 111.989 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -49.06 -33.16 10.91 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.678 1.191 . . . . 0.0 112.028 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.7 pt-20 -63.74 -36.87 85.31 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.866 0.866 . . . . 0.0 112.081 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG3' ' A' ' 21' ' ' GLU . 63.9 p -87.77 -3.88 58.92 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.131 0.572 . . . . 0.0 111.576 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.6 mt -91.32 95.7 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.2 p -101.9 157.89 32.82 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.68 -16.56 49.29 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.348 2.032 . . . . 0.0 112.63 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.51 -3.0 58.54 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.984 0.914 . . . . 0.0 110.485 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.1 m -77.94 135.0 37.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.13 0.572 . . . . 0.0 110.542 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -93.29 118.1 30.87 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -45.9 -36.73 5.63 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.473 1.109 . . . . 0.0 113.524 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.53 -41.62 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -109.33 44.96 1.1 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.939 0.876 . . . . 0.0 110.001 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -169.15 -65.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.45 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 77' ' ' LEU . 69.4 mt -72.5 -14.74 61.73 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.178 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.25 48.1 66.83 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.362 0.414 . . . . 0.0 112.563 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' HB2' ' A' ' 39' ' ' ASP . 82.2 mt -124.77 119.67 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.369 1.067 . . . . 0.0 108.943 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.39 169.43 18.33 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.32 0.648 . . . . 0.0 109.954 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.8 m -59.49 -27.61 66.29 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.275 0.63 . . . . 0.0 111.143 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.582 HD21 H301 ' A' ' 102' ' ' PNS . 2.8 mm? -60.6 -49.57 76.99 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.44 1.096 . . . . 0.0 110.378 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.608 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.8 m-20 -80.26 -23.17 40.97 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.402 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 29.4 t80 -79.23 -21.14 46.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.562 0.745 . . . . 0.0 109.944 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 37' ' ' SER . 54.2 mt -64.84 -42.44 94.91 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 169.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 18.8 t70 -67.3 -40.62 86.06 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 123.831 0.707 . . . . 0.0 110.213 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 35' ' ' ILE . 58.7 mt -57.36 -41.2 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 171.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.38 63.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.13 0.572 . . . . 0.0 111.3 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 25.0 m-85 -59.1 -44.6 91.97 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.44 0.696 . . . . 0.0 109.577 176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.26 81.03 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.392 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 84' ' ' ILE . 80.9 mt -64.39 -48.59 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.586 0.754 . . . . 0.0 111.24 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -59.25 -41.12 88.02 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.47 0.708 . . . . 0.0 110.907 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -72.3 -49.96 30.67 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.35 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.84 -51.21 69.15 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.322 0.649 . . . . 0.0 112.079 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.61 -4.75 59.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.206 1.003 . . . . 0.0 112.498 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.34 38.88 96.44 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.129 0.268 . . . . 0.0 113.474 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 pt -130.22 -166.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.829 1.252 . . . . 0.0 109.042 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -143.2 125.38 15.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 87' ' ' LEU . 82.1 mt -74.33 129.15 84.76 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 38.7 Cg_exo -64.56 55.75 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.188 2.592 . . . . 0.0 111.864 159.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.84 -43.93 87.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.163 0.985 . . . . 0.0 110.014 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 36.4 mt-10 -60.57 -46.54 89.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.173 0.921 . . . . 0.0 110.195 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -54.88 -48.02 73.51 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 124.423 1.077 . . . . 0.0 110.072 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.0 m0 -63.54 -45.79 88.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.079 -177.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.8 m -62.95 -30.81 71.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.645 0.778 . . . . 0.0 110.986 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' GLU . 99.1 mt-30 -76.94 -41.25 44.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.129 0.572 . . . . 0.0 110.467 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -61.17 -40.05 92.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.444 0.698 . . . . 0.0 110.501 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.4 t -57.81 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.713 0.805 . . . . 0.0 110.766 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.28 -21.39 65.7 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.94 0.896 . . . . 0.0 112.832 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.84 -8.67 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.512 0.725 . . . . 0.0 111.417 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.98 88.03 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -68.17 -33.8 75.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.404 0.602 . . . . 0.0 110.719 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.05 163.1 33.75 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 109.704 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.1 p -80.03 161.04 25.62 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.15 0.58 . . . . 0.0 110.586 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.7 p -61.04 -48.51 81.41 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.304 0.642 . . . . 0.0 109.506 173.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 26.8 mt-10 -36.49 -61.48 0.52 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.722 1.609 . . . . 0.0 113.014 170.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -54.56 -33.17 59.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.838 -1.073 . . . . 0.0 112.612 -170.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -118.81 4.26 11.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -133.46 8.35 3.93 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.736 1.153 . . . . 0.0 113.197 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG12 ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -98.2 137.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 173.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD11 HD11 ' A' ' 33' ' ' LEU . 56.9 mt -63.12 -27.54 69.45 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 76' ' ' VAL . 18.9 ptpt -67.6 -40.48 84.77 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.463 0.649 . . . . 0.0 109.481 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -73.4 -33.2 64.87 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -47.04 77.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.2 0.6 . . . . 0.0 109.644 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.59 -30.92 71.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.028 0.83 . . . . 0.0 111.022 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -71.68 -45.67 61.21 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.493 0.717 . . . . 0.0 110.874 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -67.61 -36.93 81.76 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.975 0.91 . . . . 0.0 112.114 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 47' ' ' ILE . 96.4 mt -60.64 -51.05 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.74 -30.1 70.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.067 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 50.5 mt-10 -61.59 -51.77 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.329 0.652 . . . . 0.0 110.279 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD23 ' A' ' 55' ' ' LEU . 77.4 mt -69.26 -30.57 68.72 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.884 -176.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.34 -38.86 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.504 0.721 . . . . 0.0 109.92 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.02 -45.31 74.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.599 0.76 . . . . 0.0 110.761 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.44 -30.63 71.38 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.17 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -82.74 -46.52 13.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.525 0.73 . . . . 0.0 110.359 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.71 -41.15 13.29 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.03 -165.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.22 4.42 48.73 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.442 0.697 . . . . 0.0 110.685 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.5 mt 62.85 -169.29 0.19 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 124.695 1.198 . . . . 0.0 111.14 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.43 -3.03 21.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.172 0.589 . . . . 0.0 111.65 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -95.87 25.16 4.87 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.594 1.158 . . . . 0.0 109.842 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -69.33 80.57 0.37 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.892 0.853 . . . . 0.0 112.016 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -72.7 -29.94 63.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.004 0.922 . . . . 0.0 109.264 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -136.24 138.29 41.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -82.12 38.76 0.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.582 H301 HD21 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 m -90.58 76.13 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 171.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -81.43 76.21 8.37 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.572 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.0 m -69.11 -51.41 38.79 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.164 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -68.87 -27.17 65.57 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.453 0.301 . . . . 0.0 111.106 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.08 -49.8 74.76 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.672 0.389 . . . . 0.0 110.12 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -63.84 -48.84 75.18 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.925 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.42 -43.67 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.733 0.813 . . . . 0.0 110.605 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.536 ' HB1' ' HG3' ' A' ' 20' ' ' ARG . . . -61.65 -45.18 95.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.4 0.68 . . . . 0.0 111.51 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.0 m -60.78 -44.65 96.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.159 0.583 . . . . 0.0 110.542 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.73 -46.82 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.488 1.115 . . . . 0.0 111.91 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.427 HG12 HD13 ' A' ' 43' ' ' ILE . 84.5 mt -66.25 -40.68 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.208 0.528 . . . . 0.0 110.018 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.66 86.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.457 174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -84.05 -22.41 31.25 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -81.86 -62.14 1.72 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.686 0.394 . . . . 0.0 111.31 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -108.24 15.97 23.64 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.05 0.54 . . . . 0.0 111.743 -170.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.1 t70 51.81 55.62 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -100.82 136.75 19.75 Favored Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 123.715 0.806 . . . . 0.0 109.549 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.69 120.17 7.82 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.174 1.916 . . . . 0.0 111.447 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 23' ' ' ILE . 71.4 ttt180 -62.39 -26.37 68.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.949 0.5 . . . . 0.0 112.012 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -66.48 -30.23 70.52 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.115 0.566 . . . . 0.0 111.415 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.4 p -93.09 -2.98 54.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.116 0.567 . . . . 0.0 111.031 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 20' ' ' ARG . 86.4 mt -85.24 94.42 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.9 p -94.65 152.78 40.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.847 0.859 . . . . 0.0 110.424 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.91 -37.58 76.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.572 2.181 . . . . 0.0 112.431 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.06 7.67 23.73 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.116 0.567 . . . . 0.0 111.38 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 138.69 39.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 110.058 -175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 57.8 t-80 -91.88 123.5 35.3 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 171.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.04 -34.35 21.21 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.808 0.843 . . . . 0.0 112.94 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.46 -47.52 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 62.6 m-20 -72.53 -53.97 10.5 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.756 0.422 . . . . 0.0 111.217 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -80.67 -62.98 1.51 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.601 -173.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 77' ' ' LEU . 81.2 mt -70.3 -18.53 63.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.55 48.39 62.98 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.446 0.466 . . . . 0.0 112.689 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 39' ' ' ASP . 77.9 mt -118.45 118.01 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.616 1.167 . . . . 0.0 108.383 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -78.57 173.72 12.11 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.68 0.392 . . . . 0.0 110.297 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.2 p -48.47 -49.28 36.2 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.099 1.36 . . . . 0.0 111.609 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 -43.03 78.18 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.863 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 35' ' ' ILE . 4.2 m-20 -76.43 -34.25 58.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.896 0.878 . . . . 0.0 110.296 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -74.79 -21.39 59.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.842 0.857 . . . . 0.0 110.45 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.6 mt -59.55 -49.71 76.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.212 0.605 . . . . 0.0 109.566 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.88 -39.47 94.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.134 0.973 . . . . 0.0 110.983 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD13 HG12 ' A' ' 12' ' ' ILE . 71.5 mt -62.77 -42.8 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.329 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.73 -30.28 59.18 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.424 0.689 . . . . 0.0 111.015 -173.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -68.45 -44.33 75.13 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.71 0.804 . . . . 0.0 109.812 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -67.35 -53.69 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.677 0.791 . . . . 0.0 110.862 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -46.76 -52.47 13.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.429 1.491 . . . . 0.0 111.156 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -73.77 -39.39 64.21 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.717 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.82 -47.7 83.9 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.337 0.655 . . . . 0.0 111.844 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.38 -3.89 59.03 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.788 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.97 17.73 63.6 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.0 pt -104.99 173.04 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.654 0.781 . . . . 0.0 109.811 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -112.04 103.3 11.49 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.36 121.36 84.05 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.551 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 96.9 Cg_endo -77.9 61.93 7.76 Favored 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.18 1.92 . . . . 0.0 110.399 169.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -44.72 86.48 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.502 -172.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.0 mt-10 -67.39 -32.9 74.12 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.539 0.736 . . . . 0.0 110.947 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HE2' ' HB2' ' A' ' 56' ' ' PRO . 40.1 ttpt -65.27 -46.48 80.33 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -60.37 -36.04 77.12 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.989 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.1 m -65.95 -38.45 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.071 0.948 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 15.7 mm100 -65.74 -41.32 92.3 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.817 0.447 . . . . 0.0 110.069 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -46.35 82.51 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.259 0.974 . . . . 0.0 111.17 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG11 ' HE2' ' A' ' 75' ' ' PHE . 42.2 t -60.94 -58.47 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.584 0.753 . . . . 0.0 110.674 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -58.19 -31.2 67.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.721 0.808 . . . . 0.0 113.041 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.92 -26.94 39.94 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.293 0.568 . . . . 0.0 110.001 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.87 3.21 59.32 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.675 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -30.92 71.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.806 0.842 . . . . 0.0 111.605 177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . -131.95 136.7 47.54 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.913 0.885 . . . . 0.0 109.463 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HG2' ' A' ' 72' ' ' GLU . 14.0 m -64.82 148.23 51.7 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.752 0.821 . . . . 0.0 110.897 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.3 p -63.02 -57.5 10.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.552 0.741 . . . . 0.0 111.043 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HG2' HG22 ' A' ' 70' ' ' THR . 12.4 pt-20 -50.47 -34.7 25.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.288 1.035 . . . . 0.0 113.728 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.429 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 9.1 tt0 -51.62 -37.44 50.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 0.0 111.632 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.21 -25.02 9.93 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.533 0.733 . . . . 0.0 112.492 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HE2' HG11 ' A' ' 64' ' ' VAL . 32.4 m-85 -104.51 -0.71 27.52 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 t -86.61 128.14 39.79 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 33' ' ' LEU . 56.4 mt -58.74 -32.21 69.04 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -164.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -76.68 -32.87 58.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.28 -41.57 76.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.683 0.793 . . . . 0.0 109.069 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.551 ' HA ' HH21 ' A' ' 83' ' ' ARG . 51.9 tp -58.41 -49.63 76.59 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.551 1.14 . . . . 0.0 108.461 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -63.4 -27.01 69.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.262 0.976 . . . . 0.0 111.338 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.61 -49.72 37.58 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 123.226 0.61 . . . . 0.0 110.84 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.551 HH21 ' HA ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -61.48 -40.69 95.47 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 117.737 0.244 . . . . 0.0 110.678 177.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 81' ' ' ALA . 73.2 mt -58.56 -49.46 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 124.11 0.881 . . . . 0.0 109.522 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.11 -41.06 95.26 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.791 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -62.7 -31.83 72.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 0.0 111.103 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.83 -21.81 27.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.177 0.591 . . . . 0.0 111.549 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 84' ' ' ILE . 47.6 t -64.27 -43.51 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.3 -46.22 74.19 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.752 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' HA ' HD12 ' A' ' 94' ' ' LEU . . . -59.74 -29.27 68.03 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.317 0.647 . . . . 0.0 111.985 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -83.42 -43.55 15.74 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.849 0.46 . . . . 0.0 111.564 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -114.73 -44.07 0.71 Allowed Glycine 0 N--CA 1.479 1.557 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 -44.63 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.466 0.706 . . . . 0.0 112.782 -167.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 90' ' ' ALA . 71.3 mt -70.51 95.38 1.06 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.241 0.617 . . . . 0.0 110.993 -172.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.6 15.98 1.44 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.727 0.811 . . . . 0.0 110.712 175.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -64.31 105.42 0.91 Allowed 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -70.68 82.84 0.62 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.303 1.049 . . . . 0.0 108.885 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.53 129.82 21.06 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.992 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -77.88 88.05 4.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 109.881 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -103.5 -65.58 1.0 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.156 0.982 . . . . 0.0 108.972 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.186 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.0 mtp . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.0 m 63.46 73.07 0.46 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 124.325 1.05 . . . . 0.0 108.87 -176.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -79.83 176.73 9.47 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.721 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HB ' ' A' ' 84' ' ' ILE . 56.5 m -57.93 -40.25 80.0 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.861 170.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.73 -48.81 79.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.508 0.723 . . . . 0.0 111.066 176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.9 -44.05 94.48 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.809 0.693 . . . . 0.0 111.402 -175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -64.12 -52.96 56.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.236 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.37 -38.29 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 123.975 0.797 . . . . 0.0 111.342 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -60.78 -46.71 89.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.304 1.042 . . . . 0.0 111.314 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 m -62.32 -40.99 98.15 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.696 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.88 -41.43 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.044 0.938 . . . . 0.0 111.064 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 43' ' ' ILE . 52.2 mt -69.05 -44.62 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.441 0.697 . . . . 0.0 110.506 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.82 82.76 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.614 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.63 -31.69 22.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.3 m -81.87 -52.66 6.87 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.488 0.315 . . . . 0.0 111.259 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 43' ' ' ILE . 82.3 m -101.87 -3.8 27.31 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.138 0.575 . . . . 0.0 112.177 -172.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.57 54.1 3.13 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.434 1.094 . . . . 0.0 111.138 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.32 137.48 19.27 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 59.8 Cg_endo -71.2 132.66 21.43 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.497 2.131 . . . . 0.0 112.013 178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.94 -26.47 59.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.515 1.126 . . . . 0.0 112.448 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 12.5 pt-20 -63.16 -31.22 72.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.867 0.867 . . . . 0.0 112.046 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -92.36 -3.64 55.04 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.22 0.608 . . . . 0.0 111.254 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.448 HG21 ' HB1' ' A' ' 9' ' ' ALA . 70.2 mt -91.48 100.02 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.9 p -122.81 162.44 38.76 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.621 1.168 . . . . 0.0 109.278 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.65 -24.38 54.06 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.56 2.173 . . . . 0.0 113.522 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.7 6.56 48.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.402 0.681 . . . . 0.0 111.926 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -81.57 129.7 34.78 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -92.09 125.85 36.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -52.64 -39.34 61.69 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 112.967 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 29.2 mt -96.28 -45.98 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.86 0.362 . . . . 0.0 110.224 -170.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.91 -39.32 30.63 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.694 0.798 . . . . 0.0 111.375 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -101.59 -53.44 2.98 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.167 0.587 . . . . 0.0 111.429 -171.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 77' ' ' LEU . 85.4 mt -76.24 -12.72 60.13 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.135 0.574 . . . . 0.0 111.204 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.31 35.56 90.43 Favored Glycine 0 C--N 1.356 1.68 0 O-C-N 123.665 0.603 . . . . 0.0 113.688 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 39' ' ' ASP . 80.7 mt -108.78 119.21 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.295 1.038 . . . . 0.0 108.487 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.6 168.78 19.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 13.4 p -47.96 -43.93 29.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.521 1.529 . . . . 0.0 111.761 173.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.7 mt -57.24 -46.52 82.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.775 1.23 . . . . 0.0 111.524 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 35' ' ' ILE . 7.3 m-20 -76.58 -32.67 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.59 0.756 . . . . 0.0 110.003 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -71.7 -20.42 61.92 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.458 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 91.5 mt -56.61 -53.85 52.87 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.67 -34.45 77.13 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.722 0.809 . . . . 0.0 111.19 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 12' ' ' ILE . 65.5 mt -63.09 -46.0 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.66 -24.76 58.86 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.656 0.783 . . . . 0.0 111.516 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -72.67 -37.47 67.91 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.763 0.825 . . . . 0.0 109.854 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 -34.42 71.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.78 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 99.2 mt -70.41 -42.86 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.774 0.83 . . . . 0.0 110.241 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -52.7 -56.68 13.81 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.947 1.299 . . . . 0.0 110.503 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -66.87 -40.68 87.92 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 112.059 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.46 -62.57 1.78 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.134 0.573 . . . . 0.0 112.297 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' ' 53' ' ' ILE . 96.2 m-85 -84.88 -1.05 56.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.206 0.602 . . . . 0.0 112.261 -173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.91 15.04 64.23 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.191 0.307 . . . . 0.0 113.673 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.5 pp -105.66 170.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.027 0.931 . . . . 0.0 109.636 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -115.18 123.48 49.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 89.9 mt -84.19 119.53 73.38 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.42 58.03 2.37 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.499 2.799 . . . . 0.0 112.225 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -35.71 75.75 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.256 1.022 . . . . 0.0 110.702 -175.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.07 -44.38 97.47 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 124.313 1.008 . . . . 0.0 110.228 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -67.57 -47.6 69.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.4 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -56.39 -45.71 80.45 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 124.513 1.133 . . . . 0.0 111.097 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.4 m -73.46 -28.76 62.12 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.89 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.66 -40.21 80.29 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.869 -0.52 . . . . 0.0 109.725 174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.11 -36.36 83.76 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.02 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.38 -53.44 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.851 0.86 . . . . 0.0 110.608 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -64.03 -35.06 79.47 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -94.98 7.33 46.41 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.34 12.46 61.01 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.337 0.495 . . . . 0.0 114.337 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -70.47 -35.54 73.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.683 0.793 . . . . 0.0 110.189 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.38 143.13 28.86 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.552 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -78.04 154.43 31.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.589 0.756 . . . . 0.0 109.749 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -62.76 -46.76 86.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.906 0.483 . . . . 0.0 110.6 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.4 mp0 -47.0 -41.28 16.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.693 1.197 . . . . 0.0 113.626 173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.479 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER -56.21 -24.65 43.35 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.317 1.011 . . . . 0.0 112.031 -177.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.24 -39.81 4.06 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -98.81 -2.18 38.51 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.3 t -84.0 127.4 39.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 173.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.589 HD11 HD11 ' A' ' 33' ' ' LEU . 57.3 mt -56.24 -25.71 48.65 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.7 pttp -76.53 -38.66 54.75 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.924 0.329 . . . . 0.0 110.736 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.479 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.1 m-20 -72.29 -34.74 68.4 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.956 0.902 . . . . 0.0 110.407 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.8 tp -66.9 -48.97 67.07 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.241 1.016 . . . . 0.0 108.533 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.3 -27.88 69.63 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.987 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.95 -54.75 13.65 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.588 0.555 . . . . 0.0 109.909 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.8 mmp_? -55.6 -45.97 77.39 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.601 0.76 . . . . 0.0 111.461 -176.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 57.4 mt -65.55 -45.76 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 -177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -64.0 -31.51 72.72 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.874 0.87 . . . . 0.0 111.072 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -74.96 -24.31 58.43 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.475 1.11 . . . . 0.0 111.547 176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.9 mt -82.42 -27.31 32.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.312 0.645 . . . . 0.0 110.477 171.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.36 -32.84 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.29 69.04 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.678 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.39 68.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.409 0.684 . . . . 0.0 111.54 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -83.94 -32.23 25.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.458 0.703 . . . . 0.0 110.558 175.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.71 -39.88 9.27 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.141 -0.481 . . . . 0.0 113.522 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -158.57 -53.86 0.07 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.635 0.774 . . . . 0.0 111.232 -174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.24 -170.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.119 0.968 . . . . 0.0 113.155 -172.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -39.74 3.22 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.952 1.701 . . . . 0.0 108.446 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -172.2 136.61 0.84 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.577 1.551 . . . . 0.0 107.09 171.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -80.42 -60.59 2.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.235 0.54 . . . . 0.0 109.634 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -131.52 160.07 36.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.791 1.236 . . . . 0.0 108.233 169.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 36.9 t60 69.19 137.6 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.528 1.131 . . . . 0.0 110.433 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -49.78 -63.25 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.974 0.91 . . . . 0.0 112.145 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.9 t60 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 124.238 1.015 . . . . 0.0 108.597 166.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.529 ' H32' ' O26' ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.7 p -98.69 122.85 42.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.459 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -73.1 176.43 5.83 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 122.871 0.468 . . . . 0.0 110.443 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.9 m -60.84 -41.25 95.43 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -60.52 -41.0 93.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.031 0.532 . . . . 0.0 111.281 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 2.2 m-20 -57.19 -47.82 80.29 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.689 0.396 . . . . 0.0 110.43 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -64.73 -53.01 53.85 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.498 1.124 . . . . 0.0 111.247 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 66.2 t -53.36 -47.91 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.563 1.145 . . . . 0.0 111.327 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.07 -45.93 89.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.586 1.155 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 40.9 m -63.9 -40.47 96.57 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.821 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.0 mt -64.06 -41.56 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.897 0.479 . . . . 0.0 111.254 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 8' ' ' VAL . 73.6 mt -64.47 -40.6 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.37 84.9 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.297 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.5 mm-40 -72.19 -26.22 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.994 0.518 . . . . 0.0 111.499 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 43' ' ' ILE . 59.0 m -75.31 -61.98 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.602 0.361 . . . . 0.0 111.1 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -111.92 19.35 18.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.131 0.572 . . . . 0.0 112.301 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 47.89 61.59 2.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.472 1.109 . . . . 0.0 111.634 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.8 mm -103.7 132.2 21.28 Favored Pre-proline 0 N--CA 1.476 0.847 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.37 111.92 1.02 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 121.924 1.749 . . . . 0.0 110.973 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -64.65 -28.86 69.9 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.964 0.506 . . . . 0.0 111.198 -175.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.63 -30.59 70.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.532 0.733 . . . . 0.0 110.784 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -88.09 -11.12 47.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.441 0.696 . . . . 0.0 111.596 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 20' ' ' ARG . 66.5 mt -72.14 108.53 3.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -93.55 145.83 30.67 Favored Pre-proline 0 C--O 1.242 0.675 0 C-N-CA 124.286 1.034 . . . . 0.0 109.16 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.576 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 55.1 Cg_endo -66.68 -20.45 52.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.327 2.018 . . . . 0.0 112.478 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -99.96 17.5 20.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.142 0.577 . . . . 0.0 110.506 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 t -85.2 138.71 32.19 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.723 0.809 . . . . 0.0 109.775 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -96.08 121.94 38.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.823 0.849 . . . . 0.0 109.043 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -54.15 -35.38 62.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.647 1.179 . . . . 0.0 113.603 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 53.3 mt -93.41 -46.01 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -174.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.28 -55.25 4.64 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.614 0.766 . . . . 0.0 111.709 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -48.82 9.73 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.819 0.447 . . . . 0.0 111.325 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 85.6 mt -76.14 -19.27 58.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.317 0.647 . . . . 0.0 111.622 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.3 45.09 94.42 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.429 0.456 . . . . 0.0 113.137 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.1 mt -118.38 124.68 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.09 147.94 47.98 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.4 p -59.19 -31.89 69.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.225 0.61 . . . . 0.0 112.447 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.419 HD11 H302 ' A' ' 102' ' ' PNS . 53.5 mt -73.51 -28.9 62.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.281 0.632 . . . . 0.0 111.048 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -78.57 -30.73 46.96 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.283 0.633 . . . . 0.0 110.121 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HD1' HD12 ' A' ' 43' ' ' ILE . 48.5 t80 -74.45 -19.21 60.48 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.789 0.836 . . . . 0.0 110.566 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 57' ' ' LEU . 89.5 mt -58.21 -36.79 73.65 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.25 0.62 . . . . 0.0 110.583 171.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.88 -40.09 75.9 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.795 0.838 . . . . 0.0 110.827 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 15' ' ' THR . 42.8 mt -64.75 -43.67 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.912 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.8 58.75 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.123 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.42 -38.56 84.8 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.488 1.115 . . . . 0.0 109.796 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.14 -40.72 74.62 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.665 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 84' ' ' ILE . 65.1 mt -66.1 -34.92 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.548 0.739 . . . . 0.0 110.816 175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.6 -53.88 52.49 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.342 1.457 . . . . 0.0 110.04 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -60.77 -45.95 92.36 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.704 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.8 82.18 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.682 0.793 . . . . 0.0 112.456 -172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.27 1.29 57.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.134 0.574 . . . . 0.0 111.651 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 58.56 32.49 69.1 Favored Glycine 0 C--N 1.358 1.788 0 O-C-N 123.5 0.5 . . . . 0.0 113.905 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD3' ' A' ' 91' ' ' LYS . 2.2 pp -129.78 142.32 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.321 1.048 . . . . 0.0 108.892 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -80.07 113.1 17.99 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD21 HG12 ' A' ' 84' ' ' ILE . 73.9 mt -76.86 123.33 87.45 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.19 46.48 1.79 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.957 2.438 . . . . 0.0 110.856 166.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -63.67 -40.12 96.03 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.204 1.002 . . . . 0.0 108.329 -174.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' A' ' 41' ' ' LEU . 2.3 mp0 -61.71 -47.77 83.76 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.609 1.193 . . . . 0.0 109.309 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.21 -39.34 89.55 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.443 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.699 0.8 . . . . 0.0 109.72 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.4 m -60.39 -37.54 81.11 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.538 1.149 . . . . 0.0 110.332 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 20.2 mm-40 -71.08 -47.09 60.28 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -68.02 -29.87 68.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.783 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.06 -55.45 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.417 0.687 . . . . 0.0 109.736 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -79.71 -15.27 57.85 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.887 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -80.11 -9.63 59.72 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.074 0.55 . . . . 0.0 111.084 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.79 32.85 48.58 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.47 -0.332 . . . . 0.0 113.436 -174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -96.78 -43.39 7.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.894 0.878 . . . . 0.0 110.039 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.8 161.15 36.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.184 0.994 . . . . 0.0 109.229 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 m -88.68 158.3 18.26 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.276 0.63 . . . . 0.0 110.687 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.8 p -57.75 -61.58 2.42 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.876 0.871 . . . . 0.0 110.995 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -50.63 -30.92 14.66 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.918 1.287 . . . . 0.0 114.247 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.56 -32.23 49.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.455 1.102 . . . . 0.0 112.255 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -119.83 -25.78 5.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.167 0.587 . . . . 0.0 112.536 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -100.23 -3.41 31.57 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG12 ' HG2' ' A' ' 78' ' ' LYS . 56.0 t -87.74 127.62 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 54.7 mt -58.44 -22.24 53.79 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -165.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 62.3 pttt -80.89 -40.79 24.13 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.72 0.408 . . . . 0.0 110.718 173.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -65.82 -50.44 64.61 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.751 0.821 . . . . 0.0 109.439 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 tp -51.81 -49.52 62.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.052 1.741 . . . . 0.0 111.328 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.74 74.28 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 0.0 110.682 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.57 -34.03 67.19 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.353 0.661 . . . . 0.0 111.482 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.6 mmp_? -63.42 -45.81 89.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.69 0.757 . . . . 0.0 110.256 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 47' ' ' ILE . 52.8 mt -68.41 -41.17 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.07 -41.47 99.44 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.516 1.126 . . . . 0.0 112.138 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.68 -26.11 59.62 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.049 0.54 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.31 -29.2 61.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.535 0.334 . . . . 0.0 111.141 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 84' ' ' ILE . 68.9 t -72.68 -33.66 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.144 0.578 . . . . 0.0 109.595 173.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.98 70.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.461 0.704 . . . . 0.0 110.327 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.17 75.02 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.664 0.786 . . . . 0.0 110.584 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HD3' HG23 ' A' ' 53' ' ' ILE . 30.7 ttpt -79.78 -16.95 54.55 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.167 0.987 . . . . 0.0 109.38 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.78 -21.97 79.36 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.561 0.601 . . . . 0.0 112.904 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.58 3.18 45.45 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.447 0.699 . . . . 0.0 110.618 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.7 mt 58.29 107.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.599 1.96 . . . . 0.0 113.347 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.85 110.64 1.06 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.463 172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -71.19 86.04 0.77 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 124.157 0.911 . . . . 0.0 109.937 -176.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -120.72 24.7 10.13 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.542 1.137 . . . . 0.0 109.588 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 64.66 86.2 0.13 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.924 1.29 . . . . 0.0 111.295 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -90.97 91.95 8.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.101 0.56 . . . . 0.0 109.618 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -114.27 -62.17 1.64 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--O 1.247 0.971 0 C-N-CA 124.919 1.288 . . . . 0.0 107.585 173.332 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.419 H302 HD11 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.924 -0.084 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 5' ' ' PHE . 9.0 m -82.18 66.58 7.83 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.003 0.521 . . . . 0.0 110.441 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 18.3 m 21.94 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.489 2.315 . . . . 0.0 116.268 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.1 m -69.68 -46.62 65.65 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.453 0.701 . . . . 0.0 110.569 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HD2' ' HB ' ' A' ' 2' ' ' THR . 21.5 t80 -57.39 -41.19 79.77 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.732 0.645 . . . . 0.0 110.214 175.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.49 -36.75 84.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.487 0.715 . . . . 0.0 110.411 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 3' ' ' SER . 19.5 mmt180 -65.91 -47.43 74.78 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.623 0.769 . . . . 0.0 110.626 172.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.97 -37.28 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.251 1.021 . . . . 0.0 111.044 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.59 82.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.644 1.178 . . . . 0.0 110.254 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 32.6 m -61.66 -46.29 90.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.236 172.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.7 mt -58.32 -45.03 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 111.115 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 76.6 mt -67.16 -45.29 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.922 0.489 . . . . 0.0 110.277 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.59 74.09 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.065 0.946 . . . . 0.0 112.491 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 36.0 mm-40 -69.55 -31.95 70.46 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.408 0.683 . . . . 0.0 111.976 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -77.78 -48.02 17.58 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.909 0.484 . . . . 0.0 110.964 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 43' ' ' ILE . 59.7 m -111.07 -7.01 14.53 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -160.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 64.46 35.32 9.59 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.797 0.839 . . . . 0.0 111.324 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 HD22 ' A' ' 33' ' ' LEU . 1.7 mp -98.44 128.85 31.83 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.09 131.1 27.53 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.071 1.847 . . . . 0.0 111.977 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -47.45 -37.3 11.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.757 1.623 . . . . 0.0 112.624 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.72 -31.57 72.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.593 0.757 . . . . 0.0 111.449 -175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -90.34 2.99 54.99 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.822 0.449 . . . . 0.0 111.602 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.28 95.91 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.0 p -92.14 155.62 42.72 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.712 0.805 . . . . 0.0 109.899 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.71 -23.39 76.2 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.338 2.025 . . . . 0.0 112.239 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.46 3.65 55.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.803 0.841 . . . . 0.0 110.815 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -76.06 137.97 40.53 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.169 0.587 . . . . 0.0 109.473 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.1 t-80 -96.64 119.78 35.76 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.81 -35.03 13.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.741 1.216 . . . . 0.0 113.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.3 mt -92.16 -50.62 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.1 t70 -72.48 -54.92 7.9 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.691 -172.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.23 -64.67 1.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.243 0.617 . . . . 0.0 110.521 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 77' ' ' LEU . 85.1 mt -66.71 -20.91 66.07 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.393 0.677 . . . . 0.0 112.295 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.04 44.4 61.21 Favored Glycine 0 C--N 1.353 1.486 0 O-C-N 123.347 0.404 . . . . 0.0 113.285 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.68 121.7 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.103 0.961 . . . . 0.0 108.621 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.6 164.65 24.48 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 40' ' ' PHE . 13.6 p -61.74 -30.95 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.21 0.604 . . . . 0.0 111.85 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.05 -34.8 78.48 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.507 0.723 . . . . 0.0 111.451 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.77 -36.86 56.76 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 109.798 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 37' ' ' SER . 58.6 t80 -69.85 -18.87 63.46 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.549 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.78 -55.2 24.62 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.328 0.651 . . . . 0.0 110.414 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.3 -38.45 89.44 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.48 0.712 . . . . 0.0 110.93 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 16' ' ' CYS . 49.8 mt -63.08 -41.8 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.913 0.485 . . . . 0.0 110.033 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -77.26 -23.76 51.18 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.889 0.876 . . . . 0.0 110.376 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.87 -31.46 56.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.753 0.821 . . . . 0.0 110.247 172.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 -41.41 74.79 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.47 -42.79 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.23 0.612 . . . . 0.0 110.428 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 13.6 t70 -50.59 -58.9 4.73 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.402 1.481 . . . . 0.0 110.71 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -76.69 -32.69 58.04 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.842 -173.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.72 63.39 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.846 0.459 . . . . 0.0 111.04 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -83.58 -0.08 48.89 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.611 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.35 31.49 74.1 Favored Glycine 0 C--N 1.359 1.829 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.67 -178.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.554 1.142 . . . . 0.0 109.659 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.7 119.64 33.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.408 HD21 HG12 ' A' ' 84' ' ' ILE . 97.5 mt -86.89 115.24 61.8 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.482 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.79 66.59 3.94 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -38.33 90.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.889 1.275 . . . . 0.0 109.759 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.26 -44.23 88.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.947 0.899 . . . . 0.0 110.491 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -62.57 -44.95 95.06 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.366 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.07 -39.01 90.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.878 0.871 . . . . 0.0 111.393 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.1 m -57.51 -44.99 85.48 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.974 . . . . 0.0 110.531 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -70.88 -39.02 73.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.281 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -62.87 -44.61 95.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.835 0.854 . . . . 0.0 111.865 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.43 -54.88 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.093 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -68.49 -20.93 64.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.844 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -84.12 -18.49 36.66 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.657 0.783 . . . . 0.0 111.234 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.33 81.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.629 -0.54 . . . . 0.0 114.247 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -67.07 -39.22 86.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.563 0.697 . . . . 0.0 109.723 171.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.7 148.81 44.41 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 p -75.32 160.99 29.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 120.819 0.342 . . . . 0.0 110.536 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 56.6 p -57.39 -51.72 68.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.863 175.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -38.64 -50.79 1.63 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.688 1.595 . . . . 0.0 113.713 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -59.48 -35.9 75.0 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.516 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.59 -0.31 15.2 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.31 8.94 3.72 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 72' ' ' GLU . 78.0 t -100.92 129.52 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 169.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.642 HD11 HD11 ' A' ' 33' ' ' LEU . 57.7 mt -62.74 -25.81 68.38 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -164.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.3 pttt -72.29 -41.06 67.07 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.043 0.449 . . . . 0.0 110.097 174.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -71.36 -35.31 71.08 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.009 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 63.9 tp -61.13 -56.36 21.69 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.588 1.155 . . . . 0.0 109.939 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -61.63 -29.33 69.99 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.244 0.965 . . . . 0.0 111.586 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -65.91 -51.93 54.42 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 175.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 80' ' ' LEU . 19.4 mtp180 -60.71 -39.17 87.57 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.418 1.087 . . . . 0.0 111.994 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 81' ' ' ALA . 57.6 mt -61.62 -45.83 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.534 0.734 . . . . 0.0 109.467 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.96 -29.08 67.24 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.634 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 33.9 mm-40 -63.99 -36.08 82.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.185 0.594 . . . . 0.0 109.777 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 80.5 mt -81.35 -25.75 36.12 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.194 0.934 . . . . 0.0 111.683 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 84' ' ' ILE . 67.5 t -69.28 -41.92 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.22 0.608 . . . . 0.0 109.59 172.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.85 75.95 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.921 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 87' ' ' LEU . . . -68.7 -25.06 64.59 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.387 176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.21 -39.95 68.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.97 1.02 76.45 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.128 -0.487 . . . . 0.0 114.26 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.72 -43.14 0.27 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.252 0.621 . . . . 0.0 111.109 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.0 mt 68.13 26.54 7.11 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.471 1.109 . . . . 0.0 111.6 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.83 -47.13 66.77 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.146 0.978 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -110.6 134.31 52.53 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.461 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -147.15 165.26 30.54 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.464 1.106 . . . . 0.0 108.972 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -145.5 100.15 3.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 62.85 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.294 1.438 . . . . 0.0 110.95 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -87.19 42.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.501 0.72 . . . . 0.0 109.898 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t60 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.306 1.042 . . . . 0.0 109.62 -172.265 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.58 HG23 HH21 ' A' ' 7' ' ' ARG . 4.7 m 65.73 18.91 11.31 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.613 1.165 . . . . 0.0 111.865 170.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -67.0 157.22 33.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.697 0.799 . . . . 0.0 112.377 -174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.9 m -63.73 -46.66 84.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.104 -172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -57.19 -49.46 75.9 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.521 0.513 . . . . 0.0 111.293 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.66 -35.73 81.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.145 0.578 . . . . 0.0 111.63 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.58 HH21 HG23 ' A' ' 2' ' ' THR . 35.3 mmt180 -60.44 -49.15 78.71 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.759 0.662 . . . . 0.0 110.623 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.25 -36.73 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.968 0.907 . . . . 0.0 111.51 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.41 89.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.171 0.989 . . . . 0.0 110.738 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.6 m -60.11 -50.63 72.93 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.932 0.77 . . . . 0.0 109.947 170.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.85 -48.0 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.736 1.215 . . . . 0.0 111.733 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.36 -46.73 89.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 110.428 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.81 -43.78 77.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.019 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.6 mm-40 -77.35 -38.43 50.27 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.988 0.515 . . . . 0.0 112.347 -176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.4 m -69.83 -57.84 4.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.839 0.456 . . . . 0.0 111.315 -173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 39' ' ' ASP . 78.2 m -115.86 8.63 14.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.613 0.765 . . . . 0.0 112.438 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 t70 55.46 72.83 0.46 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.226 1.01 . . . . 0.0 111.977 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.95 131.31 23.56 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -56.46 122.06 11.13 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.493 2.129 . . . . 0.0 111.718 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -51.48 -33.24 30.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.083 1.353 . . . . 0.0 111.77 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.0 pt-20 -63.18 -34.89 78.6 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.319 1.047 . . . . 0.0 111.766 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.1 p -88.71 -6.35 57.51 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.549 . . . . 0.0 111.645 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.63 93.72 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 77' ' ' LEU . 64.8 p -105.75 153.3 40.08 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.273 0.629 . . . . 0.0 109.322 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -60.45 -23.46 75.09 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.87 2.38 . . . . 0.0 113.827 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -99.22 14.62 28.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.208 0.603 . . . . 0.0 110.761 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.7 m -84.52 138.66 32.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.339 0.656 . . . . 0.0 109.626 176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -91.34 115.03 27.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.26 12.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.69 1.196 . . . . 0.0 113.397 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 mt -92.72 -40.51 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 118.051 0.387 . . . . 0.0 110.853 -169.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.7 -47.36 7.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.353 0.661 . . . . 0.0 110.89 -171.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.01 -53.23 5.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.619 0.767 . . . . 0.0 111.244 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 77' ' ' LEU . 89.4 mt -79.36 -12.45 59.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.198 0.599 . . . . 0.0 111.222 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.72 33.04 84.89 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.693 0.621 . . . . 0.0 114.272 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 69.4 mt -95.01 116.37 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.52 163.65 26.11 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 47.4 t -48.58 -47.7 39.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.201 1.0 . . . . 0.0 112.102 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.77 -23.61 67.31 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 11.5 m-20 -86.12 -38.59 17.58 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.312 0.645 . . . . 0.0 109.697 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.01 -19.61 62.49 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.426 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' SER . 82.2 mt -56.21 -56.03 25.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.074 0.55 . . . . 0.0 110.682 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.69 -30.2 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.984 0.513 . . . . 0.0 111.001 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.8 mt -58.8 -41.29 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.07 69.97 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 123.174 0.59 . . . . 0.0 110.215 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -60.89 -39.78 90.54 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.231 0.612 . . . . 0.0 111.108 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.98 75.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.559 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 53' ' ' ILE . 84.4 mt -63.16 -46.76 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.216 0.606 . . . . 0.0 110.27 174.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 53' ' ' ILE . 36.5 m-20 -55.63 -53.15 60.06 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.534 1.134 . . . . 0.0 111.632 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.26 -23.37 51.22 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.648 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.23 -54.41 14.9 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.841 0.456 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -92.17 -3.8 55.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.405 0.682 . . . . 0.0 112.303 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.61 14.97 79.4 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 120.137 -0.257 . . . . 0.0 113.613 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 48' ' ' ASP . 2.8 pp -105.37 -170.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.044 0.938 . . . . 0.0 110.022 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -141.18 127.58 19.91 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD21 HG12 ' A' ' 84' ' ' ILE . 48.9 mt -77.89 116.46 58.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 170.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 58.5 Cg_endo -70.87 77.6 1.46 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.802 1.668 . . . . 0.0 109.875 171.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.32 -45.86 75.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.86 -167.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.2 -41.89 99.24 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.722 0.638 . . . . 0.0 110.825 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 52.5 tttp -54.75 -52.54 62.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.994 0.918 . . . . 0.0 111.035 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.0 m0 -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.345 1.028 . . . . 0.0 110.71 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.8 m -59.08 -37.9 78.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.237 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -74.99 -41.93 58.55 Favored 'General case' 0 C--O 1.215 -0.761 0 C-N-CA 122.902 0.481 . . . . 0.0 109.978 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.53 -35.11 75.21 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.195 0.598 . . . . 0.0 111.113 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.75 -47.88 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 123.957 0.903 . . . . 0.0 110.613 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.52 -28.95 70.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.0 0.92 . . . . 0.0 112.315 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -86.83 -4.82 59.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.594 0.757 . . . . 0.0 112.008 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.2 11.51 59.07 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -74.69 -31.79 62.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.407 0.683 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.38 141.54 48.94 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.511 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -70.93 152.78 43.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.741 0.817 . . . . 0.0 110.186 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.9 p -56.56 -52.72 63.74 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG23 ' A' ' 76' ' ' VAL . 37.1 mt-10 -48.8 -36.46 16.74 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.349 1.459 . . . . 0.0 114.316 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -55.32 -26.95 43.82 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.771 0.828 . . . . 0.0 112.064 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -113.1 -41.91 3.63 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.144 0.578 . . . . 0.0 111.706 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -98.2 11.09 38.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -164.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' A' ' 78' ' ' LYS . 44.3 t -103.1 129.45 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 168.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 33' ' ' LEU . 55.4 mt -55.02 -30.02 58.63 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -164.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.525 ' HG2' HG12 ' A' ' 76' ' ' VAL . 59.7 pttt -75.71 -39.11 57.89 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.005 0.431 . . . . 0.0 110.058 176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.0 m-20 -72.76 -36.37 67.66 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.273 1.029 . . . . 0.0 110.333 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 84' ' ' ILE . 61.5 tp -64.6 -47.69 77.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.709 1.204 . . . . 0.0 109.259 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -60.52 -36.0 77.33 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.979 0.799 . . . . 0.0 111.193 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -69.16 -37.8 78.42 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.303 0.641 . . . . 0.0 111.611 175.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.9 mmp_? -64.43 -43.77 93.27 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.319 0.648 . . . . 0.0 110.781 178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG12 HD21 ' A' ' 55' ' ' LEU . 62.1 mt -57.72 -45.78 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.915 0.886 . . . . 0.0 109.646 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.58 -37.39 87.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.448 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 43.0 mm-40 -58.72 -42.62 89.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.41 0.684 . . . . 0.0 110.208 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.2 mt -75.33 -26.85 58.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.779 0.832 . . . . 0.0 111.751 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 53.7 t -66.7 -48.78 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.467 0.707 . . . . 0.0 109.728 173.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.52 84.38 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.485 0.714 . . . . 0.0 110.682 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.44 97.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.92 0.888 . . . . 0.0 111.466 176.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -64.88 -29.26 70.2 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.262 1.025 . . . . 0.0 111.474 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.82 -10.3 57.8 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.396 -0.669 . . . . 0.0 113.808 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -175.85 108.1 0.09 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.492 0.717 . . . . 0.0 110.407 -171.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.81 161.6 13.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.425 0.69 . . . . 0.0 109.886 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.46 115.37 2.7 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.09 0.869 . . . . 0.0 109.989 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.6 m170 71.7 -67.69 0.25 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.659 1.584 . . . . 0.0 111.25 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -172.7 -171.76 0.81 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.777 1.231 . . . . 0.0 109.298 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -65.6 83.38 0.06 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -91.51 86.11 5.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.008 0.908 . . . . 0.0 110.419 -171.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -81.21 95.14 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.2 t60 . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 125.384 1.474 . . . . 0.0 109.736 -165.247 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.1 m 54.75 52.05 12.76 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.271 1.034 . . . . 0.0 110.719 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -121.3 -171.84 2.29 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.399 1.08 . . . . 0.0 109.697 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 34.8 m -55.54 -42.42 74.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.052 0.941 . . . . 0.0 110.293 173.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -53.0 -47.86 67.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.144 0.978 . . . . 0.0 111.518 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.37 -37.02 82.52 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.59 0.756 . . . . 0.0 111.508 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.38 -50.22 73.76 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.052 0.845 . . . . 0.0 110.345 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 81.1 t -62.11 -40.08 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.079 0.952 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.39 -41.31 98.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.387 1.075 . . . . 0.0 111.075 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -61.02 -43.05 99.47 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.605 172.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.05 -39.92 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.065 0.946 . . . . 0.0 111.752 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 8' ' ' VAL . 81.4 mt -68.26 -41.02 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.265 0.555 . . . . 0.0 109.622 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 18' ' ' ILE . . . -58.0 -39.77 79.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.552 173.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -72.77 -42.45 63.98 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.144 0.577 . . . . 0.0 111.796 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.3 m -80.49 -46.69 15.45 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.005 0.522 . . . . 0.0 111.969 -170.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -117.3 0.84 12.34 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.901 0.88 . . . . 0.0 110.951 -164.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.73 64.98 1.63 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.86 1.264 . . . . 0.0 111.484 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 33' ' ' LEU . 45.0 mm -114.44 123.93 31.53 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -57.15 128.45 29.78 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.857 2.371 . . . . 0.0 112.017 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -57.07 -32.44 66.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.979 0.912 . . . . 0.0 111.884 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 22' ' ' THR . 11.1 pt-20 -66.06 -33.83 76.69 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.572 0.749 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.494 HG23 ' HG3' ' A' ' 21' ' ' GLU . 81.7 p -96.45 22.5 7.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.725 0.81 . . . . 0.0 110.972 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.11 99.22 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 35.7 p -95.69 158.46 34.35 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.794 0.838 . . . . 0.0 109.874 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.92 -23.32 68.32 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.329 2.019 . . . . 0.0 112.258 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.43 7.32 46.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.272 0.629 . . . . 0.0 110.433 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.6 t -76.57 136.41 39.26 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -99.51 126.03 45.38 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.46 59.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.964 0.906 . . . . 0.0 113.018 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.1 mt -93.17 -42.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 120.99 0.424 . . . . 0.0 110.032 -167.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -96.54 -6.15 37.65 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.614 0.766 . . . . 0.0 112.717 -169.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -126.0 -59.26 1.34 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 77' ' ' LEU . 82.8 mt -73.48 -14.41 61.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.183 0.593 . . . . 0.0 111.645 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.99 44.89 90.7 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.494 0.496 . . . . 0.0 113.218 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.87 122.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.409 1.084 . . . . 0.0 108.581 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.12 162.45 25.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.0 p -59.14 -30.78 68.39 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.54 0.736 . . . . 0.0 111.606 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.43 -42.03 92.9 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.564 0.745 . . . . 0.0 111.594 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.27 -28.38 61.18 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.14 0.495 . . . . 0.0 110.104 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -77.12 -20.5 55.54 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.32 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 37' ' ' SER . 94.8 mt -58.87 -50.33 74.41 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.046 0.538 . . . . 0.0 109.794 172.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.67 -39.24 93.33 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 124.266 0.979 . . . . 0.0 110.925 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.85 -46.83 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.713 0.633 . . . . 0.0 109.981 173.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.25 61.65 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.989 0.516 . . . . 0.0 111.519 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.68 -43.82 92.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.864 0.866 . . . . 0.0 110.171 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.06 -32.06 71.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.782 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -64.86 -53.3 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.316 0.646 . . . . 0.0 110.418 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -52.71 -55.42 22.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.348 1.059 . . . . 0.0 111.658 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -69.46 -33.74 73.36 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.475 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.32 8.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.188 0.595 . . . . 0.0 111.765 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG13 ' A' ' 53' ' ' ILE . 92.2 m-85 -81.77 -3.82 54.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.539 0.735 . . . . 0.0 111.378 -175.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.11 70.38 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HG13 ' HB2' ' A' ' 51' ' ' PHE . 2.8 pp -109.13 -173.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.006 0.922 . . . . 0.0 109.494 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -139.63 122.28 16.35 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 166.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.626 HD21 HG12 ' A' ' 84' ' ' ILE . 67.6 mt -72.92 132.84 82.5 Favored Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.86 59.19 4.23 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 121.891 1.727 . . . . 0.0 109.87 166.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.89 -38.82 92.24 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.077 1.351 . . . . 0.0 109.357 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 30.5 mt-10 -56.13 -49.07 74.96 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.304 1.003 . . . . 0.0 109.428 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -68.56 -44.7 73.92 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.456 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -55.4 -46.8 76.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.566 1.146 . . . . 0.0 110.663 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.9 m -68.07 -34.47 76.49 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.378 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 14.3 mm100 -71.11 -38.5 72.34 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.86 -45.85 91.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.037 0.935 . . . . 0.0 110.713 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.1 t -59.12 -52.4 61.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.759 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -71.55 -11.5 60.89 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -95.18 -9.75 32.48 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 118.407 0.549 . . . . 0.0 111.567 175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.95 10.3 86.31 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 114.465 0.546 . . . . 0.0 114.465 -173.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.23 -29.34 68.14 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 117.487 0.643 . . . . 0.0 110.203 170.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.0 168.25 22.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.885 0.874 . . . . 0.0 109.952 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.6 p -95.82 160.73 14.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.616 0.766 . . . . 0.0 109.792 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 p -54.81 -47.42 74.06 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.9 mp0 -42.08 -48.53 4.7 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.262 1.425 . . . . 0.0 113.422 177.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -56.39 -31.32 63.74 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.972 -172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -116.56 -23.6 8.16 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -104.38 1.38 30.12 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.213 0.605 . . . . 0.0 112.381 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' A' ' 78' ' ' LYS . 58.7 t -90.1 124.43 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 171.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.57 HD11 HD11 ' A' ' 33' ' ' LEU . 43.4 mt -60.78 -22.13 63.78 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -161.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 63.8 pttt -76.16 -40.68 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.085 0.402 . . . . 0.0 110.097 172.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -69.9 -43.79 71.04 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.817 0.847 . . . . 0.0 109.689 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 84' ' ' ILE . 66.3 tp -56.82 -53.0 62.83 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.424 1.09 . . . . 0.0 109.907 174.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.24 74.96 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.005 0.816 . . . . 0.0 111.738 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.54 -49.35 60.22 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.041 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -55.11 -43.42 74.02 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.116 0.966 . . . . 0.0 111.191 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.626 HG12 HD21 ' A' ' 55' ' ' LEU . 72.8 mt -63.0 -51.36 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.962 0.905 . . . . 0.0 109.972 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.87 -31.02 72.05 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.627 0.771 . . . . 0.0 111.174 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.44 -31.79 69.1 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.954 0.902 . . . . 0.0 110.63 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.12 -27.2 39.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.429 0.692 . . . . 0.0 111.415 175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.0 t -73.89 -35.55 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -37.79 71.5 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.826 175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.56 67.4 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.667 0.787 . . . . 0.0 111.206 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -78.95 -20.45 49.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.729 0.812 . . . . 0.0 110.074 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.5 -32.74 85.2 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.21 -170.03 1.73 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.756 0.823 . . . . 0.0 108.957 165.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.4 mt 65.36 21.99 11.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.876 0.87 . . . . 0.0 111.261 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -74.84 87.04 2.25 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.742 0.782 . . . . 0.0 111.793 -170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -96.71 33.34 1.87 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.435 1.494 . . . . 0.0 109.761 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 68.52 10.64 7.99 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.869 1.268 . . . . 0.0 112.75 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -74.4 99.15 3.44 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.02 85.59 0.13 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.457 1.103 . . . . 0.0 109.57 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -93.14 104.29 16.49 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.58 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 CA--C 1.559 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.821 -175.836 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttm . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 m 59.87 29.89 19.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.334 1.064 . . . . 0.0 109.53 -173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -69.77 154.93 41.29 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.163 -170.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.4 m -55.63 -50.63 69.68 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 124.159 0.912 . . . . 0.0 112.255 -169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.6 -38.86 92.46 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.49 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -43.0 98.26 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.703 0.401 . . . . 0.0 110.749 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 14.8 mmm180 -58.98 -50.41 74.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.739 1.275 . . . . 0.0 110.221 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 53.9 t -60.72 -41.79 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.208 1.003 . . . . 0.0 111.439 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.63 98.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.008 0.923 . . . . 0.0 110.511 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 m -61.07 -45.6 94.08 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.31 174.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 47' ' ' ILE . 93.0 mt -61.64 -41.53 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.244 1.018 . . . . 0.0 112.345 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 8' ' ' VAL . 90.7 mt -64.82 -42.99 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.155 0.582 . . . . 0.0 109.442 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -47.11 83.64 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.997 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 10' ' ' THR . 10.3 mm-40 -75.96 -29.5 58.31 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.5 m -79.72 -62.23 1.75 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.669 0.271 . . . . 0.0 111.386 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.4 m -105.92 8.96 32.81 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.403 0.681 . . . . 0.0 112.544 -165.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.7 t70 52.5 71.53 0.47 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.582 1.153 . . . . 0.0 111.324 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 HD11 ' A' ' 35' ' ' ILE . 37.2 mm -119.21 136.84 24.68 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.613 1.165 . . . . 0.0 108.581 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.5 114.36 2.1 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.104 1.87 . . . . 0.0 111.053 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 23' ' ' ILE . 3.8 tmt_? -56.7 -35.39 68.45 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.963 1.305 . . . . 0.0 110.76 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.13 -20.66 60.17 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.225 0.61 . . . . 0.0 112.175 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -93.37 5.23 52.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.77 0.428 . . . . 0.0 111.281 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 20' ' ' ARG . 85.6 mt -94.57 100.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 p -100.91 156.81 34.72 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.789 0.835 . . . . 0.0 110.034 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.22 -19.03 65.44 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.401 2.067 . . . . 0.0 112.799 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -85.96 -1.99 57.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.966 0.506 . . . . 0.0 110.825 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 74.6 m -77.37 132.67 38.67 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 123.081 0.552 . . . . 0.0 110.894 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -91.53 124.3 35.59 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.07 -35.43 15.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.175 0.99 . . . . 0.0 113.614 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -101.69 -50.92 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.083 0.553 . . . . 0.0 109.71 -171.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -77.85 -32.78 52.26 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.168 0.987 . . . . 0.0 111.877 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -103.62 -53.59 2.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.058 0.543 . . . . 0.0 111.501 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 77' ' ' LEU . 89.6 mt -79.91 -15.13 57.93 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.422 0.689 . . . . 0.0 112.767 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.03 28.92 73.26 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 113.862 0.305 . . . . 0.0 113.862 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.467 HD11 HG13 ' A' ' 18' ' ' ILE . 77.7 mt -95.96 125.64 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.89 154.58 41.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.144 0.578 . . . . 0.0 109.926 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.9 t -60.05 -33.54 72.18 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 122.789 0.436 . . . . 0.0 111.977 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.53 -43.96 95.63 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.333 0.396 . . . . 0.0 110.436 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.76 0.824 . . . . 0.0 110.475 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -67.61 -34.34 76.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.356 0.663 . . . . 0.0 109.734 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' SER . 86.0 mt -64.12 -40.76 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.45 -42.33 95.94 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.539 0.736 . . . . 0.0 110.345 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.0 mt -63.85 -41.27 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.095 0.558 . . . . 0.0 110.546 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.67 -25.69 38.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.532 0.733 . . . . 0.0 111.159 -168.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -76.7 -35.68 57.72 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.836 0.855 . . . . 0.0 109.469 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.76 85.07 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.51 0.506 . . . . 0.0 110.362 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 11' ' ' ILE . 94.5 mt -68.86 -50.34 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.121 0.968 . . . . 0.0 110.296 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.12 -52.46 20.41 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.286 1.434 . . . . 0.0 110.542 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -68.48 -48.33 64.75 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.6 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -60.47 -44.74 95.59 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -173.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -83.27 -9.05 59.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.616 0.766 . . . . 0.0 112.205 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.46 38.55 95.95 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.032 0.349 . . . . 0.0 113.053 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.4 174.94 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.909 1.283 . . . . 0.0 108.983 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -122.22 106.15 10.87 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 87' ' ' LEU . 89.0 mt -77.53 119.87 79.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.64 69.72 5.94 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.551 2.167 . . . . 0.0 111.825 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.62 -41.64 99.13 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.277 1.031 . . . . 0.0 112.031 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.14 -41.51 96.86 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.989 0.805 . . . . 0.0 109.73 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -68.8 -44.3 73.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.516 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -57.28 -40.91 78.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.553 0.741 . . . . 0.0 110.67 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.5 m -70.33 -43.11 70.94 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.299 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -71.04 -30.99 67.32 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' LYS . 45.4 mt-10 -64.84 -47.11 79.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 110.695 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -56.93 -59.58 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.758 0.661 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -66.6 -23.7 66.22 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.39 -5.07 52.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.147 0.431 . . . . 0.0 111.635 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.96 8.46 84.88 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 63' ' ' GLU . 98.0 mttt -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 117.314 0.557 . . . . 0.0 110.715 172.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.37 162.95 34.09 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.71 1.204 . . . . 0.0 109.071 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.5 p -90.24 164.6 14.34 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.265 0.626 . . . . 0.0 110.104 175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 p -61.37 -59.27 5.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.42 0.688 . . . . 0.0 109.691 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -53.8 -27.41 29.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.131 1.373 . . . . 0.0 114.287 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HA ' HD22 ' A' ' 79' ' ' ASN . 20.2 tt0 -57.91 -29.26 64.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.882 0.473 . . . . 0.0 111.918 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.77 -25.58 5.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.316 0.647 . . . . 0.0 112.381 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -94.28 -7.85 40.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -88.82 130.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD11 HD11 ' A' ' 33' ' ' LEU . 57.6 mt -65.19 -22.7 66.94 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -165.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.11 -36.92 55.18 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.761 0.709 . . . . 0.0 109.895 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.5 m-20 -70.67 -43.5 68.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.342 1.057 . . . . 0.0 109.862 176.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.19 -54.78 24.36 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 125.22 1.408 . . . . 0.0 109.171 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -70.53 -19.6 62.89 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 123.891 0.744 . . . . 0.0 110.627 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.67 -37.93 67.78 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.699 0.227 . . . . 0.0 110.666 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -39.22 82.09 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 81' ' ' ALA . 43.3 mt -68.62 -47.42 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.663 0.785 . . . . 0.0 109.041 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.35 -42.14 77.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.423 1.089 . . . . 0.0 111.168 176.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.52 -39.43 91.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.968 1.307 . . . . 0.0 111.392 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 55' ' ' LEU . 88.8 mt -79.21 -23.45 43.79 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.786 0.434 . . . . 0.0 111.543 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 84' ' ' ILE . 97.1 t -79.55 -25.92 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.45 -37.78 65.72 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.756 0.822 . . . . 0.0 109.986 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.39 67.45 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.28 0.632 . . . . 0.0 110.146 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -81.67 -22.61 37.38 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.834 0.854 . . . . 0.0 108.732 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.99 -18.96 75.98 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.634 0.635 . . . . 0.0 111.796 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.61 14.51 3.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.782 0.833 . . . . 0.0 111.699 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.5 mt -110.69 140.43 45.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.44 1.096 . . . . 0.0 108.068 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.0 92.14 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.288 0.635 . . . . 0.0 111.053 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -118.07 -46.83 2.61 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.912 0.885 . . . . 0.0 110.501 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.0 m80 68.09 119.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 111.215 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.92 91.17 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.554 0.741 . . . . 0.0 109.43 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -58.35 151.86 18.82 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.322 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -54.57 132.32 44.78 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.215 0.947 . . . . 0.0 111.566 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.476 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . 0.506 ' O25' H302 ' A' ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.451 HG21 HH21 ' A' ' 7' ' ' ARG . 44.9 p -101.07 100.07 10.6 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 111.063 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 m -81.68 170.62 15.57 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.7 m -61.96 -37.27 84.13 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -55.82 -51.04 68.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.841 0.856 . . . . 0.0 111.467 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -59.55 -41.71 90.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.617 . . . . 0.0 111.793 -174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 2' ' ' THR . 9.1 mmt180 -67.74 -43.19 80.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.29 0.994 . . . . 0.0 111.427 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -61.35 -40.98 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -64.1 -43.2 96.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.735 1.214 . . . . 0.0 111.101 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 50.6 m -63.51 -44.26 94.79 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.453 175.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.48 -44.9 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.577 . . . . 0.0 110.407 177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HD13 ' A' ' 43' ' ' ILE . 30.0 mt -65.83 -42.5 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.467 0.707 . . . . 0.0 110.535 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.28 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.852 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 10' ' ' THR . 9.4 mm-40 -74.17 -27.11 60.67 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.97 0.508 . . . . 0.0 112.368 -176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -82.4 -54.25 5.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.814 0.445 . . . . 0.0 112.123 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 43' ' ' ILE . 77.2 m -115.11 11.42 16.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.194 0.598 . . . . 0.0 112.095 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t70 57.94 51.14 9.33 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.946 0.879 . . . . 0.0 110.837 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG13 HD11 ' A' ' 35' ' ' ILE . 31.6 mm -99.25 121.92 53.77 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.47 128.8 28.52 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.756 2.304 . . . . 0.0 111.953 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -60.35 -25.75 66.07 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.171 0.589 . . . . 0.0 112.111 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.61 -31.47 72.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.333 0.653 . . . . 0.0 111.662 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -88.99 -11.12 45.17 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.015 0.526 . . . . 0.0 110.723 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 9' ' ' ALA . 74.2 mt -88.04 114.01 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 124.015 0.926 . . . . 0.0 109.679 177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.0 p -132.43 161.71 61.46 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.964 1.306 . . . . 0.0 108.664 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.14 -38.29 40.31 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.85 2.367 . . . . 0.0 113.735 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -92.25 10.97 27.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.997 0.519 . . . . 0.0 111.45 -175.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -75.29 130.49 39.17 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -86.69 116.16 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 172.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.87 -39.16 24.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.805 0.842 . . . . 0.0 112.741 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.5 mt -93.53 -42.02 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 122.156 -0.34 . . . . 0.0 110.762 -170.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -89.98 -42.64 11.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.502 0.721 . . . . 0.0 111.972 -172.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.13 -50.74 5.97 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.219 0.608 . . . . 0.0 110.728 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 77' ' ' LEU . 71.6 mt -82.93 -10.54 58.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.254 0.622 . . . . 0.0 111.663 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.39 33.39 84.71 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.504 0.503 . . . . 0.0 114.344 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD11 HG13 ' A' ' 18' ' ' ILE . 55.0 mt -96.35 114.8 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.35 -172.99 3.83 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.248 -0.282 . . . . 0.0 110.923 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 34.9 t -49.24 -69.51 0.11 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.91 1.284 . . . . 0.0 113.714 -169.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.86 -37.85 71.9 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.865 0.866 . . . . 0.0 111.653 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 43' ' ' ILE . 6.2 m-20 -64.97 -43.68 91.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.411 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -78.07 -28.81 48.89 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.837 0.455 . . . . 0.0 110.981 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 37' ' ' SER . 99.2 mt -62.06 -42.76 99.53 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.41 -39.47 89.0 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.527 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.578 HD13 HG12 ' A' ' 12' ' ' ILE . 57.9 mt -63.42 -39.91 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.968 0.507 . . . . 0.0 110.48 173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.33 66.21 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.124 0.569 . . . . 0.0 110.318 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -71.53 -33.69 69.4 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.39 0.676 . . . . 0.0 110.269 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.12 76.94 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.0 mt -74.59 -41.88 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.699 0.799 . . . . 0.0 110.649 176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.28 -45.38 68.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.967 1.307 . . . . 0.0 110.444 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -80.27 -38.55 30.66 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.615 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.81 -60.06 3.99 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.564 0.746 . . . . 0.0 112.761 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -83.37 -5.52 59.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.285 0.634 . . . . 0.0 111.807 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.13 36.58 93.43 Favored Glycine 0 C--N 1.353 1.526 0 C-N-CA 122.814 0.245 . . . . 0.0 113.532 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.24 151.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.755 0.822 . . . . 0.0 110.694 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.35 103.16 15.81 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' ILE . 95.1 mt -70.99 121.99 85.69 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 171.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 91.1 Cg_endo -78.93 57.5 6.47 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.104 1.869 . . . . 0.0 110.446 167.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -63.15 -44.46 95.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.91 1.284 . . . . 0.0 109.269 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.17 -36.22 82.52 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.484 0.714 . . . . 0.0 110.73 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HE3' ' HB2' ' A' ' 56' ' ' PRO . 25.9 ttpp -62.69 -47.3 84.23 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.425 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.3 m0 -57.95 -40.05 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 124.041 0.838 . . . . 0.0 110.45 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -63.98 -38.78 92.34 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.089 0.868 . . . . 0.0 110.287 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.452 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -73.97 -34.83 64.4 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.049 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.11 -44.97 82.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.369 0.668 . . . . 0.0 110.835 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 60' ' ' TRP . 53.3 t -57.52 -55.38 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.618 0.767 . . . . 0.0 110.742 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.84 -28.6 65.82 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.78 -6.47 59.09 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.253 0.479 . . . . 0.0 111.454 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.01 7.05 86.58 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.472 -0.626 . . . . 0.0 114.313 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -63.82 -30.73 71.79 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.464 0.65 . . . . 0.0 109.716 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.67 171.31 15.32 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.301 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 p -106.38 170.19 8.07 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.645 0.778 . . . . 0.0 109.532 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.8 p -57.89 -59.62 4.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.157 0.583 . . . . 0.0 111.181 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -26.49 38.53 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -51.11 -35.17 33.96 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.0 0.92 . . . . 0.0 112.285 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -119.04 -30.13 5.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.17 0.588 . . . . 0.0 111.744 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -99.67 12.53 36.32 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.811 0.445 . . . . 0.0 111.95 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.6 t -95.97 134.04 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 164.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.613 HD11 HD11 ' A' ' 33' ' ' LEU . 33.3 mt -54.79 -38.66 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -168.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.402 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.2 pttp -73.54 -34.18 65.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.744 0.247 . . . . 0.0 111.084 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.53 -43.24 69.98 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.84 0.856 . . . . 0.0 110.073 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.96 -46.19 91.72 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.859 1.264 . . . . 0.0 109.522 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.54 81.04 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.633 0.773 . . . . 0.0 111.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.09 89.62 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.216 0.606 . . . . 0.0 110.862 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.96 -41.44 91.21 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 0.0 112.065 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.522 HG12 HD21 ' A' ' 55' ' ' LEU . 59.2 mt -65.68 -46.77 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.777 0.673 . . . . 0.0 109.917 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.62 -34.31 77.56 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.968 0.907 . . . . 0.0 111.174 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.44 -41.08 98.47 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.364 1.066 . . . . 0.0 110.527 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.47 -31.84 67.61 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.674 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 84' ' ' ILE . 69.0 t -71.61 -33.18 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.03 74.43 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.56 74.26 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.58 0.752 . . . . 0.0 111.618 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.08 -39.75 90.29 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.22 18.06 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' HG2' ' A' ' 95' ' ' GLU . . . -135.72 2.43 2.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.476 0.71 . . . . 0.0 111.403 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt 57.18 41.45 27.02 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.524 1.13 . . . . 0.0 110.817 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 93' ' ' ALA . 45.8 mm-40 -73.67 110.05 7.65 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.748 -178.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -74.57 88.87 2.18 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -64.51 -21.31 66.64 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.23 1.012 . . . . 0.0 112.429 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -86.52 64.72 8.68 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -168.27 82.76 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.931 0.892 . . . . 0.0 108.925 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -94.43 136.99 34.1 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.887 0.875 . . . . 0.0 109.326 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 17.2 p80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 117.767 -1.111 . . . . 0.0 109.202 173.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_